<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Cell Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Cell. Biol</journal-id>
<journal-id journal-id-type="hwp">mcb</journal-id>
<journal-id journal-id-type="pmc">mcb</journal-id>
<journal-id journal-id-type="publisher-id">MCB</journal-id>
<journal-title-group>
<journal-title>Molecular and Cellular Biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-7306</issn>
<issn pub-type="epub">1098-5549</issn>
<publisher>
<publisher-name>American Society for Microbiology</publisher-name>
<publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26755558</article-id>
<article-id pub-id-type="pmc">4800790</article-id>
<article-id pub-id-type="publisher-id">00652-15</article-id>
<article-id pub-id-type="doi">10.1128/MCB.00652-15</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Minireview</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Different Facets of Copy Number Changes: Permanent, Transient, and Adaptive</article-title>
<alt-title alt-title-type="running-head">Minireview</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mishra</surname>
<given-names>Sweta</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Whetstine</surname>
<given-names>Johnathan R.</given-names>
</name>
</contrib>
<aff>Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Charlestown, Massachusetts, USA</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Address correspondence to Johnathan R. Whetstine, <email>jwhetstine@hms.harvard.edu</email>.</corresp>
<fn fn-type="other">
<p><bold>Citation</bold> Mishra S, Whetstine JR. 2016. Different facets of copy number changes: permanent, transient, and adaptive. Mol Cell Biol 36:1050–1063. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/MCB.00652-15">10.1128/MCB.00652-15</ext-link>.</p>
</fn>
</author-notes>
<pub-date pub-type="epreprint">
<day>11</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<day>1</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>18</day>
<month>3</month>
<year>2016</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
<volume>36</volume>
<issue>7</issue>
<fpage>1050</fpage>
<lpage>1063</lpage>
<permissions>
<copyright-statement>Copyright © 2016 Mishra and Whetstine</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Mishra and Whetstine</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="zmb00716001050.pdf"></self-uri>
<abstract>
<p>Chromosomal copy number changes are frequently associated with harmful consequences and are thought of as an underlying mechanism for the development of diseases. However, changes in copy number are observed during development and occur during normal biological processes. In this review, we highlight the causes and consequences of copy number changes in normal physiologic processes as well as cover their associations with cancer and acquired drug resistance. We discuss the permanent and transient nature of copy number gains and relate these observations to a new mechanism driving transient site-specific copy gains (TSSGs). Finally, we discuss implications of TSSGs in generating intratumoral heterogeneity and tumor evolution and how TSSGs can influence the therapeutic response in cancer.</p>
</abstract>
<funding-group>
<award-group id="award1">
<funding-source id="gs1">HHS | National Institutes of Health (NIH)
<named-content content-type="funder-id">http://dx.doi.org/10.13039/100000002</named-content></funding-source>
<award-id rid="gs1">GM097360</award-id>
<award-id rid="gs1">CA059267</award-id>
<principal-award-recipient>Johnathan R. Whetstine</principal-award-recipient>
</award-group>
<award-group id="award2">
<funding-source id="gs2">American Cancer Society (ACS)
<named-content content-type="funder-id">http://dx.doi.org/10.13039/100000048</named-content></funding-source>
<award-id rid="gs2">RSG-13-115-01-CCG</award-id>
<principal-award-recipient>Johnathan R. Whetstine</principal-award-recipient>
</award-group>
<funding-statement>Additional support to Johnathan R. Whetstine and Sweeta Mishra was provided by the American Lung Association, the Alex Lemonade Stand Foundation, and the Leukemia and Lymphoma Society.</funding-statement>
</funding-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="191"></ref-count>
<page-count count="14"></page-count>
<word-count count="14155"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="sec1" sec-type="intro">
<title>INTRODUCTION</title>
<p>It was long thought that the DNA sequences of healthy individuals were 99.9% identical to each other (<xref ref-type="bibr" rid="B1">1</xref>). However, genome-wide sequencing efforts in individuals from multiple ethnicities have revealed more variations in the genetic architecture than were previously appreciated (<xref ref-type="bibr" rid="B2">2</xref><xref ref-type="bibr" rid="B3">–</xref><xref ref-type="bibr" rid="B4">4</xref>).</p>
<p>These genomic alterations have been termed structural variants, which are further classified as microscopic or submicroscopic, depending on the amount of DNA involved (<xref ref-type="bibr" rid="B5">5</xref>). The microscopic variations have historically been identified through chromosome banding techniques (<xref ref-type="bibr" rid="B6">6</xref>) and comprise at least 500 kb of DNA (<xref ref-type="bibr" rid="B7">7</xref>). Examples of these variants are whole-chromosome gain or loss (referred to as aneuploidy [<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>]), translocation (change in location of a chromosomal segment [<xref ref-type="bibr" rid="B9">9</xref>]), deletion (deletion of a DNA segment relative to the rest of the chromosome [<xref ref-type="bibr" rid="B10">10</xref>]), duplication (a chromosomal segment occurs in two or more copies per haploid genome [<xref ref-type="bibr" rid="B11">11</xref>]), and inversion (reversal in orientation of a DNA segment compared to the rest of the chromosome [<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>]). A schematic of structural variants resulting in copy number changes is shown in <xref ref-type="fig" rid="F1">Fig. 1</xref>. With the development of more sophisticated tools, such as array-based comparative genomic hybridization (GGH) arrays (<xref ref-type="bibr" rid="B14">14</xref><xref ref-type="bibr" rid="B15">–</xref><xref ref-type="bibr" rid="B16">16</xref>), smaller variants (submicroscopic alterations) in the size range of 1 to 500 kb can be detected (<xref ref-type="bibr" rid="B5">5</xref>). Genome sequencing has further revealed small insertions and deletions (indels) spanning from 1 to 10,000 bp across the human genome which could cause considerable variability in the human population (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>).</p>
<fig id="F1" orientation="portrait" position="float">
<label>FIG 1</label>
<caption>
<p>Types of copy number changes. (A) Representative examples of structural chromosomal alterations are shown, with a new sequence insertion (D), deletion of region AB, and duplication of sequence B (ABB). The reference chromosome is shown at the top. (B) Aneuploidy with whole chromosome gain (the extra black chromosome) and loss (of black chromosome) are depicted with respect to a normal mitotic reference nucleus. (C) A part of a chromosome (black) can be amplified or deleted (black), giving rise to segmental aneuploidy. This is demonstrated here as involving rearrangement of only one chromosome. A more likely scenario is an unbalanced translocation, which is not shown in the figure. (D) Homogenously staining regions (HSR) and double minutes (DMs) are chromosomal structures that are generated as a consequence of gene amplification. HSRs are repeated units clustered at a single chromosomal locus (red), and DMs are unstable circular extrachromosomal DNA structures lacking a centromere or a telomere. In addition to these structures, amplicons can be present at a number of loci in the genome (not shown).</p>
</caption>
<graphic xlink:href="zmb9991011690001"></graphic>
</fig>
<p>The most common variant identified under submicroscopic alterations is copy number variation (CNV). CNV is defined as a genomic segment of more than 1 kb present at a variable copy number in comparison to a reference genome (<xref ref-type="bibr" rid="B19">19</xref><xref ref-type="bibr" rid="B20">–</xref><xref ref-type="bibr" rid="B22">22</xref>). The first studies documenting the genome-wide presence of CNVs in the normal human genome came from work in the laboratories of Lee (<xref ref-type="bibr" rid="B23">23</xref>) and Wigler (<xref ref-type="bibr" rid="B24">24</xref>). These studies described more than 200 large-scale CNVs (LCVs; about 100 kb or greater) in normal individuals. These studies also paved the way for the creation of the Database of Genomic Variants (DGV) in 2004, which catalogs all the human CNVs and structural variations present in healthy individuals.</p>
<p>The sequencing efforts from the International HapMap Consortium (<xref ref-type="bibr" rid="B25">25</xref>) and 1000 Genomes Project (<xref ref-type="bibr" rid="B26">26</xref>) have led to the identification and frequency determinations of novel CNVs in the human genome. CNVs are now known to contribute to 4.8% to 9.5% of the variability in the human genome (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>), which is more than what is accounted for by single nucleotide polymorphisms (SNPs; accounting for 0.1% of the variations) (<xref ref-type="bibr" rid="B29">29</xref>). Recently, the CNV map for the human genome was constructed (<xref ref-type="bibr" rid="B28">28</xref>), and it documented all the small- and large-scale CNVs present in normal healthy individuals. CNVs can either have no phenotypic consequences in individuals (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>) or lead to adaptive benefits that have been observed in a wide range of species (<xref ref-type="bibr" rid="B5">5</xref>).</p>
<p>One of the major challenges in the field is to distinguish benign CNVs (events that do not lead to phenotypic consequences) from pathogenic CNVs that underlie diseases (<xref ref-type="bibr" rid="B30">30</xref>). Pathogenic CNVs are often associated with deleterious consequences because of an imbalance in gene dosage (<xref ref-type="bibr" rid="B31">31</xref>) and/or aberrant chromosomal structure (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). Pathogenic CNVs have been associated with several disorders, including the following: obesity (<xref ref-type="bibr" rid="B34">34</xref>), diabetes (<xref ref-type="bibr" rid="B35">35</xref>), developmental disorders (<xref ref-type="bibr" rid="B36">36</xref>), psychiatric diseases (<xref ref-type="bibr" rid="B37">37</xref>) such as autism spectrum disorder (<xref ref-type="bibr" rid="B38">38</xref>), schizophrenia (<xref ref-type="bibr" rid="B39">39</xref>), and Alzheimer's disease (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>), and cancer (<xref ref-type="bibr" rid="B42">42</xref><xref ref-type="bibr" rid="B43">–</xref><xref ref-type="bibr" rid="B44">44</xref>). In this review, we focus mainly on copy number alterations observed in cancer and their functional implications.</p>
<p>CNVs can either be present in the germ line or can arise in phenotypically normal tissues and organs, which are referred to as somatic CNVs (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>). Instead of being randomly present in the genome, CNVs are preferentially found to occur in regions that are rich in low-copy-number repeats (segmental duplications) (<xref ref-type="bibr" rid="B47">47</xref><xref ref-type="bibr" rid="B48">–</xref><xref ref-type="bibr" rid="B50">50</xref>), heterochromatic areas (e.g., telomeres and centromeres), and replication origins and palindromic regions (<xref ref-type="bibr" rid="B28">28</xref>). There are several proposed mechanisms that underlie the generation of somatic CNVs: nonallelic homologous recombination (NAHR), nonhomologous end joining (NHEJ), defects in DNA replication, and DNA damage response and repair pathways. These mechanisms have been extensively discussed elsewhere; therefore, we refer our readers to several reviews (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B51">51</xref>).</p>
<p>In this review, we explore the relationship between copy number changes and biological consequences, with a particular focus on development and tissue homeostasis under physiological as well as pathological conditions. This review focuses on these relationships, especially in the context of cancer. We further discuss a recently discovered process driving transient site-specific copy number gains (TSSGs) in cancer cells and its implications during adaptive responses such as stress and chemotherapeutic sensitivity.</p>
</sec>
<sec id="sec2">
<title>COPY NUMBER CHANGES IN DEVELOPMENT AND PHYSIOLOGY</title>
<p>Chromosomal copy number changes and the associated gene amplifications and losses are observed during development in both lower and higher eukaryotes [reviewed in reference <xref ref-type="bibr" rid="B7">7</xref>]. The appearance of CNVs during normal biology suggests that copy number changes can have important functional consequences. A common hypothesis is that increased gene dosages during development provide an advantage during selective pressures and environmental conditions (<xref ref-type="bibr" rid="B7">7</xref>). Here, we discuss examples from developmental biology and their relationships to functional impact. We also highlight the relationship between somatic CNVs and tissue homeostasis.</p>
<p>Several lower and higher eukaryotes use gene amplification to respond to cellular signals (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Electron microscopy studies in the early 1970s demonstrated that ribosomal genes are amplified for the production of large amounts of ribosomes required during early embryogenesis (<xref ref-type="bibr" rid="B52">52</xref>). Ribosomal DNA (rDNA) amplifications were observed during oocyte formation in amphibians such as <named-content content-type="genus-species">Xenopus leavis</named-content> (<xref ref-type="bibr" rid="B53">53</xref><xref ref-type="bibr" rid="B54">–</xref><xref ref-type="bibr" rid="B55">55</xref>), insects such as water beetles (<xref ref-type="bibr" rid="B56">56</xref>), molluscs (<xref ref-type="bibr" rid="B55">55</xref>), and in the macronuclear rDNA of <named-content content-type="genus-species">Paramecium</named-content> (<xref ref-type="bibr" rid="B57">57</xref>) and <named-content content-type="genus-species">Tetrahymena</named-content> (<xref ref-type="bibr" rid="B58">58</xref>). Thus, such an increase in rDNA synthesis to meet higher protein synthesis demands in different tissues highlights gene amplification as a common principle in developmental biology.</p>
<fig id="F2" orientation="portrait" position="float">
<label>FIG 2</label>
<caption>
<p>Copy number changes during normal development and physiological conditions. Representative copy number changes are shown for organisms and specific tissues under different developmental and physiological conditions. Please refer to text for detailed descriptions and corresponding references.</p>
</caption>
<graphic xlink:href="zmb9991011690002"></graphic>
</fig>
<p>Besides rDNA, specific chromosomal regions identified as “DNA puffs” are amplified and expressed to form structural proteins required for cocoon formation in the salivary gland of sciarid flies (<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>). Amplification of the DNA puffs occurs in response to the hormone ecdysone, which is required during larval development (<xref ref-type="bibr" rid="B60">60</xref>). Another example of gene amplification triggered by developmental signals can be observed during eggshell formation in <named-content content-type="genus-species">Drosophila melanogaster</named-content> (<xref ref-type="bibr" rid="B61">61</xref>). Eggshells require amplification of chorion genes in the follicle cells of the ovary, and these genes are expressed late in differentiation (<xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B62">62</xref>). The amplifications of only specific chromosomal regions and genes and not the whole genome highlight the specific response that can occur across organisms. These examples suggest the ability of cellular cues to trigger these site-specific amplifications, which raises the question about what molecular mechanisms underpin this selective amplification across species.</p>
<p>Examples of copy number variations have been reported in various tissues in mammals. Using techniques such as spectral karyotyping (SKY), fluorescence <italic>in situ</italic> hybdridization (FISH), and single-cell sequencing approaches, various groups have reported both small- and large-scale changes in chromosomal copy numbers in mouse and human tissues, particularly in neurons, liver cells, and skin fibroblasts (<xref ref-type="fig" rid="F2">Fig. 2</xref>). For example, approximately 33% of the neuroblasts in the embryonic mouse brain and 20% of neurons in the adult mouse cerebral cortex showed aneuploidy (<xref ref-type="bibr" rid="B63">63</xref>). The reduction in aneuploidy in the adult brain was hypothesized to be due to a neuroblast programmed cell death mechanism during brain development (<xref ref-type="bibr" rid="B64">64</xref>). Westra and colleagues also uncovered that 15 to 20% of neural progenitor cells in both mouse and human cerebella exhibited aneuploidy (<xref ref-type="bibr" rid="B65">65</xref>) (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p>
<p>Additionally, high levels of subchromosomal CNVs (deletion and duplication events) were observed in the human frontal cortex neurons. Multiple copy number changes were noted within a small set of neurons, suggesting that CNVs might be restricted to either individual cells or specific neural lineages (<xref ref-type="bibr" rid="B66">66</xref>). These data suggest that the generation of copy number changes is an important process for achieving diversity in the neuronal populations during central nervous system development. However, this possibility has yet to be proven. It was reported that the transcripts arising from CNVs in the mouse brain are more tightly regulated than are other tissues such as lung, liver, heart, kidney, and testis (<xref ref-type="bibr" rid="B67">67</xref>). It would be important to determine the rate of correlation between CNVs and expression changes in the human brain and whether there are underlying functional consequences of the affected transcripts in generating neural diversity and plasticity.</p>
<p>Somatic CNVs are also observed in mammalian hepatocytes and skin. A study by Duncan and colleagues suggested that approximately 50% of normal adult hepatocytes have changes in chromosomal numbers (gains or losses) such that genetically diverse sets of cells are present in the liver (<xref ref-type="bibr" rid="B68">68</xref>, <xref ref-type="bibr" rid="B69">69</xref>). However, single-cell next-generation sequencing has reported a lower level of aneuploidy (&lt;5%) in cells of liver, skin, and human neurons (<xref ref-type="bibr" rid="B70">70</xref>). The differences in the reported levels of aneuploidies could reflect the different types of assays employed to follow copy number changes (i.e., FISH and SKY versus single-cell sequencing, respectively).</p>
<p>The genetic variation resulting from the changes in copy number could be a mechanism employed during tissue development in order to achieve diversity in cell populations. Copy number variations may allow developing tissues to adapt to cellular and growth requirements during tissue expansion and organ development. Another advantage for the observed CNVs could be to adapt to encountered metabolic or toxic challenges, especially by hepatocytes (see the discussion in “Mammals,” below). By identifying the regulatory features for regions undergoing CNV and the affected genes in different tissues, we would be able to understand tissue-specific gene expression and underlying diversity within tissues.</p>
</sec>
<sec id="sec3">
<title>COPY NUMBER CHANGES AS AN ADAPTIVE RESPONSE</title>
<p>Many studies in bacteria, yeast, and mammals have shown that copy number changes can arise as a consequence of selection, which may allow cells to exhibit an increased fitness and/or survival advantage. In this section, we discuss the relationship between different cellular conditions and the emergence of CNVs from different species (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p>
<sec id="sec3-1">
<title>Bacteria.</title>
<p>Acquisition of antibiotic resistance can occur through the uptake of foreign DNA harboring resistance genes through the bacterial competence pathway (<xref ref-type="bibr" rid="B71">71</xref>). A recent study by Slager et al. demonstrated that different species of bacteria could increase the copy number of genes involved in the competence pathway (<italic>com</italic> genes) in response to antibiotics causing replication stress (<xref ref-type="bibr" rid="B72">72</xref>). These genes are located closer to the origin of replication (OriC), and their amplification occurs through multiple origin firing events at the OriC, which increases their copy number and transcription rates. In <named-content content-type="genus-species">Salmonella enterica</named-content> serovar Typhimurium, gene amplification aids in the development of antibiotic resistance. Adaptation to the antibiotic cephalosporin occurred through amplification and increased gene dosage/expression of the β-lactamase gene (<italic>bla</italic><sub>TEM-1</sub> [<xref ref-type="bibr" rid="B73">73</xref>]). The enzyme β-lactamase results in the hydrolysis of cephalosporin (<xref ref-type="bibr" rid="B74">74</xref>, <xref ref-type="bibr" rid="B75">75</xref>), which results in a reduced drug response.</p>
<p>These highlighted examples illustrate the impact selective pressure can have on DNA amplification and gene expression in bacteria (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Additional examples have been observed and are discussed in a review by Sandegren et al. (<xref ref-type="bibr" rid="B76">76</xref>). Taken together, the existing data illustrate the relationship between input signals and changes at distinct regions of the bacterial genome. In the future, it will be interesting to know if this selection is based on fitness or the result of targeted DNA replication in prokaryotes.</p>
</sec>
<sec id="sec3-2">
<title>Yeast.</title>
<p>Similar to bacteria, yeasts also exhibit changes in DNA content based on selective pressure. For example, gene rearrangements and copy number changes have been observed in <named-content content-type="genus-species">Candida albicans</named-content> when it is passaged through a murine host (<xref ref-type="bibr" rid="B77">77</xref>). It has been hypothesized that these changes in ploidy could generate the genetic and phenotypic diversity required for adaptation in the new host environment. Consistent with these observations, CNV has been associated with antifungal drug resistance and adaptive benefits (<xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B79">79</xref>). For example, fluconazole treatment for <named-content content-type="genus-species">C. albicans</named-content> infection results in the development of whole-chromosome gains and aneuploidy (<xref ref-type="bibr" rid="B80">80</xref>). Upon CGH analyses for the copy number changes in 70 azole-resistant and -sensitive strains, Selmecki et al. found increased levels of aneuploidy in resistant strains (50%) compared to the sensitive ones (7.14%) (<xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B82">82</xref>). Trisomies of chromosome 5, including a segmental aneuploidy consisting of an isochromosome (formed by the attachment of two left arms of chromosome 5 around a single centromere), were also associated with azole resistance. Gains of this isochromosome were associated with increased expression of genes involved in drug resistance (<xref ref-type="bibr" rid="B82">82</xref>). Some of these genes encoded efflux pump proteins involved in resistance: an ATP-binding cassette (ABC) transporter and a multidrug resistance transporter (<xref ref-type="bibr" rid="B83">83</xref>). Other genes were <italic>ERG11</italic> (a target of fluconazole [<xref ref-type="bibr" rid="B84">84</xref>]) and <italic>TAC1</italic> (a transcription factor that upregulates ABC gene expression [<xref ref-type="bibr" rid="B82">82</xref>]). There is a need to identify other structural variations and affected genes conferring a survival/adaptive advantage against antibiotics and whether these changes are conserved across other fungal species.</p>
<p>Consistent with gene amplification conferring a selective advantage, <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content> cells exposed to nutrient deprivation exhibited gene amplifications that provided a cellular benefit (<xref ref-type="bibr" rid="B85">85</xref>). For example, glucose limitation in cultures resulted in the amplification of genes encoding glucose transporters (<italic>HXT6</italic> and <italic>HXT7</italic>), while sulfate limitation resulted in the amplification of <italic>SUL1</italic>, a gene that encodes a high-affinity sulfate transporter (<xref ref-type="fig" rid="F2">Fig. 2</xref>). The question remains as to whether these physiological input signals are able to drive selective DNA gains through a hard-wired mechanism, as observed in mammalian cells (discussed in “TSSGs, Tumor Heterogeneity, and Cancer Evolution,” below), or are the result of random selection. Resolution of this issue could have a profound impact on our understanding of cellular fitness and responses to antibiotics.</p>
</sec>
<sec id="sec3-3">
<title>Mammals.</title>
<p>Mammals are no exception to selective pressures promoting copy number changes or copy number alterations that impact biological consequences. For example, the copy number of the human salivary amylase gene <italic>AMY1</italic>, which encodes an enzyme that aids in the hydrolysis of starch, is increased in populations that have a higher starch content in their diets compared to low-starch-consuming populations (<xref ref-type="bibr" rid="B86">86</xref>). The increased copy number of <italic>AMY1</italic> also correlated with increased salivary amylase protein levels. This illustrates how diet-induced selective pressures could influence copy number polymorphisms in mammals. Other examples and the role of copy number polymorphisms in human adaptation have been reviewed elsewhere (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B87">87</xref>, <xref ref-type="bibr" rid="B88">88</xref>). While these studies are correlative and suggest that the environment impacts selection, they have yet to be shown to be causal.</p>
<p>Increased or decreased copy numbers of certain genes can predispose an individual to diseases. For example, susceptibility of individuals to HIV/AIDS infection is increased in populations with a decreased copy number of the chemokine gene <italic>CCL3L1</italic>. This chemokine serves as a ligand for HIV coreceptor CCR5, which inhibits viral entry by binding to CCR5. However, HIV-resistant individuals show duplications of the CCL3L1 locus (17q21.1) and increased CCL3L1 copies imparting resistance to HIV infection (<xref ref-type="bibr" rid="B89">89</xref>). Other examples of CNVs promoting susceptibility to diseases can be found with psoriasis (associated with a copy number gain of the <italic>β-defensin</italic> gene [<xref ref-type="bibr" rid="B90">90</xref>, <xref ref-type="bibr" rid="B91">91</xref>]), pancreatitis (a copy number gain of <italic>PRSS1</italic> [<xref ref-type="bibr" rid="B92">92</xref>]), and Crohn's disease (a copy number loss of <italic>HBD-2</italic> [<xref ref-type="bibr" rid="B93">93</xref>]), among others (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B94">94</xref>). The question remains as to whether there are mechanisms that would allow such changes to occur immediately in response to stimuli in the population or whether they reflect some mutation that was selected over time.</p>
<p>Somatic mosaicism for CNVs within tissues can provide an adaptive response as well. CNVs within the liver can provide protection against tissue injury. Duncan et al. demonstrated in a chronic liver injury model that selective gene loss could provide resistance to liver injury (<xref ref-type="bibr" rid="B95">95</xref>). Deficiency of fumaryl acetoacetate hydrolase (encoded by <italic>FAH</italic>; the enzyme is required in tyrosine catabolism) causes a buildup of fatty acids and toxic metabolites that result in liver failure, known as tyrosinemia. Conversely, deletion of the genes encoding enzymes that function upstream of <italic>FAH</italic> (e.g., homogentisic acid dioxygenase [HGD]) is found to be protective for tyrosinemia. Mice deficient for <italic>FAH</italic> and heterozygous for a mutation in <italic>HGD</italic> can generate healthy normal hepatocytes. These injury-resistant, aneuploid hepatocytes (characterized by the loss of chromosome 16) are present in the liver and undergo expansion only when the liver is exposed to injury, demonstrating an adaptive response of cells to metabolic or toxic challenges.</p>
<p>Taken together, these few examples illustrate the CNVs present within populations and individual tissues and how these are associated with phenotypes. These data also emphasize the variations in the genome and how the environment and selective pressures can impact genetics. However, the question remains as to whether these genetic events occur after random selection or are the result of unidentified mechanisms that selectively alter the genetic landscape in response to external stimuli and, in turn, drive targeted <italic>de novo</italic> genetic changes.</p>
</sec>
</sec>
<sec id="sec4">
<title>COPY NUMBER ALTERATIONS IN CANCER AND THEIR IMPLICATIONS IN ACQUIRED DRUG RESISTANCE</title>
<p>Copy number alterations involving whole chromosomes and/or specific chromosomal segments are frequently observed in cancer (<xref ref-type="bibr" rid="B96">96</xref>, <xref ref-type="bibr" rid="B97">97</xref>). Gains/amplifications of oncogenes and loss/deletion of tumor suppressor genes have been historically found to be major drivers of tumor development. For example, amplifications of <italic>EGFR</italic> in gliomas (<xref ref-type="bibr" rid="B98">98</xref>), <italic>MYCN</italic> in neuroblastoma (<xref ref-type="bibr" rid="B99">99</xref>), <italic>MYC</italic> in acute myeloid leukemia (<xref ref-type="bibr" rid="B100">100</xref>), and <italic>ERBB2</italic> in breast (<xref ref-type="bibr" rid="B101">101</xref>), ovarian (<xref ref-type="bibr" rid="B102">102</xref>), and lung cancers (<xref ref-type="bibr" rid="B103">103</xref>) have been reported. Similarly, loss/deletions in tumor suppressor genes such as <italic>PTEN</italic> (<xref ref-type="bibr" rid="B104">104</xref>), <italic>TP53</italic> (<xref ref-type="bibr" rid="B105">105</xref>), and <italic>VHL</italic> (<xref ref-type="bibr" rid="B106">106</xref>) have been observed in a variety of tumors. The dependence of tumors on specific oncogenes for their proliferation and survival is referred to as oncogene addiction (<xref ref-type="bibr" rid="B107">107</xref>). By targeting these oncogenes, tumor cell growth becomes limiting or abrogated. For example, clinical success has been observed with the ERBB2 antibody trastuzumab (Herceptin) in the treatment of <italic>ERBB2</italic>-amplified breast cancer (<xref ref-type="bibr" rid="B108">108</xref>), crizotinib in the treatment of <italic>MET</italic>-amplified non-small cell lung cancer (<xref ref-type="bibr" rid="B109">109</xref>), and the epidermal growth factor receptor (EGFR) inhibitors gefitinib and erlotinib (which blocks the catalytic activity of EGFR) in lung cancer patients with <italic>EGFR</italic> mutations (<xref ref-type="bibr" rid="B110">110</xref>).</p>
<p>In addition to oncogene amplifications, copy number alterations of different chromosomal regions have been observed in cancer. A genome-wide analysis of copy number alterations in cancer demonstrated a total of 76,000 gains and 55,000 losses across the 3,131 cancer samples analyzed (<xref ref-type="bibr" rid="B96">96</xref>). A typical tumor type is comprised of 17% amplifications and 16% deletions, compared to less than 0.5% in normal samples (<xref ref-type="bibr" rid="B96">96</xref>). These data suggest that somatic copy number alterations are a frequent feature in cancer cells. Analyses across 17 tumor types demonstrated that 25% of the genome is affected by whole chromosome alterations and 10% of the genome by short chromosomal changes (focal events) in a typical tumor (<xref ref-type="bibr" rid="B96">96</xref>). Interestingly, the focally amplified regions often harbor known oncogenes (e.g., <italic>MYC</italic>, <italic>CCND1</italic>, <italic>EGFR</italic>, <italic>NKX2-1</italic>, and <italic>KRAS</italic>), while the focally deleted genomic loci contain tumor suppressor genes (<italic>TP53</italic>, <italic>CDKN2A/B</italic>, and <italic>Rb1</italic>). These observations suggest that the selective pressures associated with tumorigenesis might influence targeted amplification or deletion of specific regions within tumor cells instead of occurring randomly, which would be reminiscent of the observations seen in bacteria and yeasts (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p>
<p>Focal amplifications can also harbor oncogenes or prosurvival genes that can influence drug responses. For example, ∼10% of cancers have a focal amplification of chromosome 1q21.2 that contains the antiapoptotic gene <italic>MCL1</italic> (<xref ref-type="bibr" rid="B96">96</xref>). Another focally amplified antiapoptotic gene that is observed in cancer is <italic>BCL2L1</italic> on chromosome 20q11.21 (<xref ref-type="bibr" rid="B96">96</xref>). Both of these genes are important for cell survival; hence, their amplification within tumors could confer a distinct survival advantage. Consistent with this notion, Beroukhim et al. demonstrated that increased expression of these genes protected tumor cells from chemotherapy (<xref ref-type="bibr" rid="B96">96</xref>).</p>
<p>Chromosomal alterations in several distinct regions also influence pathogenesis in different tumor types. For example, in multiple myeloma (MM), disease progression is characterized partly by the focal amplifications of a proximal region of chromosome 1q (chr 1q). Several studies have identified a region of 10 to 15 Mb that corresponds to a chr 1q12-23 amplicon in MM. This region contains a large number of genes with amplifications or deregulated expression involved in myeloma pathogenesis, including <italic>CKS1B</italic> (<xref ref-type="bibr" rid="B111">111</xref>, <xref ref-type="bibr" rid="B112">112</xref>), <italic>MUC1</italic> (<xref ref-type="bibr" rid="B113">113</xref>), <italic>MCL1</italic> (<xref ref-type="bibr" rid="B114">114</xref>), <italic>PDZK1</italic> (<xref ref-type="bibr" rid="B115">115</xref>), <italic>IL-6R</italic> (<xref ref-type="bibr" rid="B116">116</xref>), <italic>BCL9</italic> (<xref ref-type="bibr" rid="B117">117</xref>), and <italic>UBE2Q1</italic> (<xref ref-type="bibr" rid="B118">118</xref>). The amplification of a drug-resistant oncogene, <italic>CKS1B</italic>, and the proximal chr 1q21 region has been reported in ∼40% of newly diagnosed MM cases and in 70% of patients with tumor relapse (<xref ref-type="bibr" rid="B119">119</xref>, <xref ref-type="bibr" rid="B120">120</xref>). The gains observed in <italic>CKS1B</italic> are in the range of one to three copies (<xref ref-type="bibr" rid="B111">111</xref>, <xref ref-type="bibr" rid="B112">112</xref>). These focal amplifications are associated with poor prognosis and reduced response to cisplatin therapy (<xref ref-type="bibr" rid="B111">111</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). Studies in cell cultures have further demonstrated that overexpression of <italic>CKS1B</italic> confers a reduced response to cancer chemotherapeutics (<xref ref-type="bibr" rid="B121">121</xref>). Similarly, amplification of the <italic>PDZK1</italic> gene within the chr 1q12-q22 region has been observed in primary cases of MM, and the overexpression of <italic>PDZK1</italic> in cells conferred resistance to melphalan-, vincristine-, and cisplatin-induced cell deaths (<xref ref-type="bibr" rid="B115">115</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<table-wrap id="T1" orientation="portrait" position="float">
<label>TABLE 1</label>
<caption>
<p>Partial list of amplified genes that impact drug resistance<xref ref-type="table-fn" rid="T1F1"><sup><italic>a</italic></sup></xref></p>
</caption>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
</colgroup>
<thead>
<tr valign="bottom">
<th align="left" colspan="1" rowspan="1">Cancer type</th>
<th align="left" colspan="1" rowspan="1">Therapeutic agent(s)</th>
<th align="left" colspan="1" rowspan="1">Gene(s) implicated in resistance (reference[s])</th>
</tr>
</thead>
<tbody>
<tr valign="top">
<td colspan="1" rowspan="3">Multiple myeloma</td>
<td colspan="1" rowspan="1">Bortezomib, cisplatin</td>
<td colspan="1" rowspan="1"><italic>CKS1B</italic> (<xref ref-type="bibr" rid="B111">111</xref>, <xref ref-type="bibr" rid="B121">121</xref>, <xref ref-type="bibr" rid="B126">126</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Melphalan, cisplatin, vincristine</td>
<td colspan="1" rowspan="1"><italic>PDZK1</italic> (<xref ref-type="bibr" rid="B115">115</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Dexamethasone</td>
<td colspan="1" rowspan="1"><italic>FGFR3</italic> (<xref ref-type="bibr" rid="B127">127</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="2">Ovarian</td>
<td colspan="1" rowspan="1">Cisplatin, CDK2 inhibitors</td>
<td colspan="1" rowspan="1"><italic>CCNE1</italic> (<xref ref-type="bibr" rid="B128">128</xref>, <xref ref-type="bibr" rid="B142">142</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Paclitaxel</td>
<td colspan="1" rowspan="1"><italic>MDR1</italic> (<xref ref-type="bibr" rid="B129">129</xref>, <xref ref-type="bibr" rid="B130">130</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="3">Lung</td>
<td colspan="1" rowspan="1">Gefitinib</td>
<td colspan="1" rowspan="1"><italic>MET</italic> (<xref ref-type="bibr" rid="B123">123</xref>, <xref ref-type="bibr" rid="B125">125</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Paclitaxel</td>
<td colspan="1" rowspan="1"><italic>MDR1</italic> (<xref ref-type="bibr" rid="B129">129</xref>, <xref ref-type="bibr" rid="B130">130</xref>, <xref ref-type="bibr" rid="B131">131</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Crizotinib</td>
<td colspan="1" rowspan="1"><italic>ALK</italic>, <italic>KIT</italic> (<xref ref-type="bibr" rid="B132">132</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Breast</td>
<td colspan="1" rowspan="1">Trastuzumab</td>
<td colspan="1" rowspan="1"><italic>MET</italic> (<xref ref-type="bibr" rid="B133">133</xref>), <italic>IQGAP1</italic> (<xref ref-type="bibr" rid="B134">134</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="2">Colorectal</td>
<td colspan="1" rowspan="1">Gefitinib</td>
<td colspan="1" rowspan="1"><italic>MET</italic> (<xref ref-type="bibr" rid="B124">124</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">5-Fluorouracil</td>
<td colspan="1" rowspan="1"><italic>TMYS</italic> (<xref ref-type="bibr" rid="B135">135</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">CML</td>
<td colspan="1" rowspan="1">Imatinib</td>
<td colspan="1" rowspan="1"><italic>BCR-ABL</italic> (<xref ref-type="bibr" rid="B136">136</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Melanoma</td>
<td colspan="1" rowspan="1">Vemurafinib</td>
<td colspan="1" rowspan="1"><italic>BRAF</italic> (<xref ref-type="bibr" rid="B137">137</xref>, <xref ref-type="bibr" rid="B138">138</xref>), <italic>BCL2A1</italic> (<xref ref-type="bibr" rid="B139">139</xref>)</td>
</tr>
<tr valign="top">
<td colspan="1" rowspan="1">Leukemia</td>
<td colspan="1" rowspan="1">Methotrexate</td>
<td colspan="1" rowspan="1"><italic>DHFR</italic> (<xref ref-type="bibr" rid="B140">140</xref>, <xref ref-type="bibr" rid="B141">141</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn fn-type="other" id="T1F1">
<label>a</label>
<p>We apologize for not being able to cite or include all studies related to gene amplification and drug resistance.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Gene amplifications are associated with drug resistance in several tumors (<xref ref-type="bibr" rid="B122">122</xref><xref ref-type="bibr" rid="B123">–</xref><xref ref-type="bibr" rid="B141">141</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). For example, ovarian cancer patients with a chr 1q12-21 amplification are more resistant to cisplatin treatment (<xref ref-type="bibr" rid="B142">142</xref>, <xref ref-type="bibr" rid="B143">143</xref>). Amplifications of cyclin E1 (CCNE1) are present in 25% of high-grade serous ovarian cancers and are associated with poor survival and impart resistance to CDK2 inhibitors (<xref ref-type="bibr" rid="B144">144</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). In the case of non-small cell lung cancer cells, an 11- to 13-fold-higher copy number of chr 7q21.12 was detected by CGH in an acquired paclitaxel-resistant lung cancer model (study NCI-H460/PTX250) compared with the parental cell line (study NCI-H460). Most of the genes within this region were also highly expressed, including a multidrug transporter gene, <italic>MDR1/ABCB1</italic> (<xref ref-type="bibr" rid="B131">131</xref>). These examples highlight how distinct regions in the genome are focally amplified and relate to altered patient outcome and cancer cell drug responses. Whether selective chromosomal alterations and gene amplifications in cells result from a stochastic process or occur in a directed manner in consequence to therapeutic pressure is yet to be determined.</p>
</sec>
<sec id="sec5">
<title>DNA AMPLIFICATION AND CANCER CHEMOTHERAPEUTIC RESISTANCE</title>
<p>Gene amplification serves as a biochemical basis for drug resistance in mammalian cells. This relationship to resistance was first documented in seminal work by Hakala (<xref ref-type="bibr" rid="B145">145</xref><xref ref-type="bibr" rid="B146">–</xref><xref ref-type="bibr" rid="B147">147</xref>) and Fischer (<xref ref-type="bibr" rid="B148">148</xref>) in the 1950s. They isolated highly resistant tumor cells under the presence of increasing concentrations of the drug methotrexate (MTX). MTX competitively inhibits the enzyme dihydrofolate reductase (DHFR), which catalyzes the conversion of dihydrofolate to active tetrahydrofolate, which is required for the <italic>de novo</italic> synthesis of thymidine. They found that the drug-resistant cells had around 155 times the level of DHFR. They also found that the drug-resistant phenotype was unstable in murine sarcoma 180 cells, which coincided with the reduced DHFR enzymatic activity. Schimke's laboratory further characterized the mechanistic basis for the increased DHFR levels (<xref ref-type="bibr" rid="B149">149</xref>). It was shown that the cells developed resistance to MTX by overproduction of DHFR protein as a result of selective gene amplification (<xref ref-type="bibr" rid="B150">150</xref>). It was from the work of the Biedler and Spengler (<xref ref-type="bibr" rid="B151">151</xref>, <xref ref-type="bibr" rid="B152">152</xref>) and Schimke (<xref ref-type="bibr" rid="B150">150</xref>, <xref ref-type="bibr" rid="B153">153</xref>) laboratories in the 1970s that the presence of cytogenetic structures associated with MTX-resistant cells was demonstrated. They found that gene amplification accounts for the overproduction of DHFR in stable and unstable drug-resistant cells (<xref ref-type="fig" rid="F3">Fig. 3A</xref>).</p>
<fig id="F3" orientation="portrait" position="float">
<label>FIG 3</label>
<caption>
<p>Permanent and transient adaptive changes under different cellular conditions. (A) Methotrexate treatment results in the amplification of the <italic>DHFR</italic> gene (shown in red). DHFR can persist either as a stable structure, such as an HSR, or as an unstable DM that is lost upon subsequent cell division. (B) Continued treatment of glioblastoma cells with a tyrosine kinase inhibitor such as erlotinib results in the loss of EGFR vIII-positive extrachromosomal DNA (red) and its reemergence upon drug removal. (C) Hypoxia or overexpression of histone demethylase KDM4A results in site-specific genome amplification (purple), which is generated every S phase. The amplification is reversible after KDM4 inhibitor treatment or with increased succinate dose. Studies related to these data are discussed in the text.</p>
</caption>
<graphic xlink:href="zmb9991011690003"></graphic>
</fig>
<p>Gene amplification forms two common structures: extrachromosomal double minutes (DMs) and intrachromosomal homogenously staining regions (HSRs). DMs were first observed in lung cancer cells in 1962 (<xref ref-type="bibr" rid="B154">154</xref>). They are defined as chromatin bodies that lack centromeres and telomeres that are not transmitted to 100% of daughter cells during mitosis (<xref ref-type="bibr" rid="B155">155</xref>) (<xref ref-type="fig" rid="F1">Fig. 1D</xref>). HSRs are chromosomal structures containing permanently integrated genes (<xref ref-type="fig" rid="F1">Fig. 1D</xref>). These were first described by Biedler and Spengler in 1976 (<xref ref-type="bibr" rid="B152">152</xref>) in drug-resistant cells. DHFR was found to reside on HSRs in highly methotrexate-resistant CHO cells (<xref ref-type="bibr" rid="B156">156</xref>) and murine leukemia cells (<xref ref-type="bibr" rid="B157">157</xref>). Kauffmann et al. further showed that the amplified <italic>DHFR</italic> genes were associated with DMs in unstable MTX-resistant cells (<xref ref-type="bibr" rid="B158">158</xref>).</p>
<p>A large body of work has contributed to our understanding of the generation of DMs and HSRs (<xref ref-type="bibr" rid="B159">159</xref><xref ref-type="bibr" rid="B160">–</xref><xref ref-type="bibr" rid="B162">162</xref>). For example, Storlazzi et al. investigated the structures of <italic>MYCN</italic> amplifications by using eight neuroblastoma and two small cell carcinoma cell lines (<xref ref-type="bibr" rid="B162">162</xref>). The study provided evidence of generation of HSRs from DMs by an episome model wherein DNA segments were excised from a chromosome and then circularized and amplified to form DMs and chromosomally integrated to form HSRs. DMs are unstable and can be eliminated after drug treatment (<xref ref-type="bibr" rid="B163">163</xref>, <xref ref-type="bibr" rid="B164">164</xref>); however, HSRs are more stable (<xref ref-type="bibr" rid="B165">165</xref>) (<xref ref-type="fig" rid="F1">Fig. 1D</xref> and <xref ref-type="fig" rid="F3">3A</xref>). Amplified genes present on extrachromosomal DNA have been frequently observed in different tumor types (<xref ref-type="bibr" rid="B159">159</xref>, <xref ref-type="bibr" rid="B166">166</xref><xref ref-type="bibr" rid="B167">–</xref><xref ref-type="bibr" rid="B168">168</xref>). The reversion of a malignant phenotype and cellular differentiation by the elimination of DMs has been shown extensively in a variety of tumors and cancer cell lines (<xref ref-type="bibr" rid="B167">167</xref>, <xref ref-type="bibr" rid="B169">169</xref>, <xref ref-type="bibr" rid="B170">170</xref>). Taken together, these observations demonstrate that transient gene amplifications can be an effective strategy for quick adaptation to selective pressures in tumor cells (<xref ref-type="fig" rid="F3">Fig. 3A</xref>).</p>
<p>In a recent study by Nathanson et al., another example of drug-induced transient gene selection was demonstrated (<xref ref-type="fig" rid="F3">Fig. 3B</xref>). In that study, oncogenes maintained on extrachromosomal DNA were transiently gained/lost in response to drug treatment (<xref ref-type="bibr" rid="B171">171</xref>). Glioblastoma patients harbor a constitutively active oncogenic variant of epidermal growth factor receptor (EGFR-vIII) that is formed by the in-frame deletion of exons 2 to 7 in the <italic>EGFR</italic> gene and found on extrachromosomal DNA (<xref ref-type="bibr" rid="B171">171</xref>, <xref ref-type="bibr" rid="B172">172</xref>). The presence of EGFR-vIII makes tumor cells more sensitive to EGFR tyrosine kinase inhibitors (TKIs) (<xref ref-type="bibr" rid="B173">173</xref>). The continued treatment with EGFR TKIs (e.g., erlotinib) resulted in a loss of extrachromosomal EGFR-vIII, thus conferring resistance to the TKI. When the drug was withdrawn for a short period of time, there was an increase in EGFR-vIII on extrachromosomal DNA and, in turn, the cells were resensitized to erlotinib treatment (<xref ref-type="fig" rid="F3">Fig. 3B</xref>). These data reiterate the reversibility of copy number gains and how transient copy number changes could impact chemotherapeutic response.</p>
<p>Furthermore, Nathanson and colleagues have suggested that instead of a continuous therapeutic regimen, a drug holiday during therapy might be a more effective mechanism to restore the sensitivity of tumor cells to drugs (<xref ref-type="bibr" rid="B171">171</xref>). These studies raise the possibility that chemotherapy could result in the selection of cells with gene amplifications, which allow them to survive under this drug-induced stress (<xref ref-type="fig" rid="F3">Fig. 3</xref>). Therefore, understanding the mechanisms that result in transient or nonpermanent amplifications of <italic>DHFR</italic>, <italic>EGFR</italic>, and alike in cancer (<xref ref-type="table" rid="T1">Table 1</xref>) will have a profound impact on how we view copy number control as well as how we identify novel biomarkers and therapeutic targets for treating drug-resistant cancers.</p>
</sec>
<sec id="sec6">
<title>TSSGs, TUMOR HETEROGENEITY, AND CANCER EVOLUTION</title>
<p>There are frequent gains/amplifications observed across cancer genomes, which are often thought to be permanent events (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B160">160</xref>). However, a recent discovery from our laboratory (<xref ref-type="bibr" rid="B174">174</xref>, <xref ref-type="bibr" rid="B175">175</xref>) suggested a possible mechanism for the intratumoral heterogeneity of copy number alterations observed in tumors. This recent discovery could also provide a molecular basis for the emergence of amplified drug resistance genes and enhanced cancer cell survival.</p>
<p>Chromatin modulation plays an important role in replication fidelity (<xref ref-type="bibr" rid="B176">176</xref>, <xref ref-type="bibr" rid="B177">177</xref>). A recent study demonstrated that alterations in chromatin states could modulate copy number gains at distinct regions in the genome (<xref ref-type="bibr" rid="B175">175</xref>). KDM4A/JMJD2A demethylates trimethylated histone H3 lysines 9 and 36 (H3K9/36me3) to a dimethylated state (K3K9/36me2) (<xref ref-type="bibr" rid="B178">178</xref><xref ref-type="bibr" rid="B179">–</xref><xref ref-type="bibr" rid="B182">182</xref>). KDM4A overexpression promoted faster S-phase progression and altered replication timing at specific regions in the genome in a catalytically dependent manner (<xref ref-type="bibr" rid="B175">175</xref>, <xref ref-type="bibr" rid="B183">183</xref>). The regulation of S phase and replication timing were conserved from <named-content content-type="genus-species">Caenorhabditis elegans</named-content> to human cells and were the result of dysregulating specific HP1 members in the genome (HPL-2 in <named-content content-type="genus-species">C. elegans</named-content> and HP1γ in human cells) (<xref ref-type="bibr" rid="B183">183</xref>).</p>
<p>Even though the S phase was faster in mammalian cells, the rate of cell proliferation was the same, which was consistent with the observed slowing into the G<sub>2</sub>/M phase. This delayed G<sub>2</sub>/M was not associated with major genome instability. However, KDM4A overexpression directly generated site-specific copy gains of regions affiliated with drug resistance (e.g., chr 1q21-22) by altering methylation states and heterochromatin association. KDM4A was enriched at these sites and promoted their rereplication. Furthermore, direct H3K9/36me3 interference promoted site-specific copy number gain events. This study demonstrated for the first time that an enzyme has the ability to directly regulate copy number gain at specific regions in the genome and that the chromatin/methylation states play an essential role in the process (<xref ref-type="bibr" rid="B175">175</xref>) (<xref ref-type="fig" rid="F3">Fig. 3C</xref>).</p>
<p>Since the copy number gain regions are not permanent and are only generated and present during S phase, they have been termed transient site-specific copy gains (<xref ref-type="bibr" rid="B174">174</xref>, <xref ref-type="bibr" rid="B175">175</xref>, <xref ref-type="bibr" rid="B184">184</xref>). Currently, we do not know the exact sizes of the rereplicated fragments and whether there are cellular checkpoints/machinery involved in their clearance. In fact, different cells in a population have differentially amplified regions, and certain regions are mutually exclusive. Furthermore, the rate that these fragments are removed as cells move through S phase is different (<xref ref-type="bibr" rid="B174">174</xref>). It is important to determine the molecular features (e.g., presence of repetitive elements, insulators, and other regulatory machinery) at and surrounding the rereplicated and regions that gain copies. These molecular details will help establish whether unique sequence features or chromatin states have a predilection for rereplication and whether site-specific copy gains can be integrated in the genome.</p>
<p>Stabilization of KDM4A as a result of exposure to cellular triggers such as hypoxia also resulted in TSSGs in cell lines, tumors, and normal primary cells (<xref ref-type="fig" rid="F2">Fig. 2</xref>, T cells) (<xref ref-type="bibr" rid="B174">174</xref>). In fact, these copy number gains were found to be conserved at a syntenic region in zebrafish cells subjected to hypoxia. The return of cells to normoxia resulted in the reversion of copy number gains to the baseline levels (<xref ref-type="fig" rid="F3">Fig. 3C</xref>). Hence, generation of transient copy number gains could be an adaptive cellular response of cells to external stresses or stimuli. These data provide a mechanism for heterogeneity within a cell population even though the same genetic event occurred in the population.</p>
<p>The stabilization of KDM4A upon hypoxic exposure or inhibition or loss of microRNAs regulating KDM4A promoted copy number gains of the drug resistance oncogene <italic>CKS1B</italic> (<xref ref-type="bibr" rid="B111">111</xref>, <xref ref-type="bibr" rid="B112">112</xref>, <xref ref-type="bibr" rid="B121">121</xref>, <xref ref-type="bibr" rid="B185">185</xref>), which had a concomitant increase in transcripts (<xref ref-type="bibr" rid="B174">174</xref>, <xref ref-type="bibr" rid="B191">191</xref>). When cells were returned to normoxic conditions, both copy number and transcripts of <italic>CKS1B</italic> returned to normal levels. Finally, we demonstrated that succinate (a natural inhibitor for the KDM4 class of demethylases [<xref ref-type="bibr" rid="B186">186</xref>]), chemical inhibition or microRNA-targeted depletion of KDM4A blocked the copy number gains upon hypoxic exposure (<xref ref-type="bibr" rid="B174">174</xref>, <xref ref-type="bibr" rid="B191">191</xref>). These data emphasize the impact that metabolites could have on copy number gain, but most importantly, they identify a mechanism for blocking their generation (<xref ref-type="fig" rid="F3">Fig. 3C</xref>). Since drug resistance oncogenes were increased, the inhibition of KDM4A may provide a novel mechanism for modulating TSSGs and provide a method for reducing 1q21 drug resistance-associated cancers.</p>
<p>The fact that transient exposure to elevated KDM4A can promote copy number gain that is only present during S phase suggests that other mechanisms must be present to remove the TSSGs. Similar mechanisms may be involved in the removal of extrachomosomal <italic>DHFR</italic> and <italic>EGFR</italic> amplifications. The TSSG data support the notion that chromosomal regions with specific genes that confer a survival advantage are amplified to protect the cell. Selectively amplifying genes that confer distinct advantages related either to cell survival, metabolism of drugs, mounting responses to counteract drug sensitivity, or features promoting tumorigenesis could aid in the evolution/adaptation of cancer cells. The question remains as to whether the classical oncogenes (e.g., <italic>EGFR</italic>, <italic>MYC</italic>, <italic>ERBB2</italic>, etc.) (<xref ref-type="table" rid="T1">Table 1</xref>) are subjected to site-specific copy gains in tumors and subsequent retention upon genetic, intrinsic, or extrinsic exposure. Some extrinsic cues could be therapeutic or metabolic challenge, stress conditions (such as hypoxia, nutrient deprivation), and vasculature and extracellular matrix plasticity. Future studies investigating their impact on TSSGs and gene amplification will be critical.</p>
<sec id="sec6-1">
<title>Tumor heterogeneity.</title>
<p>Tumor heterogeneity presents a major diagnostic and therapeutic challenge in the treatment of cancer. Indeed, recent sequencing efforts with next-generation sequencing helped in the tracing of clonal lineages in tumors (<xref ref-type="bibr" rid="B187">187</xref>, <xref ref-type="bibr" rid="B188">188</xref>). Focal gains or losses of chromosomes can result in diversity among cells in a tumor population (intratumoral heterogeneity [<xref ref-type="bibr" rid="B189">189</xref>]) as well as between tumors (intertumoral heterogeneity [<xref ref-type="bibr" rid="B189">189</xref>]). For example, next-generation sequencing of five bladder tumors from patients with transitional cell carcinoma of the urinary bladder showed genomic rearrangements and mutational heterogeneity within tumors (<xref ref-type="bibr" rid="B188">188</xref>). Whole-exome sequencing of samples from 18 patients with chronic lymphocytic leukemia (CLL) revealed the emergence of subclones within selected populations of cells treated with chemotherapy (<xref ref-type="bibr" rid="B190">190</xref>). These populations of cells might be more fit than their pretreatment counterparts and could contribute to relapse after therapy. Thus, identifying the mutational landscape before and after chemotherapy could not only identify mechanisms of tumor relapse but also help to design effective therapeutic options for the elimination of dominant subclones arising after chemotherapeutic selection pressures.</p>
<p>Another mechanism contributing to intratumoral heterogeneity could be the regulation of TSSGs from KDM4A levels, oxygen concentrations, cell division rates, metabolites, and KDM4A inhibition. Cells could be cycling at different rates in a tumor population, thereby affecting the rate at which rereplicated fragments are generated (<xref ref-type="fig" rid="F3">Fig. 3C</xref>). Differential levels of KDM4A expression, hypoxia levels, or metabolic status in cells within a tumor population could also generate copy number gains at different rates, thereby affecting heterogeneity. We hypothesize that the site-specific rereplication events could be one of the characteristics acquired in specific population of cells during subclonal divergence. Specific environmental, metabolic, or therapeutic stress conditions can produce site-specific chromosomal alterations in the subclonal populations, which could either be transient, persisting only when the signal is there, or could eventually become integrated elsewhere in the genome upon subsequent genetic/epigenetic changes. TSSGs within specific cell populations could either influence the emergence of the dominant subclone or could go hand in hand with the germ line mutations occurring during tumor evolution. Whether these events result in the emergence of the fittest clone that promotes survival and if these sets of “fit” cells clonally expand after a therapeutic challenge is a hypothesis that needs to be investigated.</p>
</sec>
</sec>
<sec id="sec7" sec-type="conclusions">
<title>CONCLUSIONS</title>
<p>CNVs influence the ability of normal cells to respond to physiological triggers and can serve as an adaptive strategy for a variety of responses, such as hypoxia, nutrient deprivation, toxic challenges, or cell survival and proliferation. Alterations in copy number often lead to diseases such as cancer, where the tumor cells can also coopt these aberrations as an adaptive response to amplify genes involved in chemotherapeutic resistance. It is important to determine whether the processes of generating copy number alterations under normal physiological, developmental, or pathological conditions are based on an active cell-directed and regulated mechanism or are the result of random aberrations that have occurred during cell division. Whether random or directed, it is important to understand that copy number changes are not always permanent. The recent discovery of a specific chromatin regulator controlling rereplication and site-specific copy number changes suggests that copy number changes can be regulated and are reversible. These transient site-specific copy gains may generate intratumoral heterogeneity that could have important consequences in chemotherapeutic sensitivity and patient outcome. Hence, identifying regulators of CNVs and delineating processes affected by CNVs will be important therapeutically.</p>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGMENTS</title>
<p>We thank members of the Whetstine laboratory for their critical comments on the manuscript. We also thank Mo Motamedi, Amity Manning, and Deepak Kumar Jha for helpful discussions.
</p>
<p>Work related to this review is supported by funding to Johnathan R. Whetstine from the American Cancer Society (RSG-13-115-01-CCG) and the National Institutes of Health (CA059267 and R01GM097360). J.R.W. is a Tepper Family Massachusetts General Hospital Scholar and Leukemia and Lymphoma Scholar. J.R.W. is a recipient of an American Lung Cancer Discovery Award and an Innovation Award from the Alex Lemonade Stand Foundation. Sweta Mishra is supported by a Senior Research Training Fellowship from the American Lung Association.</p>
</ack>
<ref-list>
<title>REFERENCES</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reich</surname><given-names>DE</given-names></name>, <name><surname>Schaffner</surname><given-names>SF</given-names></name>, <name><surname>Daly</surname><given-names>MJ</given-names></name>, <name><surname>McVean</surname><given-names>G</given-names></name>, <name><surname>Mullikin</surname><given-names>JC</given-names></name>, <name><surname>Higgins</surname><given-names>JM</given-names></name>, <name><surname>Richter</surname><given-names>DJ</given-names></name>, <name><surname>Lander</surname><given-names>ES</given-names></name>, <name><surname>Altshuler</surname><given-names>D</given-names></name></person-group>
<year>2002</year>
<article-title>Human genome sequence variation and the influence of gene history, mutation and recombination</article-title>. <source/>Nat Genet
<volume>32</volume>:<fpage>135</fpage>–<lpage>142</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng947</pub-id>.<pub-id pub-id-type="pmid">12161752</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lander</surname><given-names>ES</given-names></name>, <name><surname>Linton</surname><given-names>LM</given-names></name>, <name><surname>Birren</surname><given-names>B</given-names></name>, <name><surname>Nusbaum</surname><given-names>C</given-names></name>, <name><surname>Zody</surname><given-names>MC</given-names></name>, <name><surname>Baldwin</surname><given-names>J</given-names></name>, <name><surname>Devon</surname><given-names>K</given-names></name>, <name><surname>Dewar</surname><given-names>K</given-names></name>, <name><surname>Doyle</surname><given-names>M</given-names></name>, <name><surname>FitzHugh</surname><given-names>W</given-names></name>, <name><surname>Funke</surname><given-names>R</given-names></name>, <name><surname>Gage</surname><given-names>D</given-names></name>, <name><surname>Harris</surname><given-names>K</given-names></name>, <name><surname>Heaford</surname><given-names>A</given-names></name>, <name><surname>Howland</surname><given-names>J</given-names></name>, <name><surname>Kann</surname><given-names>L</given-names></name>, <name><surname>Lehoczky</surname><given-names>J</given-names></name>, <name><surname>LeVine</surname><given-names>R</given-names></name>, <name><surname>McEwan</surname><given-names>P</given-names></name>, <name><surname>McKernan</surname><given-names>K</given-names></name>, <name><surname>Meldrim</surname><given-names>J</given-names></name>, <name><surname>Mesirov</surname><given-names>JP</given-names></name>, <name><surname>Miranda</surname><given-names>C</given-names></name>, <name><surname>Morris</surname><given-names>W</given-names></name>, <name><surname>Naylor</surname><given-names>J</given-names></name>, <name><surname>Raymond</surname><given-names>C</given-names></name>, <name><surname>Rosetti</surname><given-names>M</given-names></name>, <name><surname>Santos</surname><given-names>R</given-names></name>, <name><surname>Sheridan</surname><given-names>A</given-names></name>, <name><surname>Sougnez</surname><given-names>C</given-names></name>, <name><surname>Stange-Thomann</surname><given-names>Y</given-names></name>, <name><surname>Stojanovic</surname><given-names>N</given-names></name>, <name><surname>Subramanian</surname><given-names>A</given-names></name>, <name><surname>Wyman</surname><given-names>D</given-names></name>, <name><surname>Rogers</surname><given-names>J</given-names></name>, <name><surname>Sulston</surname><given-names>J</given-names></name>, <name><surname>Ainscough</surname><given-names>R</given-names></name>, <name><surname>Beck</surname><given-names>S</given-names></name>, <name><surname>Bentley</surname><given-names>D</given-names></name>, <name><surname>Burton</surname><given-names>J</given-names></name>, <name><surname>Clee</surname><given-names>C</given-names></name>, <name><surname>Carter</surname><given-names>N</given-names></name>, <name><surname>Coulson</surname><given-names>A</given-names></name>, <name><surname>Deadman</surname><given-names>R</given-names></name>, <name><surname>Deloukas</surname><given-names>P</given-names></name>, <name><surname>Dunham</surname><given-names>A</given-names></name>, <name><surname>Dunham</surname><given-names>I</given-names></name>, <name><surname>Durbin</surname><given-names>R</given-names></name>, <name><surname>French</surname><given-names>L</given-names></name>, <name><surname>Grafham</surname><given-names>D</given-names></name>, <etal></etal></person-group>
<year>2001</year>
<article-title>Initial sequencing and analysis of the human genome</article-title>. <source/>Nature
<volume>409</volume>:<fpage>860</fpage>–<lpage>921</lpage>. doi:<pub-id pub-id-type="doi">10.1038/35057062</pub-id>.<pub-id pub-id-type="pmid">11237011</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheeler</surname><given-names>DA</given-names></name>, <name><surname>Srinivasan</surname><given-names>M</given-names></name>, <name><surname>Egholm</surname><given-names>M</given-names></name>, <name><surname>Shen</surname><given-names>Y</given-names></name>, <name><surname>Chen</surname><given-names>L</given-names></name>, <name><surname>McGuire</surname><given-names>A</given-names></name>, <name><surname>He</surname><given-names>W</given-names></name>, <name><surname>Chen</surname><given-names>YJ</given-names></name>, <name><surname>Makhijani</surname><given-names>V</given-names></name>, <name><surname>Roth</surname><given-names>GT</given-names></name>, <name><surname>Gomes</surname><given-names>X</given-names></name>, <name><surname>Tartaro</surname><given-names>K</given-names></name>, <name><surname>Niazi</surname><given-names>F</given-names></name>, <name><surname>Turcotte</surname><given-names>CL</given-names></name>, <name><surname>Irzyk</surname><given-names>GP</given-names></name>, <name><surname>Lupski</surname><given-names>JR</given-names></name>, <name><surname>Chinault</surname><given-names>C</given-names></name>, <name><surname>Song</surname><given-names>XZ</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Yuan</surname><given-names>Y</given-names></name>, <name><surname>Nazareth</surname><given-names>L</given-names></name>, <name><surname>Qin</surname><given-names>X</given-names></name>, <name><surname>Muzny</surname><given-names>DM</given-names></name>, <name><surname>Margulies</surname><given-names>M</given-names></name>, <name><surname>Weinstock</surname><given-names>GM</given-names></name>, <name><surname>Gibbs</surname><given-names>RA</given-names></name>, <name><surname>Rothberg</surname><given-names>JM</given-names></name></person-group>
<year>2008</year>
<article-title>The complete genome of an individual by massively parallel DNA sequencing</article-title>. <source/>Nature
<volume>452</volume>:<fpage>872</fpage>–<lpage>876</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature06884</pub-id>.<pub-id pub-id-type="pmid">18421352</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuzun</surname><given-names>E</given-names></name>, <name><surname>Sharp</surname><given-names>AJ</given-names></name>, <name><surname>Bailey</surname><given-names>JA</given-names></name>, <name><surname>Kaul</surname><given-names>R</given-names></name>, <name><surname>Morrison</surname><given-names>VA</given-names></name>, <name><surname>Pertz</surname><given-names>LM</given-names></name>, <name><surname>Haugen</surname><given-names>E</given-names></name>, <name><surname>Hayden</surname><given-names>H</given-names></name>, <name><surname>Albertson</surname><given-names>D</given-names></name>, <name><surname>Pinkel</surname><given-names>D</given-names></name>, <name><surname>Olson</surname><given-names>MV</given-names></name>, <name><surname>Eichler</surname><given-names>EE</given-names></name></person-group>
<year>2005</year>
<article-title>Fine-scale structural variation of the human genome</article-title>. <source/>Nat Genet
<volume>37</volume>:<fpage>727</fpage>–<lpage>732</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng1562</pub-id>.<pub-id pub-id-type="pmid">15895083</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feuk</surname><given-names>L</given-names></name>, <name><surname>Carson</surname><given-names>AR</given-names></name>, <name><surname>Scherer</surname><given-names>SW</given-names></name></person-group>
<year>2006</year>
<article-title>Structural variation in the human genome</article-title>. <source/>Nat Rev Genet
<volume>7</volume>:<fpage>85</fpage>–<lpage>97</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrg1767</pub-id>.<pub-id pub-id-type="pmid">16418744</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savage</surname><given-names>JR</given-names></name></person-group>
<year>1977</year>
<article-title>Application of chromosome banding techniques to the study of primary chromosome structural changes</article-title>. <source/>J Med Genet
<volume>14</volume>:<fpage>362</fpage>–<lpage>370</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jmg.14.5.362</pub-id>.<pub-id pub-id-type="pmid">73589</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>YC</given-names></name>, <name><surname>Amon</surname><given-names>A</given-names></name></person-group>
<year>2013</year>
<article-title>Gene copy-number alterations: a cost-benefit analysis</article-title>. <source/>Cell
<volume>152</volume>:<fpage>394</fpage>–<lpage>405</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2012.11.043</pub-id>.<pub-id pub-id-type="pmid">23374337</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>EM</given-names></name>, <name><surname>Williams</surname><given-names>BR</given-names></name>, <name><surname>Amon</surname><given-names>A</given-names></name></person-group>
<year>2008</year>
<article-title>Aneuploidy: cells losing their balance</article-title>. <source/>Genetics
<volume>179</volume>:<fpage>737</fpage>–<lpage>746</lpage>. doi:<pub-id pub-id-type="doi">10.1534/genetics.108.090878</pub-id>.<pub-id pub-id-type="pmid">18558649</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warburton</surname><given-names>D</given-names></name></person-group>
<year>1991</year>
<article-title>De novo balanced chromosome rearrangements and extra marker chromosomes identified at prenatal diagnosis: clinical significance and distribution of breakpoints</article-title>. <source/>Am J Hum Genet
<volume>49</volume>:<fpage>995</fpage>–<lpage>1013</lpage>.<pub-id pub-id-type="pmid">1928105</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumanski</surname><given-names>JP</given-names></name>, <name><surname>Piotrowski</surname><given-names>A</given-names></name></person-group>
<year>2012</year>
<article-title>Structural genetic variation in the context of somatic mosaicism</article-title>. <source/>Methods Mol Biol
<volume>838</volume>:<fpage>249</fpage>–<lpage>272</lpage>. doi:<pub-id pub-id-type="doi">10.1007/978-1-61779-507-7_12</pub-id>.<pub-id pub-id-type="pmid">22228016</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reams</surname><given-names>AB</given-names></name>, <name><surname>Roth</surname><given-names>JR</given-names></name></person-group>
<year>2015</year>
<article-title>Mechanisms of gene duplication and amplification</article-title>. <source/>Cold Spring Harb Perspect Biol
<volume>7</volume>:<fpage>a016592</fpage>. doi:<pub-id pub-id-type="doi">10.1101/cshperspect.a016592</pub-id>.<pub-id pub-id-type="pmid">25646380</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puig</surname><given-names>M</given-names></name>, <name><surname>Casillas</surname><given-names>S</given-names></name>, <name><surname>Villatoro</surname><given-names>S</given-names></name>, <name><surname>Caceres</surname><given-names>M</given-names></name></person-group>
<year>2015</year>
<article-title>Human inversions and their functional consequences</article-title>. <source/>Brief Funct Genomics
<volume>14</volume>:<fpage>369</fpage>–<lpage>379</lpage>. doi:<pub-id pub-id-type="doi">10.1093/bfgp/elv020</pub-id>.<pub-id pub-id-type="pmid">25998059</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alves</surname><given-names>JM</given-names></name>, <name><surname>Lopes</surname><given-names>AM</given-names></name>, <name><surname>Chikhi</surname><given-names>L</given-names></name>, <name><surname>Amorim</surname><given-names>A</given-names></name></person-group>
<year>2012</year>
<article-title>On the structural plasticity of the human genome: chromosomal inversions revisited</article-title>. <source/>Curr Genomics
<volume>13</volume>:<fpage>623</fpage>–<lpage>632</lpage>. doi:<pub-id pub-id-type="doi">10.2174/138920212803759703</pub-id>.<pub-id pub-id-type="pmid">23730202</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solinas-Toldo</surname><given-names>S</given-names></name>, <name><surname>Lampel</surname><given-names>S</given-names></name>, <name><surname>Stilgenbauer</surname><given-names>S</given-names></name>, <name><surname>Nickolenko</surname><given-names>J</given-names></name>, <name><surname>Benner</surname><given-names>A</given-names></name>, <name><surname>Dohner</surname><given-names>H</given-names></name>, <name><surname>Cremer</surname><given-names>T</given-names></name>, <name><surname>Lichter</surname><given-names>P</given-names></name></person-group>
<year>1997</year>
<article-title>Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances</article-title>. <source/>Genes Chromosomes Cancer
<volume>20</volume>:<fpage>399</fpage>–<lpage>407</lpage>. doi:<pub-id pub-id-type="doi">10.1002/(SICI)1098-2264(199712)20:4&lt;399::AID-GCC12&gt;3.3.CO;2-l</pub-id>.<pub-id pub-id-type="pmid">9408757</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speicher</surname><given-names>MR</given-names></name>, <name><surname>Carter</surname><given-names>NP</given-names></name></person-group>
<year>2005</year>
<article-title>The new cytogenetics: blurring the boundaries with molecular biology</article-title>. <source/>Nat Rev Genet
<volume>6</volume>:<fpage>782</fpage>–<lpage>792</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrg1692</pub-id>.<pub-id pub-id-type="pmid">16145555</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinkel</surname><given-names>D</given-names></name>, <name><surname>Segraves</surname><given-names>R</given-names></name>, <name><surname>Sudar</surname><given-names>D</given-names></name>, <name><surname>Clark</surname><given-names>S</given-names></name>, <name><surname>Poole</surname><given-names>I</given-names></name>, <name><surname>Kowbel</surname><given-names>D</given-names></name>, <name><surname>Collins</surname><given-names>C</given-names></name>, <name><surname>Kuo</surname><given-names>WL</given-names></name>, <name><surname>Chen</surname><given-names>C</given-names></name>, <name><surname>Zhai</surname><given-names>Y</given-names></name>, <name><surname>Dairkee</surname><given-names>SH</given-names></name>, <name><surname>Ljung</surname><given-names>BM</given-names></name>, <name><surname>Gray</surname><given-names>JW</given-names></name>, <name><surname>Albertson</surname><given-names>DG</given-names></name></person-group>
<year>1998</year>
<article-title>High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays</article-title>. <source/>Nat Genet
<volume>20</volume>:<fpage>207</fpage>–<lpage>211</lpage>. doi:<pub-id pub-id-type="doi">10.1038/2524</pub-id>.<pub-id pub-id-type="pmid">9771718</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullaney</surname><given-names>JM</given-names></name>, <name><surname>Mills</surname><given-names>RE</given-names></name>, <name><surname>Pittard</surname><given-names>WS</given-names></name>, <name><surname>Devine</surname><given-names>SE</given-names></name></person-group>
<year>2010</year>
<article-title>Small insertions and deletions (INDELs) in human genomes</article-title>. <source/>Hum Mol Genet
<volume>19</volume>:<fpage>R131</fpage>–<lpage>R136</lpage>. doi:<pub-id pub-id-type="doi">10.1093/hmg/ddq400</pub-id>.<pub-id pub-id-type="pmid">20858594</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>RE</given-names></name>, <name><surname>Luttig</surname><given-names>CT</given-names></name>, <name><surname>Larkins</surname><given-names>CE</given-names></name>, <name><surname>Beauchamp</surname><given-names>A</given-names></name>, <name><surname>Tsui</surname><given-names>C</given-names></name>, <name><surname>Pittard</surname><given-names>WS</given-names></name>, <name><surname>Devine</surname><given-names>SE</given-names></name></person-group>
<year>2006</year>
<article-title>An initial map of insertion and deletion (INDEL) variation in the human genome</article-title>. <source/>Genome Res
<volume>16</volume>:<fpage>1182</fpage>–<lpage>1190</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gr.4565806</pub-id>.<pub-id pub-id-type="pmid">16902084</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>S</given-names></name>, <name><surname>Sutton</surname><given-names>G</given-names></name>, <name><surname>Ng</surname><given-names>PC</given-names></name>, <name><surname>Feuk</surname><given-names>L</given-names></name>, <name><surname>Halpern</surname><given-names>AL</given-names></name>, <name><surname>Walenz</surname><given-names>BP</given-names></name>, <name><surname>Axelrod</surname><given-names>N</given-names></name>, <name><surname>Huang</surname><given-names>J</given-names></name>, <name><surname>Kirkness</surname><given-names>EF</given-names></name>, <name><surname>Denisov</surname><given-names>G</given-names></name>, <name><surname>Lin</surname><given-names>Y</given-names></name>, <name><surname>MacDonald</surname><given-names>JR</given-names></name>, <name><surname>Pang</surname><given-names>AW</given-names></name>, <name><surname>Shago</surname><given-names>M</given-names></name>, <name><surname>Stockwell</surname><given-names>TB</given-names></name>, <name><surname>Tsiamouri</surname><given-names>A</given-names></name>, <name><surname>Bafna</surname><given-names>V</given-names></name>, <name><surname>Bansal</surname><given-names>V</given-names></name>, <name><surname>Kravitz</surname><given-names>SA</given-names></name>, <name><surname>Busam</surname><given-names>DA</given-names></name>, <name><surname>Beeson</surname><given-names>KY</given-names></name>, <name><surname>McIntosh</surname><given-names>TC</given-names></name>, <name><surname>Remington</surname><given-names>KA</given-names></name>, <name><surname>Abril</surname><given-names>JF</given-names></name>, <name><surname>Gill</surname><given-names>J</given-names></name>, <name><surname>Borman</surname><given-names>J</given-names></name>, <name><surname>Rogers</surname><given-names>YH</given-names></name>, <name><surname>Frazier</surname><given-names>ME</given-names></name>, <name><surname>Scherer</surname><given-names>SW</given-names></name>, <name><surname>Strausberg</surname><given-names>RL</given-names></name>, <name><surname>Venter</surname><given-names>JC</given-names></name></person-group>
<year>2007</year>
<article-title>The diploid genome sequence of an individual human</article-title>. <source/>PLoS Biol
<volume>5</volume>:<fpage>e254</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pbio.0050254</pub-id>.<pub-id pub-id-type="pmid">17803354</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conrad</surname><given-names>DF</given-names></name>, <name><surname>Andrews</surname><given-names>TD</given-names></name>, <name><surname>Carter</surname><given-names>NP</given-names></name>, <name><surname>Hurles</surname><given-names>ME</given-names></name>, <name><surname>Pritchard</surname><given-names>JK</given-names></name></person-group>
<year>2006</year>
<article-title>A high-resolution survey of deletion polymorphism in the human genome</article-title>. <source/>Nat Genet
<volume>38</volume>:<fpage>75</fpage>–<lpage>81</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng1697</pub-id>.<pub-id pub-id-type="pmid">16327808</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redon</surname><given-names>R</given-names></name>, <name><surname>Ishikawa</surname><given-names>S</given-names></name>, <name><surname>Fitch</surname><given-names>KR</given-names></name>, <name><surname>Feuk</surname><given-names>L</given-names></name>, <name><surname>Perry</surname><given-names>GH</given-names></name>, <name><surname>Andrews</surname><given-names>TD</given-names></name>, <name><surname>Fiegler</surname><given-names>H</given-names></name>, <name><surname>Shapero</surname><given-names>MH</given-names></name>, <name><surname>Carson</surname><given-names>AR</given-names></name>, <name><surname>Chen</surname><given-names>W</given-names></name>, <name><surname>Cho</surname><given-names>EK</given-names></name>, <name><surname>Dallaire</surname><given-names>S</given-names></name>, <name><surname>Freeman</surname><given-names>JL</given-names></name>, <name><surname>Gonzalez</surname><given-names>JR</given-names></name>, <name><surname>Gratacos</surname><given-names>M</given-names></name>, <name><surname>Huang</surname><given-names>J</given-names></name>, <name><surname>Kalaitzopoulos</surname><given-names>D</given-names></name>, <name><surname>Komura</surname><given-names>D</given-names></name>, <name><surname>MacDonald</surname><given-names>JR</given-names></name>, <name><surname>Marshall</surname><given-names>CR</given-names></name>, <name><surname>Mei</surname><given-names>R</given-names></name>, <name><surname>Montgomery</surname><given-names>L</given-names></name>, <name><surname>Nishimura</surname><given-names>K</given-names></name>, <name><surname>Okamura</surname><given-names>K</given-names></name>, <name><surname>Shen</surname><given-names>F</given-names></name>, <name><surname>Somerville</surname><given-names>MJ</given-names></name>, <name><surname>Tchinda</surname><given-names>J</given-names></name>, <name><surname>Valsesia</surname><given-names>A</given-names></name>, <name><surname>Woodwark</surname><given-names>C</given-names></name>, <name><surname>Yang</surname><given-names>F</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Zerjal</surname><given-names>T</given-names></name>, <name><surname>Armengol</surname><given-names>L</given-names></name>, <name><surname>Conrad</surname><given-names>DF</given-names></name>, <name><surname>Estivill</surname><given-names>X</given-names></name>, <name><surname>Tyler-Smith</surname><given-names>C</given-names></name>, <name><surname>Carter</surname><given-names>NP</given-names></name>, <name><surname>Aburatani</surname><given-names>H</given-names></name>, <name><surname>Lee</surname><given-names>C</given-names></name>, <name><surname>Jones</surname><given-names>KW</given-names></name>, <name><surname>Scherer</surname><given-names>SW</given-names></name>, <name><surname>Hurles</surname><given-names>ME</given-names></name></person-group>
<year>2006</year>
<article-title>Global variation in copy number in the human genome</article-title>. <source/>Nature
<volume>444</volume>:<fpage>444</fpage>–<lpage>454</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature05329</pub-id>.<pub-id pub-id-type="pmid">17122850</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarroll</surname><given-names>SA</given-names></name>, <name><surname>Kuruvilla</surname><given-names>FG</given-names></name>, <name><surname>Korn</surname><given-names>JM</given-names></name>, <name><surname>Cawley</surname><given-names>S</given-names></name>, <name><surname>Nemesh</surname><given-names>J</given-names></name>, <name><surname>Wysoker</surname><given-names>A</given-names></name>, <name><surname>Shapero</surname><given-names>MH</given-names></name>, <name><surname>de Bakker</surname><given-names>PI</given-names></name>, <name><surname>Maller</surname><given-names>JB</given-names></name>, <name><surname>Kirby</surname><given-names>A</given-names></name>, <name><surname>Elliott</surname><given-names>AL</given-names></name>, <name><surname>Parkin</surname><given-names>M</given-names></name>, <name><surname>Hubbell</surname><given-names>E</given-names></name>, <name><surname>Webster</surname><given-names>T</given-names></name>, <name><surname>Mei</surname><given-names>R</given-names></name>, <name><surname>Veitch</surname><given-names>J</given-names></name>, <name><surname>Collins</surname><given-names>PJ</given-names></name>, <name><surname>Handsaker</surname><given-names>R</given-names></name>, <name><surname>Lincoln</surname><given-names>S</given-names></name>, <name><surname>Nizzari</surname><given-names>M</given-names></name>, <name><surname>Blume</surname><given-names>J</given-names></name>, <name><surname>Jones</surname><given-names>KW</given-names></name>, <name><surname>Rava</surname><given-names>R</given-names></name>, <name><surname>Daly</surname><given-names>MJ</given-names></name>, <name><surname>Gabriel</surname><given-names>SB</given-names></name>, <name><surname>Altshuler</surname><given-names>D</given-names></name></person-group>
<year>2008</year>
<article-title>Integrated detection and population-genetic analysis of SNPs and copy number variation</article-title>. <source/>Nat Genet
<volume>40</volume>:<fpage>1166</fpage>–<lpage>1174</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.238</pub-id>.<pub-id pub-id-type="pmid">18776908</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iafrate</surname><given-names>AJ</given-names></name>, <name><surname>Feuk</surname><given-names>L</given-names></name>, <name><surname>Rivera</surname><given-names>MN</given-names></name>, <name><surname>Listewnik</surname><given-names>ML</given-names></name>, <name><surname>Donahoe</surname><given-names>PK</given-names></name>, <name><surname>Qi</surname><given-names>Y</given-names></name>, <name><surname>Scherer</surname><given-names>SW</given-names></name>, <name><surname>Lee</surname><given-names>C</given-names></name></person-group>
<year>2004</year>
<article-title>Detection of large-scale variation in the human genome</article-title>. <source/>Nat Genet
<volume>36</volume>:<fpage>949</fpage>–<lpage>951</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng1416</pub-id>.<pub-id pub-id-type="pmid">15286789</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sebat</surname><given-names>J</given-names></name>, <name><surname>Lakshmi</surname><given-names>B</given-names></name>, <name><surname>Troge</surname><given-names>J</given-names></name>, <name><surname>Alexander</surname><given-names>J</given-names></name>, <name><surname>Young</surname><given-names>J</given-names></name>, <name><surname>Lundin</surname><given-names>P</given-names></name>, <name><surname>Maner</surname><given-names>S</given-names></name>, <name><surname>Massa</surname><given-names>H</given-names></name>, <name><surname>Walker</surname><given-names>M</given-names></name>, <name><surname>Chi</surname><given-names>M</given-names></name>, <name><surname>Navin</surname><given-names>N</given-names></name>, <name><surname>Lucito</surname><given-names>R</given-names></name>, <name><surname>Healy</surname><given-names>J</given-names></name>, <name><surname>Hicks</surname><given-names>J</given-names></name>, <name><surname>Ye</surname><given-names>K</given-names></name>, <name><surname>Reiner</surname><given-names>A</given-names></name>, <name><surname>Gilliam</surname><given-names>TC</given-names></name>, <name><surname>Trask</surname><given-names>B</given-names></name>, <name><surname>Patterson</surname><given-names>N</given-names></name>, <name><surname>Zetterberg</surname><given-names>A</given-names></name>, <name><surname>Wigler</surname><given-names>M</given-names></name></person-group>
<year>2004</year>
<article-title>Large-scale copy number polymorphism in the human genome</article-title>. <source/>Science
<volume>305</volume>:<fpage>525</fpage>–<lpage>528</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1098918</pub-id>.<pub-id pub-id-type="pmid">15273396</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25.</label>
<mixed-citation publication-type="journal"><collab>International HapMap Consortium</collab>. <year>2005</year>
<article-title>A haplotype map of the human genome</article-title>. <source/>Nature
<volume>437</volume>:<fpage>1299</fpage>–<lpage>1320</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature04226</pub-id>.<pub-id pub-id-type="pmid">16255080</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abecasis</surname><given-names>GR</given-names></name>, <name><surname>Altshuler</surname><given-names>D</given-names></name>, <name><surname>Auton</surname><given-names>A</given-names></name>, <name><surname>Brooks</surname><given-names>LD</given-names></name>, <name><surname>Durbin</surname><given-names>RM</given-names></name>, <name><surname>Gibbs</surname><given-names>RA</given-names></name>, <name><surname>Hurles</surname><given-names>ME</given-names></name>, <name><surname>McVean</surname><given-names>GA</given-names></name></person-group>
<year>2010</year>
<article-title>A map of human genome variation Int</article-title> doi:<pub-id pub-id-type="doi">10.1038/nature09534</pub-id>.</mixed-citation>
</ref>
<ref id="B27">
<label>27.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudmant</surname><given-names>PH</given-names></name>, <name><surname>Mallick</surname><given-names>S</given-names></name>, <name><surname>Nelson</surname><given-names>BJ</given-names></name>, <name><surname>Hormozdiari</surname><given-names>F</given-names></name>, <name><surname>Krumm</surname><given-names>N</given-names></name>, <name><surname>Huddleston</surname><given-names>J</given-names></name>, <name><surname>Coe</surname><given-names>BP</given-names></name>, <name><surname>Baker</surname><given-names>C</given-names></name>, <name><surname>Nordenfelt</surname><given-names>S</given-names></name>, <name><surname>Bamshad</surname><given-names>M</given-names></name>, <name><surname>Jorde</surname><given-names>LB</given-names></name>, <name><surname>Posukh</surname><given-names>OL</given-names></name>, <name><surname>Sahakyan</surname><given-names>H</given-names></name>, <name><surname>Watkins</surname><given-names>WS</given-names></name>, <name><surname>Yepiskoposyan</surname><given-names>L</given-names></name>, <name><surname>Abdullah</surname><given-names>MS</given-names></name>, <name><surname>Bravi</surname><given-names>CM</given-names></name>, <name><surname>Capelli</surname><given-names>C</given-names></name>, <name><surname>Hervig</surname><given-names>T</given-names></name>, <name><surname>Wee</surname><given-names>JT</given-names></name>, <name><surname>Tyler-Smith</surname><given-names>C</given-names></name>, <name><surname>van Driem</surname><given-names>G</given-names></name>, <name><surname>Romero</surname><given-names>IG</given-names></name>, <name><surname>Jha</surname><given-names>AR</given-names></name>, <name><surname>Karachanak-Yankova</surname><given-names>S</given-names></name>, <name><surname>Toncheva</surname><given-names>D</given-names></name>, <name><surname>Comas</surname><given-names>D</given-names></name>, <name><surname>Henn</surname><given-names>B</given-names></name>, <name><surname>Kivisild</surname><given-names>T</given-names></name>, <name><surname>Ruiz-Linares</surname><given-names>A</given-names></name>, <name><surname>Sajantila</surname><given-names>A</given-names></name>, <name><surname>Metspalu</surname><given-names>E</given-names></name>, <name><surname>Parik</surname><given-names>J</given-names></name>, <name><surname>Villems</surname><given-names>R</given-names></name>, <name><surname>Starikovskaya</surname><given-names>EB</given-names></name>, <name><surname>Ayodo</surname><given-names>G</given-names></name>, <name><surname>Beall</surname><given-names>CM</given-names></name>, <name><surname>Di Rienzo</surname><given-names>A</given-names></name>, <name><surname>Hammer</surname><given-names>MF</given-names></name>, <name><surname>Khusainova</surname><given-names>R</given-names></name>, <name><surname>Khusnutdinova</surname><given-names>E</given-names></name>, <name><surname>Klitz</surname><given-names>W</given-names></name>, <name><surname>Winkler</surname><given-names>C</given-names></name>, <name><surname>Labuda</surname><given-names>D</given-names></name>, <name><surname>Metspalu</surname><given-names>M</given-names></name>, <name><surname>Tishkoff</surname><given-names>SA</given-names></name>, <name><surname>Dryomov</surname><given-names>S</given-names></name>, <name><surname>Sukernik</surname><given-names>R</given-names></name>, <name><surname>Patterson</surname><given-names>N</given-names></name>, <name><surname>Reich</surname><given-names>D</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>Global diversity, population stratification, and selection of human copy-number variation</article-title>. <source/>Science
<volume>349</volume>:<fpage>aab3761</fpage>. doi:<pub-id pub-id-type="doi">10.1126/science.aab3761</pub-id>.<pub-id pub-id-type="pmid">26249230</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarrei</surname><given-names>M</given-names></name>, <name><surname>MacDonald</surname><given-names>JR</given-names></name>, <name><surname>Merico</surname><given-names>D</given-names></name>, <name><surname>Scherer</surname><given-names>SW</given-names></name></person-group>
<year>2015</year>
<article-title>A copy number variation map of the human genome</article-title>. <source/>Nat Rev Genet
<volume>16</volume>:<fpage>172</fpage>–<lpage>183</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrg3871</pub-id>.<pub-id pub-id-type="pmid">25645873</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sachidanandam</surname><given-names>R</given-names></name>, <name><surname>Weissman</surname><given-names>D</given-names></name>, <name><surname>Schmidt</surname><given-names>SC</given-names></name>, <name><surname>Kakol</surname><given-names>JM</given-names></name>, <name><surname>Stein</surname><given-names>LD</given-names></name>, <name><surname>Marth</surname><given-names>G</given-names></name>, <name><surname>Sherry</surname><given-names>S</given-names></name>, <name><surname>Mullikin</surname><given-names>JC</given-names></name>, <name><surname>Mortimore</surname><given-names>BJ</given-names></name>, <name><surname>Willey</surname><given-names>DL</given-names></name>, <name><surname>Hunt</surname><given-names>SE</given-names></name>, <name><surname>Cole</surname><given-names>CG</given-names></name>, <name><surname>Coggill</surname><given-names>PC</given-names></name>, <name><surname>Rice</surname><given-names>CM</given-names></name>, <name><surname>Ning</surname><given-names>Z</given-names></name>, <name><surname>Rogers</surname><given-names>J</given-names></name>, <name><surname>Bentley</surname><given-names>DR</given-names></name>, <name><surname>Kwok</surname><given-names>PY</given-names></name>, <name><surname>Mardis</surname><given-names>ER</given-names></name>, <name><surname>Yeh</surname><given-names>RT</given-names></name>, <name><surname>Schultz</surname><given-names>B</given-names></name>, <name><surname>Cook</surname><given-names>L</given-names></name>, <name><surname>Davenport</surname><given-names>R</given-names></name>, <name><surname>Dante</surname><given-names>M</given-names></name>, <name><surname>Fulton</surname><given-names>L</given-names></name>, <name><surname>Hillier</surname><given-names>L</given-names></name>, <name><surname>Waterston</surname><given-names>RH</given-names></name>, <name><surname>McPherson</surname><given-names>JD</given-names></name>, <name><surname>Gilman</surname><given-names>B</given-names></name>, <name><surname>Schaffner</surname><given-names>S</given-names></name>, <name><surname>Van Etten</surname><given-names>WJ</given-names></name>, <name><surname>Reich</surname><given-names>D</given-names></name>, <name><surname>Higgins</surname><given-names>J</given-names></name>, <name><surname>Daly</surname><given-names>MJ</given-names></name>, <name><surname>Blumenstiel</surname><given-names>B</given-names></name>, <name><surname>Baldwin</surname><given-names>J</given-names></name>, <name><surname>Stange-Thomann</surname><given-names>N</given-names></name>, <name><surname>Zody</surname><given-names>MC</given-names></name>, <name><surname>Linton</surname><given-names>L</given-names></name>, <name><surname>Lander</surname><given-names>ES</given-names></name>, <name><surname>Altshuler</surname><given-names>D</given-names></name></person-group>
<year>2001</year>
<article-title>A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms</article-title>. <source/>Nature
<volume>409</volume>:<fpage>928</fpage>–<lpage>933</lpage>. doi:<pub-id pub-id-type="doi">10.1038/35057149</pub-id>.<pub-id pub-id-type="pmid">11237013</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C</given-names></name>, <name><surname>Iafrate</surname><given-names>AJ</given-names></name>, <name><surname>Brothman</surname><given-names>AR</given-names></name></person-group>
<year>2007</year>
<article-title>Copy number variations and clinical cytogenetic diagnosis of constitutional disorders</article-title>. <source/>Nat Genet
<volume>39</volume>:<fpage>S48</fpage>–<lpage>S54</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng2092</pub-id>.<pub-id pub-id-type="pmid">17597782</pub-id></mixed-citation>
</ref>
<ref id="B31">
<label>31.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>TR</given-names></name>, <name><surname>Roberts</surname><given-names>CJ</given-names></name>, <name><surname>Dai</surname><given-names>H</given-names></name>, <name><surname>Jones</surname><given-names>AR</given-names></name>, <name><surname>Meyer</surname><given-names>MR</given-names></name>, <name><surname>Slade</surname><given-names>D</given-names></name>, <name><surname>Burchard</surname><given-names>J</given-names></name>, <name><surname>Dow</surname><given-names>S</given-names></name>, <name><surname>Ward</surname><given-names>TR</given-names></name>, <name><surname>Kidd</surname><given-names>MJ</given-names></name>, <name><surname>Friend</surname><given-names>SH</given-names></name>, <name><surname>Marton</surname><given-names>MJ</given-names></name></person-group>
<year>2000</year>
<article-title>Widespread aneuploidy revealed by DNA microarray expression profiling</article-title>. <source/>Nat Genet
<volume>25</volume>:<fpage>333</fpage>–<lpage>337</lpage>. doi:<pub-id pub-id-type="doi">10.1038/77116</pub-id>.<pub-id pub-id-type="pmid">10888885</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>DJ</given-names></name>, <name><surname>Resio</surname><given-names>B</given-names></name>, <name><surname>Pellman</surname><given-names>D</given-names></name></person-group>
<year>2012</year>
<article-title>Causes and consequences of aneuploidy in cancer</article-title>. <source/>Nat Rev Genet
<volume>13</volume>:<fpage>189</fpage>–<lpage>203</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrg3123</pub-id>.<pub-id pub-id-type="pmid">22269907</pub-id></mixed-citation>
</ref>
<ref id="B33">
<label>33.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hastings</surname><given-names>PJ</given-names></name>, <name><surname>Lupski</surname><given-names>JR</given-names></name>, <name><surname>Rosenberg</surname><given-names>SM</given-names></name>, <name><surname>Ira</surname><given-names>G</given-names></name></person-group>
<year>2009</year>
<article-title>Mechanisms of change in gene copy number</article-title>. <source/>Nat Rev Genet
<volume>10</volume>:<fpage>551</fpage>–<lpage>564</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrg2593</pub-id>.<pub-id pub-id-type="pmid">19597530</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheeler</surname><given-names>E</given-names></name>, <name><surname>Huang</surname><given-names>N</given-names></name>, <name><surname>Bochukova</surname><given-names>EG</given-names></name>, <name><surname>Keogh</surname><given-names>JM</given-names></name>, <name><surname>Lindsay</surname><given-names>S</given-names></name>, <name><surname>Garg</surname><given-names>S</given-names></name>, <name><surname>Henning</surname><given-names>E</given-names></name>, <name><surname>Blackburn</surname><given-names>H</given-names></name>, <name><surname>Loos</surname><given-names>RJ</given-names></name>, <name><surname>Wareham</surname><given-names>NJ</given-names></name>, <name><surname>O'Rahilly</surname><given-names>S</given-names></name>, <name><surname>Hurles</surname><given-names>ME</given-names></name>, <name><surname>Barroso</surname><given-names>I</given-names></name>, <name><surname>Farooqi</surname><given-names>IS</given-names></name></person-group>
<year>2013</year>
<article-title>Genome-wide SNP and CNV analysis identifies common and low-frequency variants associated with severe early-onset obesity</article-title>. <source/>Nat Genet
<volume>45</volume>:<fpage>513</fpage>–<lpage>517</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.2607</pub-id>.<pub-id pub-id-type="pmid">23563609</pub-id></mixed-citation>
</ref>
<ref id="B35">
<label>35.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>NJ</given-names></name>, <name><surname>Shtir</surname><given-names>CJ</given-names></name>, <name><surname>Smyth</surname><given-names>DJ</given-names></name>, <name><surname>Guo</surname><given-names>H</given-names></name>, <name><surname>Swafford</surname><given-names>AD</given-names></name>, <name><surname>Zanda</surname><given-names>M</given-names></name>, <name><surname>Hurles</surname><given-names>ME</given-names></name>, <name><surname>Walker</surname><given-names>NM</given-names></name>, <name><surname>Plagnol</surname><given-names>V</given-names></name>, <name><surname>Cooper</surname><given-names>JD</given-names></name>, <name><surname>Howson</surname><given-names>JM</given-names></name>, <name><surname>Burren</surname><given-names>OS</given-names></name>, <name><surname>Onengut-Gumuscu</surname><given-names>S</given-names></name>, <name><surname>Rich</surname><given-names>SS</given-names></name>, <name><surname>Todd</surname><given-names>JA</given-names></name></person-group>
<year>2015</year>
<article-title>Detection and correction of artefacts in estimation of rare copy number variants and analysis of rare deletions in type 1 diabetes</article-title>. <source/>Hum Mol Genet
<volume>24</volume>:<fpage>1774</fpage>–<lpage>1790</lpage>. doi:<pub-id pub-id-type="doi">10.1093/hmg/ddu581</pub-id>.<pub-id pub-id-type="pmid">25424174</pub-id></mixed-citation>
</ref>
<ref id="B36">
<label>36.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>E</given-names></name>, <name><surname>Douglas</surname><given-names>A</given-names></name>, <name><surname>Kjaegaard</surname><given-names>S</given-names></name>, <name><surname>Callewaert</surname><given-names>B</given-names></name>, <name><surname>Vanlander</surname><given-names>A</given-names></name>, <name><surname>Janssens</surname><given-names>S</given-names></name>, <name><surname>Lawson Yuen</surname><given-names>A</given-names></name>, <name><surname>Skinner</surname><given-names>C</given-names></name>, <name><surname>Failla</surname><given-names>P</given-names></name>, <name><surname>Alberti</surname><given-names>A</given-names></name>, <name><surname>Avola</surname><given-names>E</given-names></name>, <name><surname>Fichera</surname><given-names>M</given-names></name>, <name><surname>Kibaek</surname><given-names>M</given-names></name>, <name><surname>Digilio</surname><given-names>MC</given-names></name>, <name><surname>Hannibal</surname><given-names>MC</given-names></name>, <name><surname>den Hollander</surname><given-names>NS</given-names></name>, <name><surname>Bizzarri</surname><given-names>V</given-names></name>, <name><surname>Renieri</surname><given-names>A</given-names></name>, <name><surname>Mencarelli</surname><given-names>MA</given-names></name>, <name><surname>Fitzgerald</surname><given-names>T</given-names></name>, <name><surname>Piazzolla</surname><given-names>S</given-names></name>, <name><surname>van Oudenhove</surname><given-names>E</given-names></name>, <name><surname>Romano</surname><given-names>C</given-names></name>, <name><surname>Schwartz</surname><given-names>C</given-names></name>, <name><surname>Eichler</surname><given-names>EE</given-names></name>, <name><surname>Slavotinek</surname><given-names>A</given-names></name>, <name><surname>Escobar</surname><given-names>L</given-names></name>, <name><surname>Rajan</surname><given-names>D</given-names></name>, <name><surname>Crolla</surname><given-names>J</given-names></name>, <name><surname>Carter</surname><given-names>N</given-names></name>, <name><surname>Hodge</surname><given-names>JC</given-names></name>, <name><surname>Mefford</surname><given-names>HC</given-names></name></person-group>
<year>2015</year>
<article-title>Recurrent duplications of 17q12 associated with variable phenotypes</article-title>. <source/>Am J Med Genet A
<volume>167</volume>:<fpage>3038</fpage>–<lpage>3045</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.a.37351</pub-id>.<pub-id pub-id-type="pmid">26420380</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malhotra</surname><given-names>D</given-names></name>, <name><surname>Sebat</surname><given-names>J</given-names></name></person-group>
<year>2012</year>
<article-title>CNVs: harbingers of a rare variant revolution in psychiatric genetics</article-title>. <source/>Cell
<volume>148</volume>:<fpage>1223</fpage>–<lpage>1241</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2012.02.039</pub-id>.<pub-id pub-id-type="pmid">22424231</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sebat</surname><given-names>J</given-names></name>, <name><surname>Lakshmi</surname><given-names>B</given-names></name>, <name><surname>Malhotra</surname><given-names>D</given-names></name>, <name><surname>Troge</surname><given-names>J</given-names></name>, <name><surname>Lese-Martin</surname><given-names>C</given-names></name>, <name><surname>Walsh</surname><given-names>T</given-names></name>, <name><surname>Yamrom</surname><given-names>B</given-names></name>, <name><surname>Yoon</surname><given-names>S</given-names></name>, <name><surname>Krasnitz</surname><given-names>A</given-names></name>, <name><surname>Kendall</surname><given-names>J</given-names></name>, <name><surname>Leotta</surname><given-names>A</given-names></name>, <name><surname>Pai</surname><given-names>D</given-names></name>, <name><surname>Zhang</surname><given-names>R</given-names></name>, <name><surname>Lee</surname><given-names>YH</given-names></name>, <name><surname>Hicks</surname><given-names>J</given-names></name>, <name><surname>Spence</surname><given-names>SJ</given-names></name>, <name><surname>Lee</surname><given-names>AT</given-names></name>, <name><surname>Puura</surname><given-names>K</given-names></name>, <name><surname>Lehtimaki</surname><given-names>T</given-names></name>, <name><surname>Ledbetter</surname><given-names>D</given-names></name>, <name><surname>Gregersen</surname><given-names>PK</given-names></name>, <name><surname>Bregman</surname><given-names>J</given-names></name>, <name><surname>Sutcliffe</surname><given-names>JS</given-names></name>, <name><surname>Jobanputra</surname><given-names>V</given-names></name>, <name><surname>Chung</surname><given-names>W</given-names></name>, <name><surname>Warburton</surname><given-names>D</given-names></name>, <name><surname>King</surname><given-names>MC</given-names></name>, <name><surname>Skuse</surname><given-names>D</given-names></name>, <name><surname>Geschwind</surname><given-names>DH</given-names></name>, <name><surname>Gilliam</surname><given-names>TC</given-names></name>, <name><surname>Ye</surname><given-names>K</given-names></name>, <name><surname>Wigler</surname><given-names>M</given-names></name></person-group>
<year>2007</year>
<article-title>Strong association of de novo copy number mutations with autism</article-title>. <source/>Science
<volume>316</volume>:<fpage>445</fpage>–<lpage>449</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1138659</pub-id>.<pub-id pub-id-type="pmid">17363630</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39.</label>
<mixed-citation publication-type="journal"><collab>International Schizophrenia Consortium</collab>. <year>2008</year>
<article-title>Rare chromosomal deletions and duplications increase risk of schizophrenia</article-title>. <source/>Nature
<volume>455</volume>:<fpage>237</fpage>–<lpage>241</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature07239</pub-id>.<pub-id pub-id-type="pmid">18668038</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corder</surname><given-names>EH</given-names></name>, <name><surname>Saunders</surname><given-names>AM</given-names></name>, <name><surname>Strittmatter</surname><given-names>WJ</given-names></name>, <name><surname>Schmechel</surname><given-names>DE</given-names></name>, <name><surname>Gaskell</surname><given-names>PC</given-names></name>, <name><surname>Small</surname><given-names>GW</given-names></name>, <name><surname>Roses</surname><given-names>AD</given-names></name>, <name><surname>Haines</surname><given-names>JL</given-names></name>, <name><surname>Pericak-Vance</surname><given-names>MA</given-names></name></person-group>
<year>1993</year>
<article-title>Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families</article-title>. <source/>Science
<volume>261</volume>:<fpage>921</fpage>–<lpage>923</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.8346443</pub-id>.<pub-id pub-id-type="pmid">8346443</pub-id></mixed-citation>
</ref>
<ref id="B41">
<label>41.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swaminathan</surname><given-names>S</given-names></name>, <name><surname>Shen</surname><given-names>L</given-names></name>, <name><surname>Kim</surname><given-names>S</given-names></name>, <name><surname>Inlow</surname><given-names>M</given-names></name>, <name><surname>West</surname><given-names>JD</given-names></name>, <name><surname>Faber</surname><given-names>KM</given-names></name>, <name><surname>Foroud</surname><given-names>T</given-names></name>, <name><surname>Mayeux</surname><given-names>R</given-names></name>, <name><surname>Saykin</surname><given-names>AJ</given-names></name></person-group>
<year>2012</year>
<article-title>Analysis of copy number variation in Alzheimer's disease: the NIALOAD/NCRAD Family Study</article-title>. <source/>Curr Alzheimer Res
<volume>9</volume>:<fpage>801</fpage>–<lpage>814</lpage>. doi:<pub-id pub-id-type="doi">10.2174/156720512802455331</pub-id>.<pub-id pub-id-type="pmid">22486522</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krepischi</surname><given-names>AC</given-names></name>, <name><surname>Pearson</surname><given-names>PL</given-names></name>, <name><surname>Rosenberg</surname><given-names>C</given-names></name></person-group>
<year>2012</year>
<article-title>Germline copy number variations and cancer predisposition</article-title>. <source/>Future Oncol
<volume>8</volume>:<fpage>441</fpage>–<lpage>450</lpage>. doi:<pub-id pub-id-type="doi">10.2217/fon.12.34</pub-id>.<pub-id pub-id-type="pmid">22515447</pub-id></mixed-citation>
</ref>
<ref id="B43">
<label>43.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colnaghi</surname><given-names>R</given-names></name>, <name><surname>Carpenter</surname><given-names>G</given-names></name>, <name><surname>Volker</surname><given-names>M</given-names></name>, <name><surname>O'Driscoll</surname><given-names>M</given-names></name></person-group>
<year>2011</year>
<article-title>The consequences of structural genomic alterations in humans: genomic disorders, genomic instability and cancer</article-title>. <source/>Semin Cell Dev Biol
<volume>22</volume>:<fpage>875</fpage>–<lpage>885</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.semcdb.2011.07.010</pub-id>.<pub-id pub-id-type="pmid">21802523</pub-id></mixed-citation>
</ref>
<ref id="B44">
<label>44.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speleman</surname><given-names>F</given-names></name>, <name><surname>Kumps</surname><given-names>C</given-names></name>, <name><surname>Buysse</surname><given-names>K</given-names></name>, <name><surname>Poppe</surname><given-names>B</given-names></name>, <name><surname>Menten</surname><given-names>B</given-names></name>, <name><surname>De Preter</surname><given-names>K</given-names></name></person-group>
<year>2008</year>
<article-title>Copy number alterations and copy number variation in cancer: close encounters of the bad kind</article-title>. <source/>Cytogenet Genome Res
<volume>123</volume>:<fpage>176</fpage>–<lpage>182</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000184706</pub-id>.<pub-id pub-id-type="pmid">19287153</pub-id></mixed-citation>
</ref>
<ref id="B45">
<label>45.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piotrowski</surname><given-names>A</given-names></name>, <name><surname>Bruder</surname><given-names>CE</given-names></name>, <name><surname>Andersson</surname><given-names>R</given-names></name>, <name><surname>Diaz de Stahl</surname><given-names>T</given-names></name>, <name><surname>Menzel</surname><given-names>U</given-names></name>, <name><surname>Sandgren</surname><given-names>J</given-names></name>, <name><surname>Poplawski</surname><given-names>A</given-names></name>, <name><surname>von Tell</surname><given-names>D</given-names></name>, <name><surname>Crasto</surname><given-names>C</given-names></name>, <name><surname>Bogdan</surname><given-names>A</given-names></name>, <name><surname>Bartoszewski</surname><given-names>R</given-names></name>, <name><surname>Bebok</surname><given-names>Z</given-names></name>, <name><surname>Krzyzanowski</surname><given-names>M</given-names></name>, <name><surname>Jankowski</surname><given-names>Z</given-names></name>, <name><surname>Partridge</surname><given-names>EC</given-names></name>, <name><surname>Komorowski</surname><given-names>J</given-names></name>, <name><surname>Dumanski</surname><given-names>JP</given-names></name></person-group>
<year>2008</year>
<article-title>Somatic mosaicism for copy number variation in differentiated human tissues</article-title>. <source/>Hum Mutat
<volume>29</volume>:<fpage>1118</fpage>–<lpage>1124</lpage>. doi:<pub-id pub-id-type="doi">10.1002/humu.20815</pub-id>.<pub-id pub-id-type="pmid">18570184</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youssoufian</surname><given-names>H</given-names></name>, <name><surname>Pyeritz</surname><given-names>RE</given-names></name></person-group>
<year>2002</year>
<article-title>Mechanisms and consequences of somatic mosaicism in humans</article-title>. <source/>Nat Rev Genet
<volume>3</volume>:<fpage>748</fpage>–<lpage>758</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrg906</pub-id>.<pub-id pub-id-type="pmid">12360233</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>PM</given-names></name>, <name><surname>Lam</surname><given-names>HY</given-names></name>, <name><surname>Urban</surname><given-names>AE</given-names></name>, <name><surname>Korbel</surname><given-names>JO</given-names></name>, <name><surname>Affourtit</surname><given-names>J</given-names></name>, <name><surname>Grubert</surname><given-names>F</given-names></name>, <name><surname>Chen</surname><given-names>X</given-names></name>, <name><surname>Weissman</surname><given-names>S</given-names></name>, <name><surname>Snyder</surname><given-names>M</given-names></name>, <name><surname>Gerstein</surname><given-names>MB</given-names></name></person-group>
<year>2008</year>
<article-title>Analysis of copy number variants and segmental duplications in the human genome: evidence for a change in the process of formation in recent evolutionary history</article-title>. <source/>Genome Res
<volume>18</volume>:<fpage>1865</fpage>–<lpage>1874</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gr.081422.108</pub-id>.<pub-id pub-id-type="pmid">18842824</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>Z</given-names></name>, <name><surname>Ventura</surname><given-names>M</given-names></name>, <name><surname>She</surname><given-names>X</given-names></name>, <name><surname>Khaitovich</surname><given-names>P</given-names></name>, <name><surname>Graves</surname><given-names>T</given-names></name>, <name><surname>Osoegawa</surname><given-names>K</given-names></name>, <name><surname>Church</surname><given-names>D</given-names></name>, <name><surname>DeJong</surname><given-names>P</given-names></name>, <name><surname>Wilson</surname><given-names>RK</given-names></name>, <name><surname>Paabo</surname><given-names>S</given-names></name>, <name><surname>Rocchi</surname><given-names>M</given-names></name>, <name><surname>Eichler</surname><given-names>EE</given-names></name></person-group>
<year>2005</year>
<article-title>A genome-wide comparison of recent chimpanzee and human segmental duplications</article-title>. <source/>Nature
<volume>437</volume>:<fpage>88</fpage>–<lpage>93</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature04000</pub-id>.<pub-id pub-id-type="pmid">16136132</pub-id></mixed-citation>
</ref>
<ref id="B49">
<label>49.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>She</surname><given-names>X</given-names></name>, <name><surname>Jiang</surname><given-names>Z</given-names></name>, <name><surname>Clark</surname><given-names>RA</given-names></name>, <name><surname>Liu</surname><given-names>G</given-names></name>, <name><surname>Cheng</surname><given-names>Z</given-names></name>, <name><surname>Tuzun</surname><given-names>E</given-names></name>, <name><surname>Church</surname><given-names>DM</given-names></name>, <name><surname>Sutton</surname><given-names>G</given-names></name>, <name><surname>Halpern</surname><given-names>AL</given-names></name>, <name><surname>Eichler</surname><given-names>EE</given-names></name></person-group>
<year>2004</year>
<article-title>Shotgun sequence assembly and recent segmental duplications within the human genome</article-title>. <source/>Nature
<volume>431</volume>:<fpage>927</fpage>–<lpage>930</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature03062</pub-id>.<pub-id pub-id-type="pmid">15496912</pub-id></mixed-citation>
</ref>
<ref id="B50">
<label>50.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>JA</given-names></name>, <name><surname>Gu</surname><given-names>Z</given-names></name>, <name><surname>Clark</surname><given-names>RA</given-names></name>, <name><surname>Reinert</surname><given-names>K</given-names></name>, <name><surname>Samonte</surname><given-names>RV</given-names></name>, <name><surname>Schwartz</surname><given-names>S</given-names></name>, <name><surname>Adams</surname><given-names>MD</given-names></name>, <name><surname>Myers</surname><given-names>EW</given-names></name>, <name><surname>Li</surname><given-names>PW</given-names></name>, <name><surname>Eichler</surname><given-names>EE</given-names></name></person-group>
<year>2002</year>
<article-title>Recent segmental duplications in the human genome</article-title>. <source/>Science
<volume>297</volume>:<fpage>1003</fpage>–<lpage>1007</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1072047</pub-id>.<pub-id pub-id-type="pmid">12169732</pub-id></mixed-citation>
</ref>
<ref id="B51">
<label>51.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>SL</given-names></name>, <name><surname>Compton</surname><given-names>DA</given-names></name></person-group>
<year>2011</year>
<article-title>Chromosome missegregation in human cells arises through specific types of kinetochore-microtubule attachment errors</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>108</volume>:<fpage>17974</fpage>–<lpage>17978</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1109720108</pub-id>.<pub-id pub-id-type="pmid">21997207</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buongiorno-Nardelli</surname><given-names>M</given-names></name>, <name><surname>Amaldi</surname><given-names>F</given-names></name>, <name><surname>Lava-Sanchez</surname><given-names>PA</given-names></name></person-group>
<year>1976</year>
<article-title>Electron microscope analysis of amplifying ribosomal DNA from Xenopus laevis</article-title>. <source/>Exp Cell Res
<volume>98</volume>:<fpage>95</fpage>–<lpage>103</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0014-4827(76)90467-5</pub-id>.<pub-id pub-id-type="pmid">1253845</pub-id></mixed-citation>
</ref>
<ref id="B53">
<label>53.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boseley</surname><given-names>P</given-names></name>, <name><surname>Moss</surname><given-names>T</given-names></name>, <name><surname>Machler</surname><given-names>M</given-names></name>, <name><surname>Portmann</surname><given-names>R</given-names></name>, <name><surname>Birnstiel</surname><given-names>M</given-names></name></person-group>
<year>1979</year>
<article-title>Sequence organization of the spacer DNA in a ribosomal gene unit of Xenopus laevis</article-title>. <source/>Cell
<volume>17</volume>:<fpage>19</fpage>–<lpage>31</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0092-8674(79)90291-5</pub-id>.<pub-id pub-id-type="pmid">455459</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bird</surname><given-names>AP</given-names></name>, <name><surname>Birnstiel</surname><given-names>ML</given-names></name></person-group>
<year>1971</year>
<article-title>The relationship between protein synthesis and ribosomal DNA amplification in Xenopus laevis</article-title>. <source/>Biochim Biophys Acta
<volume>247</volume>:<fpage>157</fpage>–<lpage>163</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0005-2787(71)90819-7</pub-id>.<pub-id pub-id-type="pmid">5160752</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>DD</given-names></name>, <name><surname>Dawid</surname><given-names>IB</given-names></name></person-group>
<year>1968</year>
<article-title>Specific gene amplification in oocytes. Oocyte nuclei contain extrachromosomal replicas of the genes for ribosomal RNA</article-title>. <source/>Science
<volume>160</volume>:<fpage>272</fpage>–<lpage>280</lpage>.<pub-id pub-id-type="pmid">4867987</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gall</surname><given-names>JG</given-names></name>, <name><surname>Rochaix</surname><given-names>JD</given-names></name></person-group>
<year>1974</year>
<article-title>The amplified ribosomal DNA of dytiscid beetles</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>71</volume>:<fpage>1819</fpage>–<lpage>1823</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.71.5.1819</pub-id>.<pub-id pub-id-type="pmid">4525295</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Findly</surname><given-names>RC</given-names></name>, <name><surname>Gall</surname><given-names>JG</given-names></name></person-group>
<year>1978</year>
<article-title>Free ribosomal RNA genes in Paramecium are tandemly repeated</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>75</volume>:<fpage>3312</fpage>–<lpage>3316</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.75.7.3312</pub-id>.<pub-id pub-id-type="pmid">277929</pub-id></mixed-citation>
</ref>
<ref id="B58">
<label>58.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engberg</surname><given-names>J</given-names></name></person-group>
<year>1985</year>
<article-title>The ribosomal RNA genes of Tetrahymena: structure and function</article-title>. <source/>Eur J Cell Biol
<volume>36</volume>:<fpage>133</fpage>–<lpage>151</lpage>.<pub-id pub-id-type="pmid">3884336</pub-id></mixed-citation>
</ref>
<ref id="B59">
<label>59.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lara</surname><given-names>FJ</given-names></name>, <name><surname>Stocker</surname><given-names>AJ</given-names></name>, <name><surname>Amabis</surname><given-names>JM</given-names></name></person-group>
<year>1991</year>
<article-title>DNA sequence amplification in sciarid flies: results and perspectives</article-title>. <source/>Braz J Med Biol Res
<volume>24</volume>:<fpage>233</fpage>–<lpage>248</lpage>.<pub-id pub-id-type="pmid">1823237</pub-id></mixed-citation>
</ref>
<ref id="B60">
<label>60.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Candido-Silva</surname><given-names>JA</given-names></name>, <name><surname>Machado</surname><given-names>MC</given-names></name>, <name><surname>Hartfelder</surname><given-names>KH</given-names></name>, <name><surname>de Almeida</surname><given-names>JC</given-names></name>, <name><surname>Paco-Larson</surname><given-names>ML</given-names></name>, <name><surname>Monesi</surname><given-names>N</given-names></name></person-group>
<year>2015</year>
<article-title>Amplification and expression of a salivary gland DNA puff gene in the prothoracic gland of Bradysia hygida (Diptera: Sciaridae)</article-title>. <source/>J Insect Physiol
<volume>74C</volume>:<fpage>30</fpage>–<lpage>37</lpage>.<pub-id pub-id-type="pmid">25666977</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orr-Weaver</surname><given-names>TL</given-names></name></person-group>
<year>1991</year>
<article-title>Drosophila chorion genes: cracking the eggshell's secrets</article-title>. <source/>Bioessays
<volume>13</volume>:<fpage>97</fpage>–<lpage>105</lpage>. doi:<pub-id pub-id-type="doi">10.1002/bies.950130302</pub-id>.<pub-id pub-id-type="pmid">1908228</pub-id></mixed-citation>
</ref>
<ref id="B62">
<label>62.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claycomb</surname><given-names>JM</given-names></name>, <name><surname>Benasutti</surname><given-names>M</given-names></name>, <name><surname>Bosco</surname><given-names>G</given-names></name>, <name><surname>Fenger</surname><given-names>DD</given-names></name>, <name><surname>Orr-Weaver</surname><given-names>TL</given-names></name></person-group>
<year>2004</year>
<article-title>Gene amplification as a developmental strategy: isolation of two developmental amplicons in Drosophila</article-title>. <source/>Dev Cell
<volume>6</volume>:<fpage>145</fpage>–<lpage>155</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1534-5807(03)00398-8</pub-id>.<pub-id pub-id-type="pmid">14723854</pub-id></mixed-citation>
</ref>
<ref id="B63">
<label>63.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehen</surname><given-names>SK</given-names></name>, <name><surname>McConnell</surname><given-names>MJ</given-names></name>, <name><surname>Kaushal</surname><given-names>D</given-names></name>, <name><surname>Kingsbury</surname><given-names>MA</given-names></name>, <name><surname>Yang</surname><given-names>AH</given-names></name>, <name><surname>Chun</surname><given-names>J</given-names></name></person-group>
<year>2001</year>
<article-title>Chromosomal variation in neurons of the developing and adult mammalian nervous system</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>98</volume>:<fpage>13361</fpage>–<lpage>13366</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.231487398</pub-id>.<pub-id pub-id-type="pmid">11698687</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaschke</surname><given-names>AJ</given-names></name>, <name><surname>Staley</surname><given-names>K</given-names></name>, <name><surname>Chun</surname><given-names>J</given-names></name></person-group>
<year>1996</year>
<article-title>Widespread programmed cell death in proliferative and postmitotic regions of the fetal cerebral cortex</article-title>. <source/>Development
<volume>122</volume>:<fpage>1165</fpage>–<lpage>1174</lpage>.<pub-id pub-id-type="pmid">8620843</pub-id></mixed-citation>
</ref>
<ref id="B65">
<label>65.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westra</surname><given-names>JW</given-names></name>, <name><surname>Peterson</surname><given-names>SE</given-names></name>, <name><surname>Yung</surname><given-names>YC</given-names></name>, <name><surname>Mutoh</surname><given-names>T</given-names></name>, <name><surname>Barral</surname><given-names>S</given-names></name>, <name><surname>Chun</surname><given-names>J</given-names></name></person-group>
<year>2008</year>
<article-title>Aneuploid mosaicism in the developing and adult cerebellar cortex</article-title>. <source/>J Comp Neurol
<volume>507</volume>:<fpage>1944</fpage>–<lpage>1951</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cne.21648</pub-id>.<pub-id pub-id-type="pmid">18273885</pub-id></mixed-citation>
</ref>
<ref id="B66">
<label>66.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McConnell</surname><given-names>MJ</given-names></name>, <name><surname>Lindberg</surname><given-names>MR</given-names></name>, <name><surname>Brennand</surname><given-names>KJ</given-names></name>, <name><surname>Piper</surname><given-names>JC</given-names></name>, <name><surname>Voet</surname><given-names>T</given-names></name>, <name><surname>Cowing-Zitron</surname><given-names>C</given-names></name>, <name><surname>Shumilina</surname><given-names>S</given-names></name>, <name><surname>Lasken</surname><given-names>RS</given-names></name>, <name><surname>Vermeesch</surname><given-names>JR</given-names></name>, <name><surname>Hall</surname><given-names>IM</given-names></name>, <name><surname>Gage</surname><given-names>FH</given-names></name></person-group>
<year>2013</year>
<article-title>Mosaic copy number variation in human neurons</article-title>. <source/>Science
<volume>342</volume>:<fpage>632</fpage>–<lpage>637</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1243472</pub-id>.<pub-id pub-id-type="pmid">24179226</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henrichsen</surname><given-names>CN</given-names></name>, <name><surname>Vinckenbosch</surname><given-names>N</given-names></name>, <name><surname>Zollner</surname><given-names>S</given-names></name>, <name><surname>Chaignat</surname><given-names>E</given-names></name>, <name><surname>Pradervand</surname><given-names>S</given-names></name>, <name><surname>Schutz</surname><given-names>F</given-names></name>, <name><surname>Ruedi</surname><given-names>M</given-names></name>, <name><surname>Kaessmann</surname><given-names>H</given-names></name>, <name><surname>Reymond</surname><given-names>A</given-names></name></person-group>
<year>2009</year>
<article-title>Segmental copy number variation shapes tissue transcriptomes</article-title>. <source/>Nat Genet
<volume>41</volume>:<fpage>424</fpage>–<lpage>429</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.345</pub-id>.<pub-id pub-id-type="pmid">19270705</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>AW</given-names></name>, <name><surname>Taylor</surname><given-names>MH</given-names></name>, <name><surname>Hickey</surname><given-names>RD</given-names></name>, <name><surname>Hanlon Newell</surname><given-names>AE</given-names></name>, <name><surname>Lenzi</surname><given-names>ML</given-names></name>, <name><surname>Olson</surname><given-names>SB</given-names></name>, <name><surname>Finegold</surname><given-names>MJ</given-names></name>, <name><surname>Grompe</surname><given-names>M</given-names></name></person-group>
<year>2010</year>
<article-title>The ploidy conveyor of mature hepatocytes as a source of genetic variation</article-title>. <source/>Nature
<volume>467</volume>:<fpage>707</fpage>–<lpage>710</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature09414</pub-id>.<pub-id pub-id-type="pmid">20861837</pub-id></mixed-citation>
</ref>
<ref id="B69">
<label>69.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>AW</given-names></name>, <name><surname>Hanlon Newell</surname><given-names>AE</given-names></name>, <name><surname>Smith</surname><given-names>L</given-names></name>, <name><surname>Wilson</surname><given-names>EM</given-names></name>, <name><surname>Olson</surname><given-names>SB</given-names></name>, <name><surname>Thayer</surname><given-names>MJ</given-names></name>, <name><surname>Strom</surname><given-names>SC</given-names></name>, <name><surname>Grompe</surname><given-names>M</given-names></name></person-group>
<year>2012</year>
<article-title>Frequent aneuploidy among normal human hepatocytes</article-title>. <source/>Gastroenterology
<volume>142</volume>:<fpage>25</fpage>–<lpage>28</lpage>. doi:<pub-id pub-id-type="doi">10.1053/j.gastro.2011.10.029</pub-id>.<pub-id pub-id-type="pmid">22057114</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knouse</surname><given-names>KA</given-names></name>, <name><surname>Wu</surname><given-names>J</given-names></name>, <name><surname>Whittaker</surname><given-names>CA</given-names></name>, <name><surname>Amon</surname><given-names>A</given-names></name></person-group>
<year>2014</year>
<article-title>Single cell sequencing reveals low levels of aneuploidy across mammalian tissues</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>111</volume>:<fpage>13409</fpage>–<lpage>13414</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1415287111</pub-id>.<pub-id pub-id-type="pmid">25197050</pub-id></mixed-citation>
</ref>
<ref id="B71">
<label>71.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guiral</surname><given-names>S</given-names></name>, <name><surname>Mitchell</surname><given-names>TJ</given-names></name>, <name><surname>Martin</surname><given-names>B</given-names></name>, <name><surname>Claverys</surname><given-names>JP</given-names></name></person-group>
<year>2005</year>
<article-title>Competence-programmed predation of noncompetent cells in the human pathogen Streptococcus pneumoniae: genetic requirements</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>102</volume>:<fpage>8710</fpage>–<lpage>8715</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0500879102</pub-id>.<pub-id pub-id-type="pmid">15928084</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slager</surname><given-names>J</given-names></name>, <name><surname>Kjos</surname><given-names>M</given-names></name>, <name><surname>Attaiech</surname><given-names>L</given-names></name>, <name><surname>Veening</surname><given-names>JW</given-names></name></person-group>
<year>2014</year>
<article-title>Antibiotic-induced replication stress triggers bacterial competence by increasing gene dosage near the origin</article-title>. <source/>Cell
<volume>157</volume>:<fpage>395</fpage>–<lpage>406</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2014.01.068</pub-id>.<pub-id pub-id-type="pmid">24725406</pub-id></mixed-citation>
</ref>
<ref id="B73">
<label>73.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>S</given-names></name>, <name><surname>Berg</surname><given-names>OG</given-names></name>, <name><surname>Roth</surname><given-names>JR</given-names></name>, <name><surname>Andersson</surname><given-names>DI</given-names></name></person-group>
<year>2009</year>
<article-title>Contribution of gene amplification to evolution of increased antibiotic resistance in Salmonella typhimurium</article-title>. <source/>Genetics
<volume>182</volume>:<fpage>1183</fpage>–<lpage>1195</lpage>. doi:<pub-id pub-id-type="doi">10.1534/genetics.109.103028</pub-id>.<pub-id pub-id-type="pmid">19474201</pub-id></mixed-citation>
</ref>
<ref id="B74">
<label>74.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matagne</surname><given-names>A</given-names></name>, <name><surname>Lamotte-Brasseur</surname><given-names>J</given-names></name>, <name><surname>Frere</surname><given-names>JM</given-names></name></person-group>
<year>1998</year>
<article-title>Catalytic properties of class A beta-lactamases: efficiency and diversity</article-title>. <source/>Biochem J
<volume>330</volume>:<fpage>581</fpage>–<lpage>598</lpage>. doi:<pub-id pub-id-type="doi">10.1042/bj3300581</pub-id>.<pub-id pub-id-type="pmid">9480862</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matagne</surname><given-names>A</given-names></name>, <name><surname>Misselyn-Bauduin</surname><given-names>AM</given-names></name>, <name><surname>Joris</surname><given-names>B</given-names></name>, <name><surname>Erpicum</surname><given-names>T</given-names></name>, <name><surname>Granier</surname><given-names>B</given-names></name>, <name><surname>Frere</surname><given-names>JM</given-names></name></person-group>
<year>1990</year>
<article-title>The diversity of the catalytic properties of class A beta-lactamases</article-title>. <source/>Biochem J
<volume>265</volume>:<fpage>131</fpage>–<lpage>146</lpage>. doi:<pub-id pub-id-type="doi">10.1042/bj2650131</pub-id>.<pub-id pub-id-type="pmid">2302162</pub-id></mixed-citation>
</ref>
<ref id="B76">
<label>76.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandegren</surname><given-names>L</given-names></name>, <name><surname>Andersson</surname><given-names>DI</given-names></name></person-group>
<year>2009</year>
<article-title>Bacterial gene amplification: implications for the evolution of antibiotic resistance</article-title>. <source/>Nat Rev Microbiol
<volume>7</volume>:<fpage>578</fpage>–<lpage>588</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrmicro2174</pub-id>.<pub-id pub-id-type="pmid">19609259</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forche</surname><given-names>A</given-names></name>, <name><surname>Magee</surname><given-names>PT</given-names></name>, <name><surname>Selmecki</surname><given-names>A</given-names></name>, <name><surname>Berman</surname><given-names>J</given-names></name>, <name><surname>May</surname><given-names>G</given-names></name></person-group>
<year>2009</year>
<article-title>Evolution in Candida albicans populations during a single passage through a mouse host</article-title>. <source/>Genetics
<volume>182</volume>:<fpage>799</fpage>–<lpage>811</lpage>. doi:<pub-id pub-id-type="doi">10.1534/genetics.109.103325</pub-id>.<pub-id pub-id-type="pmid">19414562</pub-id></mixed-citation>
</ref>
<ref id="B78">
<label>78.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>JA</given-names></name>, <name><surname>Ammar</surname><given-names>R</given-names></name>, <name><surname>Torti</surname><given-names>D</given-names></name>, <name><surname>Nislow</surname><given-names>C</given-names></name>, <name><surname>Cowen</surname><given-names>LE</given-names></name></person-group>
<year>2013</year>
<article-title>Genetic and genomic architecture of the evolution of resistance to antifungal drug combinations</article-title>. <source/>PLoS Genet
<volume>9</volume>:<fpage>e1003390</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pgen.1003390</pub-id>.<pub-id pub-id-type="pmid">23593013</pub-id></mixed-citation>
</ref>
<ref id="B79">
<label>79.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname><given-names>CB</given-names></name>, <name><surname>Funt</surname><given-names>JM</given-names></name>, <name><surname>Abbey</surname><given-names>D</given-names></name>, <name><surname>Issi</surname><given-names>L</given-names></name>, <name><surname>Guiducci</surname><given-names>C</given-names></name>, <name><surname>Martinez</surname><given-names>DA</given-names></name>, <name><surname>Delorey</surname><given-names>T</given-names></name>, <name><surname>Li</surname><given-names>BY</given-names></name>, <name><surname>White</surname><given-names>TC</given-names></name>, <name><surname>Cuomo</surname><given-names>C</given-names></name>, <name><surname>Rao</surname><given-names>RP</given-names></name>, <name><surname>Berman</surname><given-names>J</given-names></name>, <name><surname>Thompson</surname><given-names>DA</given-names></name>, <name><surname>Regev</surname><given-names>A</given-names></name></person-group>
<year>2015</year>
<article-title>The evolution of drug resistance in clinical isolates of Candida albicans</article-title>. <source/>eLife
<volume>4</volume>:<fpage>e00662</fpage>. doi:<pub-id pub-id-type="doi">10.7554/eLife.00662</pub-id>.<pub-id pub-id-type="pmid">25646566</pub-id></mixed-citation>
</ref>
<ref id="B80">
<label>80.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrow</surname><given-names>CA</given-names></name>, <name><surname>Fraser</surname><given-names>JA</given-names></name></person-group>
<year>2013</year>
<article-title>Ploidy variation as an adaptive mechanism in human pathogenic fungi</article-title>. <source/>Semin Cell Dev Biol
<volume>24</volume>:<fpage>339</fpage>–<lpage>346</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.semcdb.2013.01.008</pub-id>.<pub-id pub-id-type="pmid">23380396</pub-id></mixed-citation>
</ref>
<ref id="B81">
<label>81.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selmecki</surname><given-names>A</given-names></name>, <name><surname>Forche</surname><given-names>A</given-names></name>, <name><surname>Berman</surname><given-names>J</given-names></name></person-group>
<year>2006</year>
<article-title>Aneuploidy and isochromosome formation in drug-resistant Candida albicans</article-title>. <source/>Science
<volume>313</volume>:<fpage>367</fpage>–<lpage>370</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1128242</pub-id>.<pub-id pub-id-type="pmid">16857942</pub-id></mixed-citation>
</ref>
<ref id="B82">
<label>82.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selmecki</surname><given-names>A</given-names></name>, <name><surname>Gerami-Nejad</surname><given-names>M</given-names></name>, <name><surname>Paulson</surname><given-names>C</given-names></name>, <name><surname>Forche</surname><given-names>A</given-names></name>, <name><surname>Berman</surname><given-names>J</given-names></name></person-group>
<year>2008</year>
<article-title>An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1</article-title>. <source/>Mol Microbiol
<volume>68</volume>:<fpage>624</fpage>–<lpage>641</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2958.2008.06176.x</pub-id>.<pub-id pub-id-type="pmid">18363649</pub-id></mixed-citation>
</ref>
<ref id="B83">
<label>83.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coste</surname><given-names>AT</given-names></name>, <name><surname>Karababa</surname><given-names>M</given-names></name>, <name><surname>Ischer</surname><given-names>F</given-names></name>, <name><surname>Bille</surname><given-names>J</given-names></name>, <name><surname>Sanglard</surname><given-names>D</given-names></name></person-group>
<year>2004</year>
<article-title>TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2</article-title>. <source/>Eukaryot Cell
<volume>3</volume>:<fpage>1639</fpage>–<lpage>1652</lpage>. doi:<pub-id pub-id-type="doi">10.1128/EC.3.6.1639-1652.2004</pub-id>.<pub-id pub-id-type="pmid">15590837</pub-id></mixed-citation>
</ref>
<ref id="B84">
<label>84.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>TC</given-names></name></person-group>
<year>1997</year>
<article-title>Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus</article-title>. <source/>Antimicrob Agents Chemother
<volume>41</volume>:<fpage>1482</fpage>–<lpage>1487</lpage>.<pub-id pub-id-type="pmid">9210670</pub-id></mixed-citation>
</ref>
<ref id="B85">
<label>85.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gresham</surname><given-names>D</given-names></name>, <name><surname>Desai</surname><given-names>MM</given-names></name>, <name><surname>Tucker</surname><given-names>CM</given-names></name>, <name><surname>Jenq</surname><given-names>HT</given-names></name>, <name><surname>Pai</surname><given-names>DA</given-names></name>, <name><surname>Ward</surname><given-names>A</given-names></name>, <name><surname>DeSevo</surname><given-names>CG</given-names></name>, <name><surname>Botstein</surname><given-names>D</given-names></name>, <name><surname>Dunham</surname><given-names>MJ</given-names></name></person-group>
<year>2008</year>
<article-title>The repertoire and dynamics of evolutionary adaptations to controlled nutrient-limited environments in yeast</article-title>. <source/>PLoS Genet
<volume>4</volume>:<fpage>e1000303</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pgen.1000303</pub-id>.<pub-id pub-id-type="pmid">19079573</pub-id></mixed-citation>
</ref>
<ref id="B86">
<label>86.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>GH</given-names></name>, <name><surname>Dominy</surname><given-names>NJ</given-names></name>, <name><surname>Claw</surname><given-names>KG</given-names></name>, <name><surname>Lee</surname><given-names>AS</given-names></name>, <name><surname>Fiegler</surname><given-names>H</given-names></name>, <name><surname>Redon</surname><given-names>R</given-names></name>, <name><surname>Werner</surname><given-names>J</given-names></name>, <name><surname>Villanea</surname><given-names>FA</given-names></name>, <name><surname>Mountain</surname><given-names>JL</given-names></name>, <name><surname>Misra</surname><given-names>R</given-names></name>, <name><surname>Carter</surname><given-names>NP</given-names></name>, <name><surname>Lee</surname><given-names>C</given-names></name>, <name><surname>Stone</surname><given-names>AC</given-names></name></person-group>
<year>2007</year>
<article-title>Diet and the evolution of human amylase gene copy number variation</article-title>. <source/>Nat Genet
<volume>39</volume>:<fpage>1256</fpage>–<lpage>1260</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng2123</pub-id>.<pub-id pub-id-type="pmid">17828263</pub-id></mixed-citation>
</ref>
<ref id="B87">
<label>87.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iskow</surname><given-names>RC</given-names></name>, <name><surname>Gokcumen</surname><given-names>O</given-names></name>, <name><surname>Lee</surname><given-names>C</given-names></name></person-group>
<year>2012</year>
<article-title>Exploring the role of copy number variants in human adaptation</article-title>. <source/>Trends Genet
<volume>28</volume>:<fpage>245</fpage>–<lpage>257</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tig.2012.03.002</pub-id>.<pub-id pub-id-type="pmid">22483647</pub-id></mixed-citation>
</ref>
<ref id="B88">
<label>88.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schrider</surname><given-names>DR</given-names></name>, <name><surname>Hahn</surname><given-names>MW</given-names></name></person-group>
<year>2010</year>
<article-title>Gene copy-number polymorphism in nature</article-title>. <source/>Proc Biol Sci
<volume>277</volume>:<fpage>3213</fpage>–<lpage>3221</lpage>. doi:<pub-id pub-id-type="doi">10.1098/rspb.2010.1180</pub-id>.<pub-id pub-id-type="pmid">20591863</pub-id></mixed-citation>
</ref>
<ref id="B89">
<label>89.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>E</given-names></name>, <name><surname>Kulkarni</surname><given-names>H</given-names></name>, <name><surname>Bolivar</surname><given-names>H</given-names></name>, <name><surname>Mangano</surname><given-names>A</given-names></name>, <name><surname>Sanchez</surname><given-names>R</given-names></name>, <name><surname>Catano</surname><given-names>G</given-names></name>, <name><surname>Nibbs</surname><given-names>RJ</given-names></name>, <name><surname>Freedman</surname><given-names>BI</given-names></name>, <name><surname>Quinones</surname><given-names>MP</given-names></name>, <name><surname>Bamshad</surname><given-names>MJ</given-names></name>, <name><surname>Murthy</surname><given-names>KK</given-names></name>, <name><surname>Rovin</surname><given-names>BH</given-names></name>, <name><surname>Bradley</surname><given-names>W</given-names></name>, <name><surname>Clark</surname><given-names>RA</given-names></name>, <name><surname>Anderson</surname><given-names>SA</given-names></name>, <name><surname>O'Connell</surname><given-names>RJ</given-names></name>, <name><surname>Agan</surname><given-names>BK</given-names></name>, <name><surname>Ahuja</surname><given-names>SS</given-names></name>, <name><surname>Bologna</surname><given-names>R</given-names></name>, <name><surname>Sen</surname><given-names>L</given-names></name>, <name><surname>Dolan</surname><given-names>MJ</given-names></name>, <name><surname>Ahuja</surname><given-names>SK</given-names></name></person-group>
<year>2005</year>
<article-title>The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility</article-title>. <source/>Science
<volume>307</volume>:<fpage>1434</fpage>–<lpage>1440</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1101160</pub-id>.<pub-id pub-id-type="pmid">15637236</pub-id></mixed-citation>
</ref>
<ref id="B90">
<label>90.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollox</surname><given-names>EJ</given-names></name>, <name><surname>Huffmeier</surname><given-names>U</given-names></name>, <name><surname>Zeeuwen</surname><given-names>PL</given-names></name>, <name><surname>Palla</surname><given-names>R</given-names></name>, <name><surname>Lascorz</surname><given-names>J</given-names></name>, <name><surname>Rodijk-Olthuis</surname><given-names>D</given-names></name>, <name><surname>van de Kerkhof</surname><given-names>PC</given-names></name>, <name><surname>Traupe</surname><given-names>H</given-names></name>, <name><surname>de Jongh</surname><given-names>G</given-names></name>, <name><surname>den Heijer</surname><given-names>M</given-names></name>, <name><surname>Reis</surname><given-names>A</given-names></name>, <name><surname>Armour</surname><given-names>JA</given-names></name>, <name><surname>Schalkwijk</surname><given-names>J</given-names></name></person-group>
<year>2008</year>
<article-title>Psoriasis is associated with increased beta-defensin genomic copy number</article-title>. <source/>Nat Genet
<volume>40</volume>:<fpage>23</fpage>–<lpage>25</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.2007.48</pub-id>.<pub-id pub-id-type="pmid">18059266</pub-id></mixed-citation>
</ref>
<ref id="B91">
<label>91.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollox</surname><given-names>EJ</given-names></name>, <name><surname>Barber</surname><given-names>JC</given-names></name>, <name><surname>Brookes</surname><given-names>AJ</given-names></name>, <name><surname>Armour</surname><given-names>JA</given-names></name></person-group>
<year>2008</year>
<article-title>Defensins and the dynamic genome: what we can learn from structural variation at human chromosome band 8p23.1</article-title>. <source/>Genome Res
<volume>18</volume>:<fpage>1686</fpage>–<lpage>1697</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gr.080945.108</pub-id>.<pub-id pub-id-type="pmid">18974263</pub-id></mixed-citation>
</ref>
<ref id="B92">
<label>92.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Marechal</surname><given-names>C</given-names></name>, <name><surname>Masson</surname><given-names>E</given-names></name>, <name><surname>Chen</surname><given-names>JM</given-names></name>, <name><surname>Morel</surname><given-names>F</given-names></name>, <name><surname>Ruszniewski</surname><given-names>P</given-names></name>, <name><surname>Levy</surname><given-names>P</given-names></name>, <name><surname>Ferec</surname><given-names>C</given-names></name></person-group>
<year>2006</year>
<article-title>Hereditary pancreatitis caused by triplication of the trypsinogen locus</article-title>. <source/>Nat Genet
<volume>38</volume>:<fpage>1372</fpage>–<lpage>1374</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng1904</pub-id>.<pub-id pub-id-type="pmid">17072318</pub-id></mixed-citation>
</ref>
<ref id="B93">
<label>93.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fellermann</surname><given-names>K</given-names></name>, <name><surname>Stange</surname><given-names>DE</given-names></name>, <name><surname>Schaeffeler</surname><given-names>E</given-names></name>, <name><surname>Schmalzl</surname><given-names>H</given-names></name>, <name><surname>Wehkamp</surname><given-names>J</given-names></name>, <name><surname>Bevins</surname><given-names>CL</given-names></name>, <name><surname>Reinisch</surname><given-names>W</given-names></name>, <name><surname>Teml</surname><given-names>A</given-names></name>, <name><surname>Schwab</surname><given-names>M</given-names></name>, <name><surname>Lichter</surname><given-names>P</given-names></name>, <name><surname>Radlwimmer</surname><given-names>B</given-names></name>, <name><surname>Stange</surname><given-names>EF</given-names></name></person-group>
<year>2006</year>
<article-title>A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon</article-title>. <source/>Am J Hum Genet
<volume>79</volume>:<fpage>439</fpage>–<lpage>448</lpage>. doi:<pub-id pub-id-type="doi">10.1086/505915</pub-id>.<pub-id pub-id-type="pmid">16909382</pub-id></mixed-citation>
</ref>
<ref id="B94">
<label>94.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aitman</surname><given-names>TJ</given-names></name>, <name><surname>Dong</surname><given-names>R</given-names></name>, <name><surname>Vyse</surname><given-names>TJ</given-names></name>, <name><surname>Norsworthy</surname><given-names>PJ</given-names></name>, <name><surname>Johnson</surname><given-names>MD</given-names></name>, <name><surname>Smith</surname><given-names>J</given-names></name>, <name><surname>Mangion</surname><given-names>J</given-names></name>, <name><surname>Roberton-Lowe</surname><given-names>C</given-names></name>, <name><surname>Marshall</surname><given-names>AJ</given-names></name>, <name><surname>Petretto</surname><given-names>E</given-names></name>, <name><surname>Hodges</surname><given-names>MD</given-names></name>, <name><surname>Bhangal</surname><given-names>G</given-names></name>, <name><surname>Patel</surname><given-names>SG</given-names></name>, <name><surname>Sheehan-Rooney</surname><given-names>K</given-names></name>, <name><surname>Duda</surname><given-names>M</given-names></name>, <name><surname>Cook</surname><given-names>PR</given-names></name>, <name><surname>Evans</surname><given-names>DJ</given-names></name>, <name><surname>Domin</surname><given-names>J</given-names></name>, <name><surname>Flint</surname><given-names>J</given-names></name>, <name><surname>Boyle</surname><given-names>JJ</given-names></name>, <name><surname>Pusey</surname><given-names>CD</given-names></name>, <name><surname>Cook</surname><given-names>HT</given-names></name></person-group>
<year>2006</year>
<article-title>Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans</article-title>. <source/>Nature
<volume>439</volume>:<fpage>851</fpage>–<lpage>855</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature04489</pub-id>.<pub-id pub-id-type="pmid">16482158</pub-id></mixed-citation>
</ref>
<ref id="B95">
<label>95.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>AW</given-names></name>, <name><surname>Hanlon Newell</surname><given-names>AE</given-names></name>, <name><surname>Bi</surname><given-names>W</given-names></name>, <name><surname>Finegold</surname><given-names>MJ</given-names></name>, <name><surname>Olson</surname><given-names>SB</given-names></name>, <name><surname>Beaudet</surname><given-names>AL</given-names></name>, <name><surname>Grompe</surname><given-names>M</given-names></name></person-group>
<year>2012</year>
<article-title>Aneuploidy as a mechanism for stress-induced liver adaptation</article-title>. <source/>J Clin Invest
<volume>122</volume>:<fpage>3307</fpage>–<lpage>3315</lpage>. doi:<pub-id pub-id-type="doi">10.1172/JCI64026</pub-id>.<pub-id pub-id-type="pmid">22863619</pub-id></mixed-citation>
</ref>
<ref id="B96">
<label>96.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beroukhim</surname><given-names>R</given-names></name>, <name><surname>Mermel</surname><given-names>CH</given-names></name>, <name><surname>Porter</surname><given-names>D</given-names></name>, <name><surname>Wei</surname><given-names>G</given-names></name>, <name><surname>Raychaudhuri</surname><given-names>S</given-names></name>, <name><surname>Donovan</surname><given-names>J</given-names></name>, <name><surname>Barretina</surname><given-names>J</given-names></name>, <name><surname>Boehm</surname><given-names>JS</given-names></name>, <name><surname>Dobson</surname><given-names>J</given-names></name>, <name><surname>Urashima</surname><given-names>M</given-names></name>, <name><surname>Mc Henry</surname><given-names>KT</given-names></name>, <name><surname>Pinchback</surname><given-names>RM</given-names></name>, <name><surname>Ligon</surname><given-names>AH</given-names></name>, <name><surname>Cho</surname><given-names>YJ</given-names></name>, <name><surname>Haery</surname><given-names>L</given-names></name>, <name><surname>Greulich</surname><given-names>H</given-names></name>, <name><surname>Reich</surname><given-names>M</given-names></name>, <name><surname>Winckler</surname><given-names>W</given-names></name>, <name><surname>Lawrence</surname><given-names>MS</given-names></name>, <name><surname>Weir</surname><given-names>BA</given-names></name>, <name><surname>Tanaka</surname><given-names>KE</given-names></name>, <name><surname>Chiang</surname><given-names>DY</given-names></name>, <name><surname>Bass</surname><given-names>AJ</given-names></name>, <name><surname>Loo</surname><given-names>A</given-names></name>, <name><surname>Hoffman</surname><given-names>C</given-names></name>, <name><surname>Prensner</surname><given-names>J</given-names></name>, <name><surname>Liefeld</surname><given-names>T</given-names></name>, <name><surname>Gao</surname><given-names>Q</given-names></name>, <name><surname>Yecies</surname><given-names>D</given-names></name>, <name><surname>Signoretti</surname><given-names>S</given-names></name>, <name><surname>Maher</surname><given-names>E</given-names></name>, <name><surname>Kaye</surname><given-names>FJ</given-names></name>, <name><surname>Sasaki</surname><given-names>H</given-names></name>, <name><surname>Tepper</surname><given-names>JE</given-names></name>, <name><surname>Fletcher</surname><given-names>JA</given-names></name>, <name><surname>Tabernero</surname><given-names>J</given-names></name>, <name><surname>Baselga</surname><given-names>J</given-names></name>, <name><surname>Tsao</surname><given-names>MS</given-names></name>, <name><surname>Demichelis</surname><given-names>F</given-names></name>, <name><surname>Rubin</surname><given-names>MA</given-names></name>, <name><surname>Janne</surname><given-names>PA</given-names></name>, <name><surname>Daly</surname><given-names>MJ</given-names></name>, <name><surname>Nucera</surname><given-names>C</given-names></name>, <name><surname>Levine</surname><given-names>RL</given-names></name>, <name><surname>Ebert</surname><given-names>BL</given-names></name>, <name><surname>Gabriel</surname><given-names>S</given-names></name>, <name><surname>Rustgi</surname><given-names>AK</given-names></name>, <name><surname>Antonescu</surname><given-names>CR</given-names></name>, <name><surname>Ladanyi</surname><given-names>M</given-names></name>, <name><surname>Letai</surname><given-names>A</given-names></name>, <etal></etal></person-group>
<year>2010</year>
<article-title>The landscape of somatic copy-number alteration across human cancers</article-title>. <source/>Nature
<volume>463</volume>:<fpage>899</fpage>–<lpage>905</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature08822</pub-id>.<pub-id pub-id-type="pmid">20164920</pub-id></mixed-citation>
</ref>
<ref id="B97">
<label>97.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudson</surname><given-names>TJ</given-names></name>, <name><surname>Anderson</surname><given-names>W</given-names></name>, <name><surname>Artez</surname><given-names>A</given-names></name>, <name><surname>Barker</surname><given-names>AD</given-names></name>, <name><surname>Bell</surname><given-names>C</given-names></name>, <name><surname>Bernabe</surname><given-names>RR</given-names></name>, <name><surname>Bhan</surname><given-names>MK</given-names></name>, <name><surname>Calvo</surname><given-names>F</given-names></name>, <name><surname>Eerola</surname><given-names>I</given-names></name>, <name><surname>Gerhard</surname><given-names>DS</given-names></name>, <name><surname>Guttmacher</surname><given-names>A</given-names></name>, <name><surname>Guyer</surname><given-names>M</given-names></name>, <name><surname>Hemsley</surname><given-names>FM</given-names></name>, <name><surname>Jennings</surname><given-names>JL</given-names></name>, <name><surname>Kerr</surname><given-names>D</given-names></name>, <name><surname>Klatt</surname><given-names>P</given-names></name>, <name><surname>Kolar</surname><given-names>P</given-names></name>, <name><surname>Kusada</surname><given-names>J</given-names></name>, <name><surname>Lane</surname><given-names>DP</given-names></name>, <name><surname>Laplace</surname><given-names>F</given-names></name>, <name><surname>Youyong</surname><given-names>L</given-names></name>, <name><surname>Nettekoven</surname><given-names>G</given-names></name>, <name><surname>Ozenberger</surname><given-names>B</given-names></name>, <name><surname>Peterson</surname><given-names>J</given-names></name>, <name><surname>Rao</surname><given-names>TS</given-names></name>, <name><surname>Remacle</surname><given-names>J</given-names></name>, <name><surname>Schafer</surname><given-names>AJ</given-names></name>, <name><surname>Shibata</surname><given-names>T</given-names></name>, <name><surname>Stratton</surname><given-names>MR</given-names></name>, <name><surname>Vockley</surname><given-names>JG</given-names></name>, <name><surname>Watanabe</surname><given-names>K</given-names></name>, <name><surname>Yang</surname><given-names>H</given-names></name>, <name><surname>Yuen</surname><given-names>MM</given-names></name>, <name><surname>Knoppers</surname><given-names>BM</given-names></name>, <name><surname>Bobrow</surname><given-names>M</given-names></name>, <name><surname>Cambon-Thomsen</surname><given-names>A</given-names></name>, <name><surname>Dressler</surname><given-names>LG</given-names></name>, <name><surname>Dyke</surname><given-names>SO</given-names></name>, <name><surname>Joly</surname><given-names>Y</given-names></name>, <name><surname>Kato</surname><given-names>K</given-names></name>, <name><surname>Kennedy</surname><given-names>KL</given-names></name>, <name><surname>Nicolas</surname><given-names>P</given-names></name>, <name><surname>Parker</surname><given-names>MJ</given-names></name>, <name><surname>Rial-Sebbag</surname><given-names>E</given-names></name>, <name><surname>Romeo-Casabona</surname><given-names>CM</given-names></name>, <name><surname>Shaw</surname><given-names>KM</given-names></name>, <name><surname>Wallace</surname><given-names>S</given-names></name>, <name><surname>Wiesner</surname><given-names>GL</given-names></name>, <name><surname>Zeps</surname><given-names>N</given-names></name>, <name><surname>Lichter</surname><given-names>P</given-names></name>, <etal></etal></person-group>
<year>2010</year>
<article-title>International network of cancer genome projects</article-title>. <source/>Nature
<volume>464</volume>:<fpage>993</fpage>–<lpage>998</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature08987</pub-id>.<pub-id pub-id-type="pmid">20393554</pub-id></mixed-citation>
</ref>
<ref id="B98">
<label>98.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>AJ</given-names></name>, <name><surname>Bigner</surname><given-names>SH</given-names></name>, <name><surname>Bigner</surname><given-names>DD</given-names></name>, <name><surname>Kinzler</surname><given-names>KW</given-names></name>, <name><surname>Hamilton</surname><given-names>SR</given-names></name>, <name><surname>Vogelstein</surname><given-names>B</given-names></name></person-group>
<year>1987</year>
<article-title>Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>84</volume>:<fpage>6899</fpage>–<lpage>6903</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.84.19.6899</pub-id>.<pub-id pub-id-type="pmid">3477813</pub-id></mixed-citation>
</ref>
<ref id="B99">
<label>99.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwab</surname><given-names>M</given-names></name></person-group>
<year>1990</year>
<article-title>Amplification of the MYCN oncogene and deletion of putative tumour suppressor gene in human neuroblastomas</article-title>. <source/>Brain Pathol
<volume>1</volume>:<fpage>41</fpage>–<lpage>46</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1750-3639.1990.tb00637.x</pub-id>.<pub-id pub-id-type="pmid">1669692</pub-id></mixed-citation>
</ref>
<ref id="B100">
<label>100.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>S</given-names></name>, <name><surname>Groudine</surname><given-names>M</given-names></name></person-group>
<year>1982</year>
<article-title>Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line</article-title>. <source/>Nature
<volume>298</volume>:<fpage>679</fpage>–<lpage>681</lpage>. doi:<pub-id pub-id-type="doi">10.1038/298679a0</pub-id>.<pub-id pub-id-type="pmid">6285209</pub-id></mixed-citation>
</ref>
<ref id="B101">
<label>101.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>MS</given-names></name>, <name><surname>Locher</surname><given-names>GW</given-names></name>, <name><surname>Saurer</surname><given-names>S</given-names></name>, <name><surname>Gullick</surname><given-names>WJ</given-names></name>, <name><surname>Waterfield</surname><given-names>MD</given-names></name>, <name><surname>Groner</surname><given-names>B</given-names></name>, <name><surname>Hynes</surname><given-names>NE</given-names></name></person-group>
<year>1988</year>
<article-title>Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading</article-title>. <source/>Cancer Res
<volume>48</volume>:<fpage>1238</fpage>–<lpage>1243</lpage>.<pub-id pub-id-type="pmid">2893663</pub-id></mixed-citation>
</ref>
<ref id="B102">
<label>102.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slamon</surname><given-names>DJ</given-names></name>, <name><surname>Godolphin</surname><given-names>W</given-names></name>, <name><surname>Jones</surname><given-names>LA</given-names></name>, <name><surname>Holt</surname><given-names>JA</given-names></name>, <name><surname>Wong</surname><given-names>SG</given-names></name>, <name><surname>Keith</surname><given-names>DE</given-names></name>, <name><surname>Levin</surname><given-names>WJ</given-names></name>, <name><surname>Stuart</surname><given-names>SG</given-names></name>, <name><surname>Udove</surname><given-names>J</given-names></name>, <name><surname>Ullrich</surname><given-names>A</given-names></name>, <etal></etal></person-group>
<year>1989</year>
<article-title>Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer</article-title>. <source/>Science
<volume>244</volume>:<fpage>707</fpage>–<lpage>712</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.2470152</pub-id>.<pub-id pub-id-type="pmid">2470152</pub-id></mixed-citation>
</ref>
<ref id="B103">
<label>103.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hynes</surname><given-names>NE</given-names></name></person-group>
<year>1993</year>
<article-title>Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy</article-title>. <source/>Semin Cancer Biol
<volume>4</volume>:<fpage>19</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">8095411</pub-id></mixed-citation>
</ref>
<ref id="B104">
<label>104.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollander</surname><given-names>MC</given-names></name>, <name><surname>Blumenthal</surname><given-names>GM</given-names></name>, <name><surname>Dennis</surname><given-names>PA</given-names></name></person-group>
<year>2011</year>
<article-title>PTEN loss in the continuum of common cancers, rare syndromes and mouse models</article-title>. <source/>Nat Rev Cancer
<volume>11</volume>:<fpage>289</fpage>–<lpage>301</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrc3037</pub-id>.<pub-id pub-id-type="pmid">21430697</pub-id></mixed-citation>
</ref>
<ref id="B105">
<label>105.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>AJ</given-names></name>, <name><surname>Momand</surname><given-names>J</given-names></name>, <name><surname>Finlay</surname><given-names>CA</given-names></name></person-group>
<year>1991</year>
<article-title>The p53 tumour suppressor gene</article-title>. <source/>Nature
<volume>351</volume>:<fpage>453</fpage>–<lpage>456</lpage>. doi:<pub-id pub-id-type="doi">10.1038/351453a0</pub-id>.<pub-id pub-id-type="pmid">2046748</pub-id></mixed-citation>
</ref>
<ref id="B106">
<label>106.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linehan</surname><given-names>WM</given-names></name>, <name><surname>Lerman</surname><given-names>MI</given-names></name>, <name><surname>Zbar</surname><given-names>B</given-names></name></person-group>
<year>1995</year>
<article-title>Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer</article-title>. <source/>JAMA
<volume>273</volume>:<fpage>564</fpage>–<lpage>570</lpage>.<pub-id pub-id-type="pmid">7837390</pub-id></mixed-citation>
</ref>
<ref id="B107">
<label>107.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinstein</surname><given-names>IB</given-names></name>, <name><surname>Joe</surname><given-names>AK</given-names></name></person-group>
<year>2006</year>
<article-title>Mechanisms of disease: oncogene addiction—a rationale for molecular targeting in cancer therapy</article-title>. <source/>Nat Clin Pract Oncol
<volume>3</volume>:<fpage>448</fpage>–<lpage>457</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ncponc0558</pub-id>.<pub-id pub-id-type="pmid">16894390</pub-id></mixed-citation>
</ref>
<ref id="B108">
<label>108.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arteaga</surname><given-names>CL</given-names></name></person-group>
<year>2003</year>
<article-title>Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer</article-title>. <source/>Breast Cancer Res
<volume>5</volume>:<fpage>96</fpage>–<lpage>100</lpage>. doi:<pub-id pub-id-type="doi">10.1186/bcr574</pub-id>.<pub-id pub-id-type="pmid">12631388</pub-id></mixed-citation>
</ref>
<ref id="B109">
<label>109.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minguet</surname><given-names>J</given-names></name>, <name><surname>Smith</surname><given-names>KH</given-names></name>, <name><surname>Bramlage</surname><given-names>P</given-names></name></person-group>
<day>4</day>
<month>11</month>
<year>2015</year>
<article-title>Targeted therapies for treatment of non-small cell lung cancer: recent advances and future perspectives</article-title>. <source/>Int J Cancer doi:<pub-id pub-id-type="doi">10.1002/ijc.29915</pub-id>.</mixed-citation>
</ref>
<ref id="B110">
<label>110.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arteaga</surname><given-names>CL</given-names></name>, <name><surname>Johnson</surname><given-names>DH</given-names></name></person-group>
<year>2001</year>
<article-title>Tyrosine kinase inhibitors-ZD1839 (Iressa)</article-title>. <source/>Curr Opin Oncol
<volume>13</volume>:<fpage>491</fpage>–<lpage>498</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00001622-200111000-00012</pub-id>.<pub-id pub-id-type="pmid">11673690</pub-id></mixed-citation>
</ref>
<ref id="B111">
<label>111.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaughnessy</surname><given-names>J</given-names></name></person-group>
<year>2005</year>
<article-title>Amplification and overexpression of CKS1B at chromosome band 1q21 is associated with reduced levels of p27<sup>Kip1</sup> and an aggressive clinical course in multiple myeloma</article-title>. <source/>Hematology
<volume>10</volume>(<issue>Suppl 1</issue>):<fpage>117</fpage>–<lpage>126</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1080/10245330512331390140">http://dx.doi.org/10.1080/10245330512331390140</ext-link></comment>.<pub-id pub-id-type="pmid">16188652</pub-id></mixed-citation>
</ref>
<ref id="B112">
<label>112.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fonseca</surname><given-names>R</given-names></name>, <name><surname>Van Wier</surname><given-names>SA</given-names></name>, <name><surname>Chng</surname><given-names>WJ</given-names></name>, <name><surname>Ketterling</surname><given-names>R</given-names></name>, <name><surname>Lacy</surname><given-names>MQ</given-names></name>, <name><surname>Dispenzieri</surname><given-names>A</given-names></name>, <name><surname>Bergsagel</surname><given-names>PL</given-names></name>, <name><surname>Rajkumar</surname><given-names>SV</given-names></name>, <name><surname>Greipp</surname><given-names>PR</given-names></name>, <name><surname>Litzow</surname><given-names>MR</given-names></name>, <name><surname>Price-Troska</surname><given-names>T</given-names></name>, <name><surname>Henderson</surname><given-names>KJ</given-names></name>, <name><surname>Ahmann</surname><given-names>GJ</given-names></name>, <name><surname>Gertz</surname><given-names>MA</given-names></name></person-group>
<year>2006</year>
<article-title>Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma</article-title>. <source/>Leukemia
<volume>20</volume>:<fpage>2034</fpage>–<lpage>2040</lpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.leu.2404403</pub-id>.<pub-id pub-id-type="pmid">17024118</pub-id></mixed-citation>
</ref>
<ref id="B113">
<label>113.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>L</given-names></name>, <name><surname>Kosugi</surname><given-names>M</given-names></name>, <name><surname>Kufe</surname><given-names>D</given-names></name></person-group>
<year>2012</year>
<article-title>Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPH</article-title>. <source/>Blood
<volume>119</volume>:<fpage>810</fpage>–<lpage>816</lpage>. doi:<pub-id pub-id-type="doi">10.1182/blood-2011-07-369686</pub-id>.<pub-id pub-id-type="pmid">22117045</pub-id></mixed-citation>
</ref>
<ref id="B114">
<label>114.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>F</given-names></name>, <name><surname>Tonon</surname><given-names>G</given-names></name>, <name><surname>Bashari</surname><given-names>MH</given-names></name>, <name><surname>Vallet</surname><given-names>S</given-names></name>, <name><surname>Antonini</surname><given-names>E</given-names></name>, <name><surname>Goldschmidt</surname><given-names>H</given-names></name>, <name><surname>Schulze-Bergkamen</surname><given-names>H</given-names></name>, <name><surname>Opferman</surname><given-names>JT</given-names></name>, <name><surname>Sattler</surname><given-names>M</given-names></name>, <name><surname>Anderson</surname><given-names>KC</given-names></name>, <name><surname>Jager</surname><given-names>D</given-names></name>, <name><surname>Podar</surname><given-names>K</given-names></name></person-group>
<year>2014</year>
<article-title>Targeting Mcl-1 for multiple myeloma (MM) therapy: drug-induced generation of Mcl-1 fragment Mcl-1(128-350) triggers MM cell death via c-Jun upregulation</article-title>. <source/>Cancer Lett
<volume>343</volume>:<fpage>286</fpage>–<lpage>294</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.canlet.2013.09.042</pub-id>.<pub-id pub-id-type="pmid">24120758</pub-id></mixed-citation>
</ref>
<ref id="B115">
<label>115.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>J</given-names></name>, <name><surname>Otsuki</surname><given-names>T</given-names></name>, <name><surname>Hirasawa</surname><given-names>A</given-names></name>, <name><surname>Imoto</surname><given-names>I</given-names></name>, <name><surname>Matsuo</surname><given-names>Y</given-names></name>, <name><surname>Shimizu</surname><given-names>S</given-names></name>, <name><surname>Taniwaki</surname><given-names>M</given-names></name>, <name><surname>Inazawa</surname><given-names>J</given-names></name></person-group>
<year>2004</year>
<article-title>Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma</article-title>. <source/>Am J Pathol
<volume>165</volume>:<fpage>71</fpage>–<lpage>81</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0002-9440(10)63276-2</pub-id>.<pub-id pub-id-type="pmid">15215163</pub-id></mixed-citation>
</ref>
<ref id="B116">
<label>116.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hideshima</surname><given-names>T</given-names></name>, <name><surname>Mitsiades</surname><given-names>C</given-names></name>, <name><surname>Tonon</surname><given-names>G</given-names></name>, <name><surname>Richardson</surname><given-names>PG</given-names></name>, <name><surname>Anderson</surname><given-names>KC</given-names></name></person-group>
<year>2007</year>
<article-title>Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets</article-title>. <source/>Nat Rev Cancer
<volume>7</volume>:<fpage>585</fpage>–<lpage>598</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrc2189</pub-id>.<pub-id pub-id-type="pmid">17646864</pub-id></mixed-citation>
</ref>
<ref id="B117">
<label>117.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mani</surname><given-names>M</given-names></name>, <name><surname>Carrasco</surname><given-names>DE</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Takada</surname><given-names>K</given-names></name>, <name><surname>Gatt</surname><given-names>ME</given-names></name>, <name><surname>Dutta-Simmons</surname><given-names>J</given-names></name>, <name><surname>Ikeda</surname><given-names>H</given-names></name>, <name><surname>Diaz-Griffero</surname><given-names>F</given-names></name>, <name><surname>Pena-Cruz</surname><given-names>V</given-names></name>, <name><surname>Bertagnolli</surname><given-names>M</given-names></name>, <name><surname>Myeroff</surname><given-names>LL</given-names></name>, <name><surname>Markowitz</surname><given-names>SD</given-names></name>, <name><surname>Anderson</surname><given-names>KC</given-names></name>, <name><surname>Carrasco</surname><given-names>DR</given-names></name></person-group>
<year>2009</year>
<article-title>BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells</article-title>. <source/>Cancer Res
<volume>69</volume>:<fpage>7577</fpage>–<lpage>7586</lpage>. doi:<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-0773</pub-id>.<pub-id pub-id-type="pmid">19738061</pub-id></mixed-citation>
</ref>
<ref id="B118">
<label>118.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabris</surname><given-names>S</given-names></name>, <name><surname>Ronchetti</surname><given-names>D</given-names></name>, <name><surname>Agnelli</surname><given-names>L</given-names></name>, <name><surname>Baldini</surname><given-names>L</given-names></name>, <name><surname>Morabito</surname><given-names>F</given-names></name>, <name><surname>Bicciato</surname><given-names>S</given-names></name>, <name><surname>Basso</surname><given-names>D</given-names></name>, <name><surname>Todoerti</surname><given-names>K</given-names></name>, <name><surname>Lombardi</surname><given-names>L</given-names></name>, <name><surname>Lambertenghi-Deliliers</surname><given-names>G</given-names></name>, <name><surname>Neri</surname><given-names>A</given-names></name></person-group>
<year>2007</year>
<article-title>Transcriptional features of multiple myeloma patients with chromosome 1q gain</article-title>. <source/>Leukemia
<volume>21</volume>:<fpage>1113</fpage>–<lpage>1116</lpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.leu.2404616</pub-id>.<pub-id pub-id-type="pmid">17315022</pub-id></mixed-citation>
</ref>
<ref id="B119">
<label>119.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanamura</surname><given-names>I</given-names></name>, <name><surname>Stewart</surname><given-names>JP</given-names></name>, <name><surname>Huang</surname><given-names>Y</given-names></name>, <name><surname>Zhan</surname><given-names>F</given-names></name>, <name><surname>Santra</surname><given-names>M</given-names></name>, <name><surname>Sawyer</surname><given-names>JR</given-names></name>, <name><surname>Hollmig</surname><given-names>K</given-names></name>, <name><surname>Zangarri</surname><given-names>M</given-names></name>, <name><surname>Pineda-Roman</surname><given-names>M</given-names></name>, <name><surname>van Rhee</surname><given-names>F</given-names></name>, <name><surname>Cavallo</surname><given-names>F</given-names></name>, <name><surname>Burington</surname><given-names>B</given-names></name>, <name><surname>Crowley</surname><given-names>J</given-names></name>, <name><surname>Tricot</surname><given-names>G</given-names></name>, <name><surname>Barlogie</surname><given-names>B</given-names></name>, <name><surname>Shaughnessy</surname><given-names>JD</given-names><suffix>Jr</suffix></name></person-group>
<year>2006</year>
<article-title>Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation</article-title>. <source/>Blood
<volume>108</volume>:<fpage>1724</fpage>–<lpage>1732</lpage>. doi:<pub-id pub-id-type="doi">10.1182/blood-2006-03-009910</pub-id>.<pub-id pub-id-type="pmid">16705089</pub-id></mixed-citation>
</ref>
<ref id="B120">
<label>120.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>H</given-names></name>, <name><surname>Yeung</surname><given-names>J</given-names></name>, <name><surname>Xu</surname><given-names>W</given-names></name>, <name><surname>Ning</surname><given-names>Y</given-names></name>, <name><surname>Patterson</surname><given-names>B</given-names></name></person-group>
<year>2006</year>
<article-title>Significant increase of CKS1B amplification from monoclonal gammopathy of undetermined significance to multiple myeloma and plasma cell leukaemia as demonstrated by interphase fluorescence in situ hybridisation</article-title>. <source/>Br J Haematol
<volume>134</volume>:<fpage>613</fpage>–<lpage>615</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2141.2006.06237.x</pub-id>.<pub-id pub-id-type="pmid">16889615</pub-id></mixed-citation>
</ref>
<ref id="B121">
<label>121.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>L</given-names></name>, <name><surname>Wang</surname><given-names>S</given-names></name>, <name><surname>Zangari</surname><given-names>M</given-names></name>, <name><surname>Xu</surname><given-names>H</given-names></name>, <name><surname>Cao</surname><given-names>TM</given-names></name>, <name><surname>Xu</surname><given-names>C</given-names></name>, <name><surname>Wu</surname><given-names>Y</given-names></name>, <name><surname>Xiao</surname><given-names>F</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Yang</surname><given-names>Y</given-names></name>, <name><surname>Salama</surname><given-names>M</given-names></name>, <name><surname>Li</surname><given-names>G</given-names></name>, <name><surname>Tricot</surname><given-names>G</given-names></name>, <name><surname>Zhan</surname><given-names>F</given-names></name></person-group>
<year>2010</year>
<article-title>Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance</article-title>. <source/>Oncotarget
<volume>1</volume>:<fpage>22</fpage>–<lpage>33</lpage>. doi:<pub-id pub-id-type="doi">10.18632/oncotarget.105</pub-id>.<pub-id pub-id-type="pmid">20930946</pub-id></mixed-citation>
</ref>
<ref id="B122">
<label>122.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patch</surname><given-names>AM</given-names></name>, <name><surname>Christie</surname><given-names>EL</given-names></name>, <name><surname>Etemadmoghadam</surname><given-names>D</given-names></name>, <name><surname>Garsed</surname><given-names>DW</given-names></name>, <name><surname>George</surname><given-names>J</given-names></name>, <name><surname>Fereday</surname><given-names>S</given-names></name>, <name><surname>Nones</surname><given-names>K</given-names></name>, <name><surname>Cowin</surname><given-names>P</given-names></name>, <name><surname>Alsop</surname><given-names>K</given-names></name>, <name><surname>Bailey</surname><given-names>PJ</given-names></name>, <name><surname>Kassahn</surname><given-names>KS</given-names></name>, <name><surname>Newell</surname><given-names>F</given-names></name>, <name><surname>Quinn</surname><given-names>MC</given-names></name>, <name><surname>Kazakoff</surname><given-names>S</given-names></name>, <name><surname>Quek</surname><given-names>K</given-names></name>, <name><surname>Wilhelm-Benartzi</surname><given-names>C</given-names></name>, <name><surname>Curry</surname><given-names>E</given-names></name>, <name><surname>Leong</surname><given-names>HS</given-names></name>, <name><surname>Hamilton</surname><given-names>A</given-names></name>, <name><surname>Mileshkin</surname><given-names>L</given-names></name>, <name><surname>Au-Yeung</surname><given-names>G</given-names></name>, <name><surname>Kennedy</surname><given-names>C</given-names></name>, <name><surname>Hung</surname><given-names>J</given-names></name>, <name><surname>Chiew</surname><given-names>YE</given-names></name>, <name><surname>Harnett</surname><given-names>P</given-names></name>, <name><surname>Friedlander</surname><given-names>M</given-names></name>, <name><surname>Quinn</surname><given-names>M</given-names></name>, <name><surname>Pyman</surname><given-names>J</given-names></name>, <name><surname>Cordner</surname><given-names>S</given-names></name>, <name><surname>O'Brien</surname><given-names>P</given-names></name>, <name><surname>Leditschke</surname><given-names>J</given-names></name>, <name><surname>Young</surname><given-names>G</given-names></name>, <name><surname>Strachan</surname><given-names>K</given-names></name>, <name><surname>Waring</surname><given-names>P</given-names></name>, <name><surname>Azar</surname><given-names>W</given-names></name>, <name><surname>Mitchell</surname><given-names>C</given-names></name>, <name><surname>Traficante</surname><given-names>N</given-names></name>, <name><surname>Hendley</surname><given-names>J</given-names></name>, <name><surname>Thorne</surname><given-names>H</given-names></name>, <name><surname>Shackleton</surname><given-names>M</given-names></name>, <name><surname>Miller</surname><given-names>DK</given-names></name>, <name><surname>Arnau</surname><given-names>GM</given-names></name>, <name><surname>Tothill</surname><given-names>RW</given-names></name>, <name><surname>Holloway</surname><given-names>TP</given-names></name>, <name><surname>Semple</surname><given-names>T</given-names></name>, <name><surname>Harliwong</surname><given-names>I</given-names></name>, <name><surname>Nourse</surname><given-names>C</given-names></name>, <name><surname>Nourbakhsh</surname><given-names>E</given-names></name>, <name><surname>Manning</surname><given-names>S</given-names></name>, <name><surname>Idrisoglu</surname><given-names>S</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>Whole-genome characterization of chemoresistant ovarian cancer</article-title>. <source/>Nature
<volume>521</volume>:<fpage>489</fpage>–<lpage>494</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature14410</pub-id>.<pub-id pub-id-type="pmid">26017449</pub-id></mixed-citation>
</ref>
<ref id="B123">
<label>123.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noro</surname><given-names>R</given-names></name>, <name><surname>Seike</surname><given-names>M</given-names></name>, <name><surname>Zou</surname><given-names>F</given-names></name>, <name><surname>Soeno</surname><given-names>C</given-names></name>, <name><surname>Matsuda</surname><given-names>K</given-names></name>, <name><surname>Sugano</surname><given-names>T</given-names></name>, <name><surname>Nishijima</surname><given-names>N</given-names></name>, <name><surname>Matsumoto</surname><given-names>M</given-names></name>, <name><surname>Kitamura</surname><given-names>K</given-names></name>, <name><surname>Kosaihira</surname><given-names>S</given-names></name>, <name><surname>Minegishi</surname><given-names>Y</given-names></name>, <name><surname>Yoshimura</surname><given-names>A</given-names></name>, <name><surname>Kubota</surname><given-names>K</given-names></name>, <name><surname>Gemma</surname><given-names>A</given-names></name></person-group>
<year>2015</year>
<article-title>MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation</article-title>. <source/>BMC Cancer
<volume>15</volume>:<fpage>31</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12885-015-1019-1</pub-id>.<pub-id pub-id-type="pmid">25886066</pub-id></mixed-citation>
</ref>
<ref id="B124">
<label>124.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bardelli</surname><given-names>A</given-names></name>, <name><surname>Corso</surname><given-names>S</given-names></name>, <name><surname>Bertotti</surname><given-names>A</given-names></name>, <name><surname>Hobor</surname><given-names>S</given-names></name>, <name><surname>Valtorta</surname><given-names>E</given-names></name>, <name><surname>Siravegna</surname><given-names>G</given-names></name>, <name><surname>Sartore-Bianchi</surname><given-names>A</given-names></name>, <name><surname>Scala</surname><given-names>E</given-names></name>, <name><surname>Cassingena</surname><given-names>A</given-names></name>, <name><surname>Zecchin</surname><given-names>D</given-names></name>, <name><surname>Apicella</surname><given-names>M</given-names></name>, <name><surname>Migliardi</surname><given-names>G</given-names></name>, <name><surname>Galimi</surname><given-names>F</given-names></name>, <name><surname>Lauricella</surname><given-names>C</given-names></name>, <name><surname>Zanon</surname><given-names>C</given-names></name>, <name><surname>Perera</surname><given-names>T</given-names></name>, <name><surname>Veronese</surname><given-names>S</given-names></name>, <name><surname>Corti</surname><given-names>G</given-names></name>, <name><surname>Amatu</surname><given-names>A</given-names></name>, <name><surname>Gambacorta</surname><given-names>M</given-names></name>, <name><surname>Diaz</surname><given-names>LA</given-names><suffix>Jr</suffix></name>, <name><surname>Sausen</surname><given-names>M</given-names></name>, <name><surname>Velculescu</surname><given-names>VE</given-names></name>, <name><surname>Comoglio</surname><given-names>P</given-names></name>, <name><surname>Trusolino</surname><given-names>L</given-names></name>, <name><surname>Di Nicolantonio</surname><given-names>F</given-names></name>, <name><surname>Giordano</surname><given-names>S</given-names></name>, <name><surname>Siena</surname><given-names>S</given-names></name></person-group>
<year>2013</year>
<article-title>Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer</article-title>. <source/>Cancer Discov
<volume>3</volume>:<fpage>658</fpage>–<lpage>673</lpage>. doi:<pub-id pub-id-type="doi">10.1158/2159-8290.CD-12-0558</pub-id>.<pub-id pub-id-type="pmid">23729478</pub-id></mixed-citation>
</ref>
<ref id="B125">
<label>125.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engelman</surname><given-names>JA</given-names></name>, <name><surname>Zejnullahu</surname><given-names>K</given-names></name>, <name><surname>Mitsudomi</surname><given-names>T</given-names></name>, <name><surname>Song</surname><given-names>Y</given-names></name>, <name><surname>Hyland</surname><given-names>C</given-names></name>, <name><surname>Park</surname><given-names>JO</given-names></name>, <name><surname>Lindeman</surname><given-names>N</given-names></name>, <name><surname>Gale</surname><given-names>CM</given-names></name>, <name><surname>Zhao</surname><given-names>X</given-names></name>, <name><surname>Christensen</surname><given-names>J</given-names></name>, <name><surname>Kosaka</surname><given-names>T</given-names></name>, <name><surname>Holmes</surname><given-names>AJ</given-names></name>, <name><surname>Rogers</surname><given-names>AM</given-names></name>, <name><surname>Cappuzzo</surname><given-names>F</given-names></name>, <name><surname>Mok</surname><given-names>T</given-names></name>, <name><surname>Lee</surname><given-names>C</given-names></name>, <name><surname>Johnson</surname><given-names>BE</given-names></name>, <name><surname>Cantley</surname><given-names>LC</given-names></name>, <name><surname>Janne</surname><given-names>PA</given-names></name></person-group>
<year>2007</year>
<article-title>MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling</article-title>. <source/>Science
<volume>316</volume>:<fpage>1039</fpage>–<lpage>1043</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1141478</pub-id>.<pub-id pub-id-type="pmid">17463250</pub-id></mixed-citation>
</ref>
<ref id="B126">
<label>126.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J</given-names></name>, <name><surname>Zhou</surname><given-names>Y</given-names></name>, <name><surname>Thomas</surname><given-names>GS</given-names></name>, <name><surname>Gu</surname><given-names>Z</given-names></name>, <name><surname>Yang</surname><given-names>Y</given-names></name>, <name><surname>Xu</surname><given-names>H</given-names></name>, <name><surname>Tricot</surname><given-names>G</given-names></name>, <name><surname>Zhan</surname><given-names>F</given-names></name></person-group>
<year>2015</year>
<article-title>NEDD8 inhibition overcomes CKS1B-induced drug resistance by upregulation of p21 in multiple myeloma</article-title>. <source/>Clin Cancer Res
<volume>21</volume>:<fpage>5532</fpage>–<lpage>5542</lpage>. doi:<pub-id pub-id-type="doi">10.1158/1078-0432.CCR-15-0254</pub-id>.<pub-id pub-id-type="pmid">26156395</pub-id></mixed-citation>
</ref>
<ref id="B127">
<label>127.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollett</surname><given-names>JB</given-names></name>, <name><surname>Trudel</surname><given-names>S</given-names></name>, <name><surname>Stern</surname><given-names>D</given-names></name>, <name><surname>Li</surname><given-names>ZH</given-names></name>, <name><surname>Stewart</surname><given-names>AK</given-names></name></person-group>
<year>2002</year>
<article-title>Overexpression of the myeloma-associated oncogene fibroblast growth factor receptor 3 confers dexamethasone resistance</article-title>. <source/>Blood
<volume>100</volume>:<fpage>3819</fpage>–<lpage>3821</lpage>. doi:<pub-id pub-id-type="doi">10.1182/blood-2002-02-0608</pub-id>.<pub-id pub-id-type="pmid">12393593</pub-id></mixed-citation>
</ref>
<ref id="B128">
<label>128.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etemadmoghadam</surname><given-names>D</given-names></name>, <name><surname>George</surname><given-names>J</given-names></name>, <name><surname>Cowin</surname><given-names>PA</given-names></name>, <name><surname>Cullinane</surname><given-names>C</given-names></name>, <name><surname>Kansara</surname><given-names>M</given-names></name>, <name><surname>Gorringe</surname><given-names>KL</given-names></name>, <name><surname>Smyth</surname><given-names>GK</given-names></name>, <name><surname>Bowtell</surname><given-names>DD</given-names></name></person-group>
<year>2010</year>
<article-title>Amplicon-dependent CCNE1 expression is critical for clonogenic survival after cisplatin treatment and is correlated with 20q11 gain in ovarian cancer</article-title>. <source/>PLoS One
<volume>5</volume>:<fpage>e15498</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0015498</pub-id>.<pub-id pub-id-type="pmid">21103391</pub-id></mixed-citation>
</ref>
<ref id="B129">
<label>129.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B</given-names></name>, <name><surname>Li</surname><given-names>S</given-names></name>, <name><surname>Meng</surname><given-names>X</given-names></name>, <name><surname>Shang</surname><given-names>H</given-names></name>, <name><surname>Guan</surname><given-names>Y</given-names></name></person-group>
<year>2015</year>
<article-title>Inhibition of mdr1 by G-quadruplex oligonucleotides and reversal of paclitaxel resistance in human ovarian cancer cells</article-title>. <source/>Tumour Biol
<volume>36</volume>:<fpage>6433</fpage>–<lpage>6443</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s13277-015-3333-2</pub-id>.<pub-id pub-id-type="pmid">25801244</pub-id></mixed-citation>
</ref>
<ref id="B130">
<label>130.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>Z</given-names></name>, <name><surname>Brakora</surname><given-names>KA</given-names></name>, <name><surname>Seiden</surname><given-names>MV</given-names></name></person-group>
<year>2004</year>
<article-title>Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells</article-title>. <source/>Mol Cancer Ther
<volume>3</volume>:<fpage>833</fpage>–<lpage>838</lpage>.<pub-id pub-id-type="pmid">15252144</pub-id></mixed-citation>
</ref>
<ref id="B131">
<label>131.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yabuki</surname><given-names>N</given-names></name>, <name><surname>Sakata</surname><given-names>K</given-names></name>, <name><surname>Yamasaki</surname><given-names>T</given-names></name>, <name><surname>Terashima</surname><given-names>H</given-names></name>, <name><surname>Mio</surname><given-names>T</given-names></name>, <name><surname>Miyazaki</surname><given-names>Y</given-names></name>, <name><surname>Fujii</surname><given-names>T</given-names></name>, <name><surname>Kitada</surname><given-names>K</given-names></name></person-group>
<year>2007</year>
<article-title>Gene amplification and expression in lung cancer cells with acquired paclitaxel resistance</article-title>. <source/>Cancer Genet Cytogenet
<volume>173</volume>:<fpage>1</fpage>–<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cancergencyto.2006.07.020</pub-id>.<pub-id pub-id-type="pmid">17284363</pub-id></mixed-citation>
</ref>
<ref id="B132">
<label>132.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katayama</surname><given-names>R</given-names></name>, <name><surname>Shaw</surname><given-names>AT</given-names></name>, <name><surname>Khan</surname><given-names>TM</given-names></name>, <name><surname>Mino-Kenudson</surname><given-names>M</given-names></name>, <name><surname>Solomon</surname><given-names>BJ</given-names></name>, <name><surname>Halmos</surname><given-names>B</given-names></name>, <name><surname>Jessop</surname><given-names>NA</given-names></name>, <name><surname>Wain</surname><given-names>JC</given-names></name>, <name><surname>Yeo</surname><given-names>AT</given-names></name>, <name><surname>Benes</surname><given-names>C</given-names></name>, <name><surname>Drew</surname><given-names>L</given-names></name>, <name><surname>Saeh</surname><given-names>JC</given-names></name>, <name><surname>Crosby</surname><given-names>K</given-names></name>, <name><surname>Sequist</surname><given-names>LV</given-names></name>, <name><surname>Iafrate</surname><given-names>AJ</given-names></name>, <name><surname>Engelman</surname><given-names>JA</given-names></name></person-group>
<year>2012</year>
<article-title>Mechanisms of acquired crizotinib resistance in ALK-rearranged lung cancers</article-title>. <source/>Sci Transl Med
<volume>4</volume>:<fpage>120ra117</fpage>.</mixed-citation>
</ref>
<ref id="B133">
<label>133.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shattuck</surname><given-names>DL</given-names></name>, <name><surname>Miller</surname><given-names>JK</given-names></name>, <name><surname>Carraway</surname><given-names>KL</given-names><suffix>III</suffix></name>, <name><surname>Sweeney</surname><given-names>C</given-names></name></person-group>
<year>2008</year>
<article-title>Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells</article-title>. <source/>Cancer Res
<volume>68</volume>:<fpage>1471</fpage>–<lpage>1477</lpage>. doi:<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-5962</pub-id>.<pub-id pub-id-type="pmid">18316611</pub-id></mixed-citation>
</ref>
<ref id="B134">
<label>134.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>CD</given-names></name>, <name><surname>Li</surname><given-names>Z</given-names></name>, <name><surname>Dillon</surname><given-names>DA</given-names></name>, <name><surname>Sacks</surname><given-names>DB</given-names></name></person-group>
<year>2011</year>
<article-title>IQGAP1 protein binds human epidermal growth factor receptor 2 (HER2) and modulates trastuzumab resistance</article-title>. <source/>J Biol Chem
<volume>286</volume>:<fpage>29734</fpage>–<lpage>29747</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M111.220939</pub-id>.<pub-id pub-id-type="pmid">21724847</pub-id></mixed-citation>
</ref>
<ref id="B135">
<label>135.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>TL</given-names></name>, <name><surname>Diaz</surname><given-names>LA</given-names><suffix>Jr</suffix></name>, <name><surname>Romans</surname><given-names>K</given-names></name>, <name><surname>Bardelli</surname><given-names>A</given-names></name>, <name><surname>Saha</surname><given-names>S</given-names></name>, <name><surname>Galizia</surname><given-names>G</given-names></name>, <name><surname>Choti</surname><given-names>M</given-names></name>, <name><surname>Donehower</surname><given-names>R</given-names></name>, <name><surname>Parmigiani</surname><given-names>G</given-names></name>, <name><surname>Shih</surname><given-names>IM</given-names></name>, <name><surname>Iacobuzio-Donahue</surname><given-names>C</given-names></name>, <name><surname>Kinzler</surname><given-names>KW</given-names></name>, <name><surname>Vogelstein</surname><given-names>B</given-names></name>, <name><surname>Lengauer</surname><given-names>C</given-names></name>, <name><surname>Velculescu</surname><given-names>VE</given-names></name></person-group>
<year>2004</year>
<article-title>Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>101</volume>:<fpage>3089</fpage>–<lpage>3094</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0308716101</pub-id>.<pub-id pub-id-type="pmid">14970324</pub-id></mixed-citation>
</ref>
<ref id="B136">
<label>136.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorre</surname><given-names>ME</given-names></name>, <name><surname>Mohammed</surname><given-names>M</given-names></name>, <name><surname>Ellwood</surname><given-names>K</given-names></name>, <name><surname>Hsu</surname><given-names>N</given-names></name>, <name><surname>Paquette</surname><given-names>R</given-names></name>, <name><surname>Rao</surname><given-names>PN</given-names></name>, <name><surname>Sawyers</surname><given-names>CL</given-names></name></person-group>
<year>2001</year>
<article-title>Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification</article-title>. <source/>Science
<volume>293</volume>:<fpage>876</fpage>–<lpage>880</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1062538</pub-id>.<pub-id pub-id-type="pmid">11423618</pub-id></mixed-citation>
</ref>
<ref id="B137">
<label>137.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>H</given-names></name>, <name><surname>Moriceau</surname><given-names>G</given-names></name>, <name><surname>Kong</surname><given-names>X</given-names></name>, <name><surname>Lee</surname><given-names>MK</given-names></name>, <name><surname>Lee</surname><given-names>H</given-names></name>, <name><surname>Koya</surname><given-names>RC</given-names></name>, <name><surname>Ng</surname><given-names>C</given-names></name>, <name><surname>Chodon</surname><given-names>T</given-names></name>, <name><surname>Scolyer</surname><given-names>RA</given-names></name>, <name><surname>Dahlman</surname><given-names>KB</given-names></name>, <name><surname>Sosman</surname><given-names>JA</given-names></name>, <name><surname>Kefford</surname><given-names>RF</given-names></name>, <name><surname>Long</surname><given-names>GV</given-names></name>, <name><surname>Nelson</surname><given-names>SF</given-names></name>, <name><surname>Ribas</surname><given-names>A</given-names></name>, <name><surname>Lo</surname><given-names>RS</given-names></name></person-group>
<year>2012</year>
<article-title>Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance</article-title>. <source/>Nat Commun
<volume>3</volume>:<fpage>724</fpage>. doi:<pub-id pub-id-type="doi">10.1038/ncomms1727</pub-id>.<pub-id pub-id-type="pmid">22395615</pub-id></mixed-citation>
</ref>
<ref id="B138">
<label>138.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villanueva</surname><given-names>J</given-names></name>, <name><surname>Infante</surname><given-names>JR</given-names></name>, <name><surname>Krepler</surname><given-names>C</given-names></name>, <name><surname>Reyes-Uribe</surname><given-names>P</given-names></name>, <name><surname>Samanta</surname><given-names>M</given-names></name>, <name><surname>Chen</surname><given-names>HY</given-names></name>, <name><surname>Li</surname><given-names>B</given-names></name>, <name><surname>Swoboda</surname><given-names>RK</given-names></name>, <name><surname>Wilson</surname><given-names>M</given-names></name>, <name><surname>Vultur</surname><given-names>A</given-names></name>, <name><surname>Fukunaba-Kalabis</surname><given-names>M</given-names></name>, <name><surname>Wubbenhorst</surname><given-names>B</given-names></name>, <name><surname>Chen</surname><given-names>TY</given-names></name>, <name><surname>Liu</surname><given-names>Q</given-names></name>, <name><surname>Sproesser</surname><given-names>K</given-names></name>, <name><surname>DeMarini</surname><given-names>DJ</given-names></name>, <name><surname>Gilmer</surname><given-names>TM</given-names></name>, <name><surname>Martin</surname><given-names>AM</given-names></name>, <name><surname>Marmorstein</surname><given-names>R</given-names></name>, <name><surname>Schultz</surname><given-names>DC</given-names></name>, <name><surname>Speicher</surname><given-names>DW</given-names></name>, <name><surname>Karakousis</surname><given-names>GC</given-names></name>, <name><surname>Xu</surname><given-names>W</given-names></name>, <name><surname>Amaravadi</surname><given-names>RK</given-names></name>, <name><surname>Xu</surname><given-names>X</given-names></name>, <name><surname>Schuchter</surname><given-names>LM</given-names></name>, <name><surname>Herlyn</surname><given-names>M</given-names></name>, <name><surname>Nathanson</surname><given-names>KL</given-names></name></person-group>
<year>2013</year>
<article-title>Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanoma</article-title>. <source/>Cell Rep
<volume>4</volume>:<fpage>1090</fpage>–<lpage>1099</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.celrep.2013.08.023</pub-id>.<pub-id pub-id-type="pmid">24055054</pub-id></mixed-citation>
</ref>
<ref id="B139">
<label>139.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haq</surname><given-names>R</given-names></name>, <name><surname>Yokoyama</surname><given-names>S</given-names></name>, <name><surname>Hawryluk</surname><given-names>EB</given-names></name>, <name><surname>Jonsson</surname><given-names>GB</given-names></name>, <name><surname>Frederick</surname><given-names>DT</given-names></name>, <name><surname>McHenry</surname><given-names>K</given-names></name>, <name><surname>Porter</surname><given-names>D</given-names></name>, <name><surname>Tran</surname><given-names>TN</given-names></name>, <name><surname>Love</surname><given-names>KT</given-names></name>, <name><surname>Langer</surname><given-names>R</given-names></name>, <name><surname>Anderson</surname><given-names>DG</given-names></name>, <name><surname>Garraway</surname><given-names>LA</given-names></name>, <name><surname>Duncan</surname><given-names>LM</given-names></name>, <name><surname>Morton</surname><given-names>DL</given-names></name>, <name><surname>Hoon</surname><given-names>DS</given-names></name>, <name><surname>Wargo</surname><given-names>JA</given-names></name>, <name><surname>Song</surname><given-names>JS</given-names></name>, <name><surname>Fisher</surname><given-names>DE</given-names></name></person-group>
<year>2013</year>
<article-title>BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>110</volume>:<fpage>4321</fpage>–<lpage>4326</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1205575110</pub-id>.<pub-id pub-id-type="pmid">23447565</pub-id></mixed-citation>
</ref>
<ref id="B140">
<label>140.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horns</surname><given-names>RC</given-names><suffix>Jr</suffix></name>, <name><surname>Dower</surname><given-names>WJ</given-names></name>, <name><surname>Schimke</surname><given-names>RT</given-names></name></person-group>
<year>1984</year>
<article-title>Gene amplification in a leukemic patient treated with methotrexate</article-title>. <source/>J Clin Oncol
<volume>2</volume>:<fpage>2</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">6583327</pub-id></mixed-citation>
</ref>
<ref id="B141">
<label>141.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carman</surname><given-names>MD</given-names></name>, <name><surname>Schornagel</surname><given-names>JH</given-names></name>, <name><surname>Rivest</surname><given-names>RS</given-names></name>, <name><surname>Srimatkandada</surname><given-names>S</given-names></name>, <name><surname>Portlock</surname><given-names>CS</given-names></name>, <name><surname>Duffy</surname><given-names>T</given-names></name>, <name><surname>Bertino</surname><given-names>JR</given-names></name></person-group>
<year>1984</year>
<article-title>Resistance to methotrexate due to gene amplification in a patient with acute leukemia</article-title>. <source/>J Clin Oncol
<volume>2</volume>:<fpage>16</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">6583326</pub-id></mixed-citation>
</ref>
<ref id="B142">
<label>142.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kudoh</surname><given-names>K</given-names></name>, <name><surname>Takano</surname><given-names>M</given-names></name>, <name><surname>Koshikawa</surname><given-names>T</given-names></name>, <name><surname>Hirai</surname><given-names>M</given-names></name>, <name><surname>Yoshida</surname><given-names>S</given-names></name>, <name><surname>Mano</surname><given-names>Y</given-names></name>, <name><surname>Yamamoto</surname><given-names>K</given-names></name>, <name><surname>Ishii</surname><given-names>K</given-names></name>, <name><surname>Kita</surname><given-names>T</given-names></name>, <name><surname>Kikuchi</surname><given-names>Y</given-names></name>, <name><surname>Nagata</surname><given-names>I</given-names></name>, <name><surname>Miwa</surname><given-names>M</given-names></name>, <name><surname>Uchida</surname><given-names>K</given-names></name></person-group>
<year>1999</year>
<article-title>Gains of 1q21-q22 and 13q12-q14 are potential indicators for resistance to cisplatin-based chemotherapy in ovarian cancer patients</article-title>. <source/>Clin Cancer Res
<volume>5</volume>:<fpage>2526</fpage>–<lpage>2531</lpage>.<pub-id pub-id-type="pmid">10499629</pub-id></mixed-citation>
</ref>
<ref id="B143">
<label>143.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takano</surname><given-names>M</given-names></name>, <name><surname>Kudo</surname><given-names>K</given-names></name>, <name><surname>Goto</surname><given-names>T</given-names></name>, <name><surname>Yamamoto</surname><given-names>K</given-names></name>, <name><surname>Kita</surname><given-names>T</given-names></name>, <name><surname>Kikuchi</surname><given-names>Y</given-names></name></person-group>
<year>2001</year>
<article-title>Analyses by comparative genomic hybridization of genes relating with cisplatin-resistance in ovarian cancer</article-title>. <source/>Hum Cell
<volume>14</volume>:<fpage>267</fpage>–<lpage>271</lpage>.<pub-id pub-id-type="pmid">11925927</pub-id></mixed-citation>
</ref>
<ref id="B144">
<label>144.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etemadmoghadam</surname><given-names>D</given-names></name>, <name><surname>Au-Yeung</surname><given-names>G</given-names></name>, <name><surname>Wall</surname><given-names>M</given-names></name>, <name><surname>Mitchell</surname><given-names>C</given-names></name>, <name><surname>Kansara</surname><given-names>M</given-names></name>, <name><surname>Loehrer</surname><given-names>E</given-names></name>, <name><surname>Batzios</surname><given-names>C</given-names></name>, <name><surname>George</surname><given-names>J</given-names></name>, <name><surname>Ftouni</surname><given-names>S</given-names></name>, <name><surname>Weir</surname><given-names>BA</given-names></name>, <name><surname>Carter</surname><given-names>S</given-names></name>, <name><surname>Gresshoff</surname><given-names>I</given-names></name>, <name><surname>Mileshkin</surname><given-names>L</given-names></name>, <name><surname>Rischin</surname><given-names>D</given-names></name>, <name><surname>Hahn</surname><given-names>WC</given-names></name>, <name><surname>Waring</surname><given-names>PM</given-names></name>, <name><surname>Getz</surname><given-names>G</given-names></name>, <name><surname>Cullinane</surname><given-names>C</given-names></name>, <name><surname>Campbell</surname><given-names>LJ</given-names></name>, <name><surname>Bowtell</surname><given-names>DD</given-names></name></person-group>
<year>2013</year>
<article-title>Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer</article-title>. <source/>Clin Cancer Res
<volume>19</volume>:<fpage>5960</fpage>–<lpage>5971</lpage>. doi:<pub-id pub-id-type="doi">10.1158/1078-0432.CCR-13-1337</pub-id>.<pub-id pub-id-type="pmid">24004674</pub-id></mixed-citation>
</ref>
<ref id="B145">
<label>145.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hakala</surname><given-names>MT</given-names></name></person-group>
<year>1957</year>
<article-title>Prevention of toxicity of amethopterin for sarcoma-180 cells in tissue culture</article-title>. <source/>Science
<volume>126</volume>:<fpage>255</fpage>.<pub-id pub-id-type="pmid">13454808</pub-id></mixed-citation>
</ref>
<ref id="B146">
<label>146.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hakala</surname><given-names>MT</given-names></name>, <name><surname>Taylor</surname><given-names>E</given-names></name></person-group>
<year>1959</year>
<article-title>The ability of purine and thymine derivatives and of glycine to support the growth of mammalian cells in culture</article-title>. <source/>J Biol Chem
<volume>234</volume>:<fpage>126</fpage>–<lpage>128</lpage>.<pub-id pub-id-type="pmid">13610906</pub-id></mixed-citation>
</ref>
<ref id="B147">
<label>147.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hakala</surname><given-names>MT</given-names></name>, <name><surname>Zakrzewski</surname><given-names>SF</given-names></name>, <name><surname>Nichol</surname><given-names>CA</given-names></name></person-group>
<year>1961</year>
<article-title>Relation of folic acid reductase to amethopterin resistance in cultured mammalian cells</article-title>. <source/>J Biol Chem
<volume>236</volume>:<fpage>952</fpage>–<lpage>958</lpage>.<pub-id pub-id-type="pmid">13710631</pub-id></mixed-citation>
</ref>
<ref id="B148">
<label>148.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>GA</given-names></name></person-group>
<year>1961</year>
<article-title>Increased levels of folic acid reductase as a mechanism of resistance to amethopterin in leukemic cells</article-title>. <source/>Biochem Pharmacol
<volume>7</volume>:<fpage>75</fpage>–<lpage>77</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0006-2952(61)90128-9</pub-id>.<pub-id pub-id-type="pmid">13699838</pub-id></mixed-citation>
</ref>
<ref id="B149">
<label>149.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schimke</surname><given-names>RT</given-names></name></person-group>
<year>1986</year>
<article-title>Methotrexate resistance and gene amplification. Mechanisms and implications</article-title>. <source/>Cancer
<volume>57</volume>:<fpage>1912</fpage>–<lpage>1917</lpage>.<pub-id pub-id-type="pmid">3513938</pub-id></mixed-citation>
</ref>
<ref id="B150">
<label>150.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alt</surname><given-names>FW</given-names></name>, <name><surname>Kellems</surname><given-names>RE</given-names></name>, <name><surname>Bertino</surname><given-names>JR</given-names></name>, <name><surname>Schimke</surname><given-names>RT</given-names></name></person-group>
<year>1978</year>
<article-title>Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells</article-title>. <source/>J Biol Chem
<volume>253</volume>:<fpage>1357</fpage>–<lpage>1370</lpage>.<pub-id pub-id-type="pmid">627542</pub-id></mixed-citation>
</ref>
<ref id="B151">
<label>151.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biedler</surname><given-names>JL</given-names></name>, <name><surname>Spengler</surname><given-names>BA</given-names></name></person-group>
<year>1976</year>
<article-title>A novel chromosome abnormality in human neuroblastoma and antifolate-resistant Chinese hamster cell lives in culture</article-title>. <source/>J Natl Cancer Inst
<volume>57</volume>:<fpage>683</fpage>–<lpage>695</lpage>.<pub-id pub-id-type="pmid">62055</pub-id></mixed-citation>
</ref>
<ref id="B152">
<label>152.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biedler</surname><given-names>JL</given-names></name>, <name><surname>Spengler</surname><given-names>BA</given-names></name></person-group>
<year>1976</year>
<article-title>Metaphase chromosome anomaly: association with drug resistance and cell-specific products</article-title>. <source/>Science
<volume>191</volume>:<fpage>185</fpage>–<lpage>187</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.942798</pub-id>.<pub-id pub-id-type="pmid">942798</pub-id></mixed-citation>
</ref>
<ref id="B153">
<label>153.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haber</surname><given-names>DA</given-names></name>, <name><surname>Schimke</surname><given-names>RT</given-names></name></person-group>
<year>1981</year>
<article-title>Unstable amplification of an altered dihydrofolate reductase gene associated with double-minute chromosomes</article-title>. <source/>Cell
<volume>26</volume>:<fpage>355</fpage>–<lpage>362</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0092-8674(81)90204-X</pub-id>.<pub-id pub-id-type="pmid">7326744</pub-id></mixed-citation>
</ref>
<ref id="B154">
<label>154.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spriggs</surname><given-names>AI</given-names></name>, <name><surname>Boddington</surname><given-names>MM</given-names></name>, <name><surname>Clarke</surname><given-names>CM</given-names></name></person-group>
<year>1962</year>
<article-title>Chromosomes of human cancer cells</article-title>. <source/>Br Med J
<volume>2</volume>:<fpage>1431</fpage>–<lpage>1435</lpage>. doi:<pub-id pub-id-type="doi">10.1136/bmj.2.5317.1431</pub-id>.<pub-id pub-id-type="pmid">13978541</pub-id></mixed-citation>
</ref>
<ref id="B155">
<label>155.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gebhart</surname><given-names>E</given-names></name></person-group>
<year>2005</year>
<article-title>Double minutes, cytogenetic equivalents of gene amplification, in human neoplasia: a review</article-title>. <source/>Clin Transl Oncol
<volume>7</volume>:<fpage>477</fpage>–<lpage>485</lpage>. doi:<pub-id pub-id-type="doi">10.1007/BF02717000</pub-id>.<pub-id pub-id-type="pmid">16373058</pub-id></mixed-citation>
</ref>
<ref id="B156">
<label>156.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunberg</surname><given-names>JH</given-names></name>, <name><surname>Kaufman</surname><given-names>RJ</given-names></name>, <name><surname>Schimke</surname><given-names>RT</given-names></name>, <name><surname>Urlaub</surname><given-names>G</given-names></name>, <name><surname>Chasin</surname><given-names>LA</given-names></name></person-group>
<year>1978</year>
<article-title>Amplified dihydrofolate reductase genes are localized to a homogeneously staining region of a single chromosome in a methotrexate-resistant Chinese hamster ovary cell line</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>75</volume>:<fpage>5553</fpage>–<lpage>5556</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.75.11.5553</pub-id>.<pub-id pub-id-type="pmid">281704</pub-id></mixed-citation>
</ref>
<ref id="B157">
<label>157.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolnick</surname><given-names>BJ</given-names></name>, <name><surname>Berenson</surname><given-names>RJ</given-names></name>, <name><surname>Bertino</surname><given-names>JR</given-names></name>, <name><surname>Kaufman</surname><given-names>RJ</given-names></name>, <name><surname>Nunberg</surname><given-names>JH</given-names></name>, <name><surname>Schimke</surname><given-names>RT</given-names></name></person-group>
<year>1979</year>
<article-title>Correlation of dihydrofolate reductase elevation with gene amplification in a homogeneously staining chromosomal region in L5178Y cells</article-title>. <source/>J Cell Biol
<volume>83</volume>:<fpage>394</fpage>–<lpage>402</lpage>. doi:<pub-id pub-id-type="doi">10.1083/jcb.83.2.394</pub-id>.<pub-id pub-id-type="pmid">500787</pub-id></mixed-citation>
</ref>
<ref id="B158">
<label>158.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufman</surname><given-names>RJ</given-names></name>, <name><surname>Brown</surname><given-names>PC</given-names></name>, <name><surname>Schimke</surname><given-names>RT</given-names></name></person-group>
<year>1979</year>
<article-title>Amplified dihydrofolate reductase genes in unstably methotrexate-resistant cells are associated with double minute chromosomes</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>76</volume>:<fpage>5669</fpage>–<lpage>5673</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.76.11.5669</pub-id>.<pub-id pub-id-type="pmid">293670</pub-id></mixed-citation>
</ref>
<ref id="B159">
<label>159.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>N</given-names></name></person-group>
<year>2009</year>
<article-title>Extrachromosomal double minutes and chromosomal homogeneously staining regions as probes for chromosome research</article-title>. <source/>Cytogenet Genome Res
<volume>124</volume>:<fpage>312</fpage>–<lpage>326</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000218135</pub-id>.<pub-id pub-id-type="pmid">19556783</pub-id></mixed-citation>
</ref>
<ref id="B160">
<label>160.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albertson</surname><given-names>DG</given-names></name></person-group>
<year>2006</year>
<article-title>Gene amplification in cancer</article-title>. <source/>Trends Genet
<volume>22</volume>:<fpage>447</fpage>–<lpage>455</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tig.2006.06.007</pub-id>.<pub-id pub-id-type="pmid">16787682</pub-id></mixed-citation>
</ref>
<ref id="B161">
<label>161.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>X</given-names></name>, <name><surname>Qi</surname><given-names>X</given-names></name>, <name><surname>Guo</surname><given-names>H</given-names></name>, <name><surname>Cai</surname><given-names>M</given-names></name>, <name><surname>Li</surname><given-names>C</given-names></name>, <name><surname>Zhu</surname><given-names>J</given-names></name>, <name><surname>Chen</surname><given-names>F</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>P</given-names></name>, <name><surname>Jia</surname><given-names>X</given-names></name>, <name><surname>Yu</surname><given-names>J</given-names></name>, <name><surname>Zhang</surname><given-names>C</given-names></name>, <name><surname>Sun</surname><given-names>W</given-names></name>, <name><surname>Yu</surname><given-names>Y</given-names></name>, <name><surname>Jin</surname><given-names>Y</given-names></name>, <name><surname>Bai</surname><given-names>J</given-names></name>, <name><surname>Wang</surname><given-names>M</given-names></name>, <name><surname>Rosales</surname><given-names>J</given-names></name>, <name><surname>Lee</surname><given-names>KY</given-names></name>, <name><surname>Fu</surname><given-names>S</given-names></name></person-group>
<year>2015</year>
<article-title>Novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells</article-title>. <source/>J Med Genet
<volume>52</volume>:<fpage>135</fpage>–<lpage>144</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jmedgenet-2014-102703</pub-id>.<pub-id pub-id-type="pmid">25537274</pub-id></mixed-citation>
</ref>
<ref id="B162">
<label>162.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storlazzi</surname><given-names>CT</given-names></name>, <name><surname>Lonoce</surname><given-names>A</given-names></name>, <name><surname>Guastadisegni</surname><given-names>MC</given-names></name>, <name><surname>Trombetta</surname><given-names>D</given-names></name>, <name><surname>D'Addabbo</surname><given-names>P</given-names></name>, <name><surname>Daniele</surname><given-names>G</given-names></name>, <name><surname>L'Abbate</surname><given-names>A</given-names></name>, <name><surname>Macchia</surname><given-names>G</given-names></name>, <name><surname>Surace</surname><given-names>C</given-names></name>, <name><surname>Kok</surname><given-names>K</given-names></name>, <name><surname>Ullmann</surname><given-names>R</given-names></name>, <name><surname>Purgato</surname><given-names>S</given-names></name>, <name><surname>Palumbo</surname><given-names>O</given-names></name>, <name><surname>Carella</surname><given-names>M</given-names></name>, <name><surname>Ambros</surname><given-names>PF</given-names></name>, <name><surname>Rocchi</surname><given-names>M</given-names></name></person-group>
<year>2010</year>
<article-title>Gene amplification as double minutes or homogeneously staining regions in solid tumors: origin and structure</article-title>. <source/>Genome Res
<volume>20</volume>:<fpage>1198</fpage>–<lpage>1206</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gr.106252.110</pub-id>.<pub-id pub-id-type="pmid">20631050</pub-id></mixed-citation>
</ref>
<ref id="B163">
<label>163.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambros</surname><given-names>IM</given-names></name>, <name><surname>Rumpler</surname><given-names>S</given-names></name>, <name><surname>Luegmayr</surname><given-names>A</given-names></name>, <name><surname>Hattinger</surname><given-names>CM</given-names></name>, <name><surname>Strehl</surname><given-names>S</given-names></name>, <name><surname>Kovar</surname><given-names>H</given-names></name>, <name><surname>Gadner</surname><given-names>H</given-names></name>, <name><surname>Ambros</surname><given-names>PF</given-names></name></person-group>
<year>1997</year>
<article-title>Neuroblastoma cells can actively eliminate supernumerary MYCN gene copies by micronucleus formation: sign of tumour cell revertance?</article-title>
<source/>Eur J Cancer
<volume>33</volume>:<fpage>2043</fpage>–<lpage>2049</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0959-8049(97)00204-9</pub-id>.<pub-id pub-id-type="pmid">9516850</pub-id></mixed-citation>
</ref>
<ref id="B164">
<label>164.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narath</surname><given-names>R</given-names></name>, <name><surname>Ambros</surname><given-names>IM</given-names></name>, <name><surname>Kowalska</surname><given-names>A</given-names></name>, <name><surname>Bozsaky</surname><given-names>E</given-names></name>, <name><surname>Boukamp</surname><given-names>P</given-names></name>, <name><surname>Ambros</surname><given-names>PF</given-names></name></person-group>
<year>2007</year>
<article-title>Induction of senescence in MYCN amplified neuroblastoma cell lines by hydroxyurea</article-title>. <source/>Genes Chromosomes Cancer
<volume>46</volume>:<fpage>130</fpage>–<lpage>142</lpage>. doi:<pub-id pub-id-type="doi">10.1002/gcc.20393</pub-id>.<pub-id pub-id-type="pmid">17106870</pub-id></mixed-citation>
</ref>
<ref id="B165">
<label>165.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balaban-Malenbaum</surname><given-names>G</given-names></name>, <name><surname>Gilbert</surname><given-names>F</given-names></name></person-group>
<year>1977</year>
<article-title>Double minute chromosomes and the homogeneously staining regions in chromosomes of a human neuroblastoma cell line</article-title>. <source/>Science
<volume>198</volume>:<fpage>739</fpage>–<lpage>741</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.71759</pub-id>.<pub-id pub-id-type="pmid">71759</pub-id></mixed-citation>
</ref>
<ref id="B166">
<label>166.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benner</surname><given-names>SE</given-names></name>, <name><surname>Wahl</surname><given-names>GM</given-names></name>, <name><surname>Von Hoff</surname><given-names>DD</given-names></name></person-group>
<year>1991</year>
<article-title>Double minute chromosomes and homogeneously staining regions in tumors taken directly from patients versus in human tumor cell lines</article-title>. <source/>Anticancer Drugs
<volume>2</volume>:<fpage>11</fpage>–<lpage>25</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00001813-199102000-00002</pub-id>.<pub-id pub-id-type="pmid">1720337</pub-id></mixed-citation>
</ref>
<ref id="B167">
<label>167.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>JL</given-names></name>, <name><surname>Walsh</surname><given-names>JT</given-names></name>, <name><surname>Degen</surname><given-names>DR</given-names></name>, <name><surname>Drabek</surname><given-names>SM</given-names></name>, <name><surname>McGill</surname><given-names>JR</given-names></name>, <name><surname>von Hoff</surname><given-names>DD</given-names></name></person-group>
<year>1993</year>
<article-title>Evidence of gene amplification in the form of double minute chromosomes is frequently observed in lung cancer</article-title>. <source/>Cancer Genet Cytogenet
<volume>65</volume>:<fpage>120</fpage>–<lpage>124</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0165-4608(93)90219-C</pub-id>.<pub-id pub-id-type="pmid">8384074</pub-id></mixed-citation>
</ref>
<ref id="B168">
<label>168.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwab</surname><given-names>M</given-names></name>, <name><surname>Alitalo</surname><given-names>K</given-names></name>, <name><surname>Klempnauer</surname><given-names>KH</given-names></name>, <name><surname>Varmus</surname><given-names>HE</given-names></name>, <name><surname>Bishop</surname><given-names>JM</given-names></name>, <name><surname>Gilbert</surname><given-names>F</given-names></name>, <name><surname>Brodeur</surname><given-names>G</given-names></name>, <name><surname>Goldstein</surname><given-names>M</given-names></name>, <name><surname>Trent</surname><given-names>J</given-names></name></person-group>
<year>1983</year>
<article-title>Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour</article-title>. <source/>Nature
<volume>305</volume>:<fpage>245</fpage>–<lpage>248</lpage>. doi:<pub-id pub-id-type="doi">10.1038/305245a0</pub-id>.<pub-id pub-id-type="pmid">6888561</pub-id></mixed-citation>
</ref>
<ref id="B169">
<label>169.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Von Hoff</surname><given-names>DD</given-names></name>, <name><surname>McGill</surname><given-names>JR</given-names></name>, <name><surname>Forseth</surname><given-names>BJ</given-names></name>, <name><surname>Davidson</surname><given-names>KK</given-names></name>, <name><surname>Bradley</surname><given-names>TP</given-names></name>, <name><surname>Van Devanter</surname><given-names>DR</given-names></name>, <name><surname>Wahl</surname><given-names>GM</given-names></name></person-group>
<year>1992</year>
<article-title>Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>89</volume>:<fpage>8165</fpage>–<lpage>8169</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.89.17.8165</pub-id>.<pub-id pub-id-type="pmid">1518843</pub-id></mixed-citation>
</ref>
<ref id="B170">
<label>170.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckhardt</surname><given-names>SG</given-names></name>, <name><surname>Dai</surname><given-names>A</given-names></name>, <name><surname>Davidson</surname><given-names>KK</given-names></name>, <name><surname>Forseth</surname><given-names>BJ</given-names></name>, <name><surname>Wahl</surname><given-names>GM</given-names></name>, <name><surname>Von Hoff</surname><given-names>DD</given-names></name></person-group>
<year>1994</year>
<article-title>Induction of differentiation in HL60 cells by the reduction of extrachromosomally amplified c-myc</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>91</volume>:<fpage>6674</fpage>–<lpage>6678</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.91.14.6674</pub-id>.<pub-id pub-id-type="pmid">8022834</pub-id></mixed-citation>
</ref>
<ref id="B171">
<label>171.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nathanson</surname><given-names>DA</given-names></name>, <name><surname>Gini</surname><given-names>B</given-names></name>, <name><surname>Mottahedeh</surname><given-names>J</given-names></name>, <name><surname>Visnyei</surname><given-names>K</given-names></name>, <name><surname>Koga</surname><given-names>T</given-names></name>, <name><surname>Gomez</surname><given-names>G</given-names></name>, <name><surname>Eskin</surname><given-names>A</given-names></name>, <name><surname>Hwang</surname><given-names>K</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Masui</surname><given-names>K</given-names></name>, <name><surname>Paucar</surname><given-names>A</given-names></name>, <name><surname>Yang</surname><given-names>H</given-names></name>, <name><surname>Ohashi</surname><given-names>M</given-names></name>, <name><surname>Zhu</surname><given-names>S</given-names></name>, <name><surname>Wykosky</surname><given-names>J</given-names></name>, <name><surname>Reed</surname><given-names>R</given-names></name>, <name><surname>Nelson</surname><given-names>SF</given-names></name>, <name><surname>Cloughesy</surname><given-names>TF</given-names></name>, <name><surname>James</surname><given-names>CD</given-names></name>, <name><surname>Rao</surname><given-names>PN</given-names></name>, <name><surname>Kornblum</surname><given-names>HI</given-names></name>, <name><surname>Heath</surname><given-names>JR</given-names></name>, <name><surname>Cavenee</surname><given-names>WK</given-names></name>, <name><surname>Furnari</surname><given-names>FB</given-names></name>, <name><surname>Mischel</surname><given-names>PS</given-names></name></person-group>
<year>2014</year>
<article-title>Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA</article-title>. <source/>Science
<volume>343</volume>:<fpage>72</fpage>–<lpage>76</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1241328</pub-id>.<pub-id pub-id-type="pmid">24310612</pub-id></mixed-citation>
</ref>
<ref id="B172">
<label>172.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gajadhar</surname><given-names>AS</given-names></name>, <name><surname>Bogdanovic</surname><given-names>E</given-names></name>, <name><surname>Munoz</surname><given-names>DM</given-names></name>, <name><surname>Guha</surname><given-names>A</given-names></name></person-group>
<year>2012</year>
<article-title>In situ analysis of mutant EGFRs prevalent in glioblastoma multiforme reveals aberrant dimerization, activation, and differential response to anti-EGFR targeted therapy</article-title>. <source/>Mol Cancer Res
<volume>10</volume>:<fpage>428</fpage>–<lpage>440</lpage>. doi:<pub-id pub-id-type="doi">10.1158/1541-7786.MCR-11-0531</pub-id>.<pub-id pub-id-type="pmid">22232519</pub-id></mixed-citation>
</ref>
<ref id="B173">
<label>173.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vivanco</surname><given-names>I</given-names></name>, <name><surname>Robins</surname><given-names>HI</given-names></name>, <name><surname>Rohle</surname><given-names>D</given-names></name>, <name><surname>Campos</surname><given-names>C</given-names></name>, <name><surname>Grommes</surname><given-names>C</given-names></name>, <name><surname>Nghiemphu</surname><given-names>PL</given-names></name>, <name><surname>Kubek</surname><given-names>S</given-names></name>, <name><surname>Oldrini</surname><given-names>B</given-names></name>, <name><surname>Chheda</surname><given-names>MG</given-names></name>, <name><surname>Yannuzzi</surname><given-names>N</given-names></name>, <name><surname>Tao</surname><given-names>H</given-names></name>, <name><surname>Zhu</surname><given-names>S</given-names></name>, <name><surname>Iwanami</surname><given-names>A</given-names></name>, <name><surname>Kuga</surname><given-names>D</given-names></name>, <name><surname>Dang</surname><given-names>J</given-names></name>, <name><surname>Pedraza</surname><given-names>A</given-names></name>, <name><surname>Brennan</surname><given-names>CW</given-names></name>, <name><surname>Heguy</surname><given-names>A</given-names></name>, <name><surname>Liau</surname><given-names>LM</given-names></name>, <name><surname>Lieberman</surname><given-names>F</given-names></name>, <name><surname>Yung</surname><given-names>WK</given-names></name>, <name><surname>Gilbert</surname><given-names>MR</given-names></name>, <name><surname>Reardon</surname><given-names>DA</given-names></name>, <name><surname>Drappatz</surname><given-names>J</given-names></name>, <name><surname>Wen</surname><given-names>PY</given-names></name>, <name><surname>Lamborn</surname><given-names>KR</given-names></name>, <name><surname>Chang</surname><given-names>SM</given-names></name>, <name><surname>Prados</surname><given-names>MD</given-names></name>, <name><surname>Fine</surname><given-names>HA</given-names></name>, <name><surname>Horvath</surname><given-names>S</given-names></name>, <name><surname>Wu</surname><given-names>N</given-names></name>, <name><surname>Lassman</surname><given-names>AB</given-names></name>, <name><surname>DeAngelis</surname><given-names>LM</given-names></name>, <name><surname>Yong</surname><given-names>WH</given-names></name>, <name><surname>Kuhn</surname><given-names>JG</given-names></name>, <name><surname>Mischel</surname><given-names>PS</given-names></name>, <name><surname>Mehta</surname><given-names>MP</given-names></name>, <name><surname>Cloughesy</surname><given-names>TF</given-names></name>, <name><surname>Mellinghoff</surname><given-names>IK</given-names></name></person-group>
<year>2012</year>
<article-title>Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors</article-title>. <source/>Cancer Discov
<volume>2</volume>:<fpage>458</fpage>–<lpage>471</lpage>. doi:<pub-id pub-id-type="doi">10.1158/2159-8290.CD-11-0284</pub-id>.<pub-id pub-id-type="pmid">22588883</pub-id></mixed-citation>
</ref>
<ref id="B174">
<label>174.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>JC</given-names></name>, <name><surname>Atabakhsh</surname><given-names>E</given-names></name>, <name><surname>Kim</surname><given-names>J</given-names></name>, <name><surname>Biette</surname><given-names>KM</given-names></name>, <name><surname>Van Rechem</surname><given-names>C</given-names></name>, <name><surname>Ladd</surname><given-names>B</given-names></name>, <name><surname>Burrowes</surname><given-names>PD</given-names></name>, <name><surname>Donado</surname><given-names>C</given-names></name>, <name><surname>Mattoo</surname><given-names>H</given-names></name>, <name><surname>Kleinstiver</surname><given-names>BP</given-names></name>, <name><surname>Song</surname><given-names>B</given-names></name>, <name><surname>Andriani</surname><given-names>G</given-names></name>, <name><surname>Joung</surname><given-names>JK</given-names></name>, <name><surname>Iliopoulos</surname><given-names>O</given-names></name>, <name><surname>Montagna</surname><given-names>C</given-names></name>, <name><surname>Pillai</surname><given-names>S</given-names></name>, <name><surname>Getz</surname><given-names>G</given-names></name>, <name><surname>Whetstine</surname><given-names>JR</given-names></name></person-group>
<year>2015</year>
<article-title>Hypoxia drives transient site-specific copy gain and drug-resistant gene expression</article-title>. <source/>Genes Dev
<volume>29</volume>:<fpage>1018</fpage>–<lpage>1031</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.259796.115</pub-id>.<pub-id pub-id-type="pmid">25995187</pub-id></mixed-citation>
</ref>
<ref id="B175">
<label>175.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>JC</given-names></name>, <name><surname>Manning</surname><given-names>AL</given-names></name>, <name><surname>Van Rechem</surname><given-names>C</given-names></name>, <name><surname>Kim</surname><given-names>J</given-names></name>, <name><surname>Ladd</surname><given-names>B</given-names></name>, <name><surname>Cho</surname><given-names>J</given-names></name>, <name><surname>Pineda</surname><given-names>CM</given-names></name>, <name><surname>Murphy</surname><given-names>N</given-names></name>, <name><surname>Daniels</surname><given-names>DL</given-names></name>, <name><surname>Montagna</surname><given-names>C</given-names></name>, <name><surname>Lewis</surname><given-names>PW</given-names></name>, <name><surname>Glass</surname><given-names>K</given-names></name>, <name><surname>Allis</surname><given-names>CD</given-names></name>, <name><surname>Dyson</surname><given-names>NJ</given-names></name>, <name><surname>Getz</surname><given-names>G</given-names></name>, <name><surname>Whetstine</surname><given-names>JR</given-names></name></person-group>
<year>2013</year>
<article-title>KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors</article-title>. <source/>Cell
<volume>154</volume>:<fpage>541</fpage>–<lpage>555</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2013.06.051</pub-id>.<pub-id pub-id-type="pmid">23871696</pub-id></mixed-citation>
</ref>
<ref id="B176">
<label>176.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacAlpine</surname><given-names>DM</given-names></name>, <name><surname>Almouzni</surname><given-names>G</given-names></name></person-group>
<year>2013</year>
<article-title>Chromatin and DNA replication</article-title>. <source/>Cold Spring Harb Perspect Biol
<volume>5</volume>:<fpage>a010207</fpage>. doi:<pub-id pub-id-type="doi">10.1101/cshperspect.a010207</pub-id>.<pub-id pub-id-type="pmid">23751185</pub-id></mixed-citation>
</ref>
<ref id="B177">
<label>177.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Truong</surname><given-names>LN</given-names></name>, <name><surname>Wu</surname><given-names>X</given-names></name></person-group>
<year>2011</year>
<article-title>Prevention of DNA re-replication in eukaryotic cells</article-title>. <source/>J Mol Cell Biol
<volume>3</volume>:<fpage>13</fpage>–<lpage>22</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jmcb/mjq052</pub-id>.<pub-id pub-id-type="pmid">21278447</pub-id></mixed-citation>
</ref>
<ref id="B178">
<label>178.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name>, <name><surname>Zang</surname><given-names>J</given-names></name>, <name><surname>Whetstine</surname><given-names>J</given-names></name>, <name><surname>Hong</surname><given-names>X</given-names></name>, <name><surname>Davrazou</surname><given-names>F</given-names></name>, <name><surname>Kutateladze</surname><given-names>TG</given-names></name>, <name><surname>Simpson</surname><given-names>M</given-names></name>, <name><surname>Mao</surname><given-names>Q</given-names></name>, <name><surname>Pan</surname><given-names>CH</given-names></name>, <name><surname>Dai</surname><given-names>S</given-names></name>, <name><surname>Hagman</surname><given-names>J</given-names></name>, <name><surname>Hansen</surname><given-names>K</given-names></name>, <name><surname>Shi</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>G</given-names></name></person-group>
<year>2006</year>
<article-title>Structural insights into histone demethylation by JMJD2 family members</article-title>. <source/>Cell
<volume>125</volume>:<fpage>691</fpage>–<lpage>702</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2006.04.024</pub-id>.<pub-id pub-id-type="pmid">16677698</pub-id></mixed-citation>
</ref>
<ref id="B179">
<label>179.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whetstine</surname><given-names>JR</given-names></name>, <name><surname>Nottke</surname><given-names>A</given-names></name>, <name><surname>Lan</surname><given-names>F</given-names></name>, <name><surname>Huarte</surname><given-names>M</given-names></name>, <name><surname>Smolikov</surname><given-names>S</given-names></name>, <name><surname>Chen</surname><given-names>Z</given-names></name>, <name><surname>Spooner</surname><given-names>E</given-names></name>, <name><surname>Li</surname><given-names>E</given-names></name>, <name><surname>Zhang</surname><given-names>G</given-names></name>, <name><surname>Colaiacovo</surname><given-names>M</given-names></name>, <name><surname>Shi</surname><given-names>Y</given-names></name></person-group>
<year>2006</year>
<article-title>Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases</article-title>. <source/>Cell
<volume>125</volume>:<fpage>467</fpage>–<lpage>481</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2006.03.028</pub-id>.<pub-id pub-id-type="pmid">16603238</pub-id></mixed-citation>
</ref>
<ref id="B180">
<label>180.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cloos</surname><given-names>PA</given-names></name>, <name><surname>Christensen</surname><given-names>J</given-names></name>, <name><surname>Agger</surname><given-names>K</given-names></name>, <name><surname>Maiolica</surname><given-names>A</given-names></name>, <name><surname>Rappsilber</surname><given-names>J</given-names></name>, <name><surname>Antal</surname><given-names>T</given-names></name>, <name><surname>Hansen</surname><given-names>KH</given-names></name>, <name><surname>Helin</surname><given-names>K</given-names></name></person-group>
<year>2006</year>
<article-title>The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3</article-title>. <source/>Nature
<volume>442</volume>:<fpage>307</fpage>–<lpage>311</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature04837</pub-id>.<pub-id pub-id-type="pmid">16732293</pub-id></mixed-citation>
</ref>
<ref id="B181">
<label>181.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klose</surname><given-names>RJ</given-names></name>, <name><surname>Yamane</surname><given-names>K</given-names></name>, <name><surname>Bae</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>D</given-names></name>, <name><surname>Erdjument-Bromage</surname><given-names>H</given-names></name>, <name><surname>Tempst</surname><given-names>P</given-names></name>, <name><surname>Wong</surname><given-names>J</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name></person-group>
<year>2006</year>
<article-title>The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36</article-title>. <source/>Nature
<volume>442</volume>:<fpage>312</fpage>–<lpage>316</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature04853</pub-id>.<pub-id pub-id-type="pmid">16732292</pub-id></mixed-citation>
</ref>
<ref id="B182">
<label>182.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lan</surname><given-names>F</given-names></name>, <name><surname>Nottke</surname><given-names>AC</given-names></name>, <name><surname>Shi</surname><given-names>Y</given-names></name></person-group>
<year>2008</year>
<article-title>Mechanisms involved in the regulation of histone lysine demethylases</article-title>. <source/>Curr Opin Cell Biol
<volume>20</volume>:<fpage>316</fpage>–<lpage>325</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ceb.2008.03.004</pub-id>.<pub-id pub-id-type="pmid">18440794</pub-id></mixed-citation>
</ref>
<ref id="B183">
<label>183.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>JC</given-names></name>, <name><surname>Allen</surname><given-names>A</given-names></name>, <name><surname>Van Rechem</surname><given-names>C</given-names></name>, <name><surname>Forbes</surname><given-names>E</given-names></name>, <name><surname>Longworth</surname><given-names>M</given-names></name>, <name><surname>Tschop</surname><given-names>K</given-names></name>, <name><surname>Rinehart</surname><given-names>C</given-names></name>, <name><surname>Quiton</surname><given-names>J</given-names></name>, <name><surname>Walsh</surname><given-names>R</given-names></name>, <name><surname>Smallwood</surname><given-names>A</given-names></name>, <name><surname>Dyson</surname><given-names>NJ</given-names></name>, <name><surname>Whetstine</surname><given-names>JR</given-names></name></person-group>
<year>2010</year>
<article-title>Conserved antagonism between JMJD2A/KDM4A and HP1γ during cell cycle progression</article-title>. <source/>Mol Cell
<volume>40</volume>:<fpage>736</fpage>–<lpage>748</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molcel.2010.11.008</pub-id>.<pub-id pub-id-type="pmid">21145482</pub-id></mixed-citation>
</ref>
<ref id="B184">
<label>184.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>JC</given-names></name>, <name><surname>Whetstine</surname><given-names>JR</given-names></name></person-group>
<year>2015</year>
<article-title>Too little O<sub>2</sub> too much gain</article-title>. <source/>Cell Cycle
<volume>14</volume>:<fpage>2869</fpage>–<lpage>2870</lpage>. doi:<pub-id pub-id-type="doi">10.1080/15384101.2015.1076659</pub-id>.<pub-id pub-id-type="pmid">26221746</pub-id></mixed-citation>
</ref>
<ref id="B185">
<label>185.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin-Ezquerra</surname><given-names>G</given-names></name>, <name><surname>Salgado</surname><given-names>R</given-names></name>, <name><surname>Toll</surname><given-names>A</given-names></name>, <name><surname>Baro</surname><given-names>T</given-names></name>, <name><surname>Mojal</surname><given-names>S</given-names></name>, <name><surname>Yebenes</surname><given-names>M</given-names></name>, <name><surname>Garcia-Muret</surname><given-names>MP</given-names></name>, <name><surname>Sole</surname><given-names>F</given-names></name>, <name><surname>Quitllet</surname><given-names>FA</given-names></name>, <name><surname>Espinet</surname><given-names>B</given-names></name>, <name><surname>Pujol</surname><given-names>RM</given-names></name></person-group>
<year>2011</year>
<article-title>CDC28 protein kinase regulatory subunit 1B (CKS1B) expression and genetic status analysis in oral squamous cell carcinoma</article-title>. <source/>Histol Histopathol
<volume>26</volume>:<fpage>71</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">21117028</pub-id></mixed-citation>
</ref>
<ref id="B186">
<label>186.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>EH</given-names></name>, <name><surname>Janknecht</surname><given-names>R</given-names></name>, <name><surname>Maher</surname><given-names>LJ</given-names><suffix>III</suffix></name></person-group>
<year>2007</year>
<article-title>Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma</article-title>. <source/>Hum Mol Genet
<volume>16</volume>:<fpage>3136</fpage>–<lpage>3148</lpage>. doi:<pub-id pub-id-type="doi">10.1093/hmg/ddm275</pub-id>.<pub-id pub-id-type="pmid">17884808</pub-id></mixed-citation>
</ref>
<ref id="B187">
<label>187.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nik-Zainal</surname><given-names>S</given-names></name>, <name><surname>Van Loo</surname><given-names>P</given-names></name>, <name><surname>Wedge</surname><given-names>DC</given-names></name>, <name><surname>Alexandrov</surname><given-names>LB</given-names></name>, <name><surname>Greenman</surname><given-names>CD</given-names></name>, <name><surname>Lau</surname><given-names>KW</given-names></name>, <name><surname>Raine</surname><given-names>K</given-names></name>, <name><surname>Jones</surname><given-names>D</given-names></name>, <name><surname>Marshall</surname><given-names>J</given-names></name>, <name><surname>Ramakrishna</surname><given-names>M</given-names></name>, <name><surname>Shlien</surname><given-names>A</given-names></name>, <name><surname>Cooke</surname><given-names>SL</given-names></name>, <name><surname>Hinton</surname><given-names>J</given-names></name>, <name><surname>Menzies</surname><given-names>A</given-names></name>, <name><surname>Stebbings</surname><given-names>LA</given-names></name>, <name><surname>Leroy</surname><given-names>C</given-names></name>, <name><surname>Jia</surname><given-names>M</given-names></name>, <name><surname>Rance</surname><given-names>R</given-names></name>, <name><surname>Mudie</surname><given-names>LJ</given-names></name>, <name><surname>Gamble</surname><given-names>SJ</given-names></name>, <name><surname>Stephens</surname><given-names>PJ</given-names></name>, <name><surname>McLaren</surname><given-names>S</given-names></name>, <name><surname>Tarpey</surname><given-names>PS</given-names></name>, <name><surname>Papaemmanuil</surname><given-names>E</given-names></name>, <name><surname>Davies</surname><given-names>HR</given-names></name>, <name><surname>Varela</surname><given-names>I</given-names></name>, <name><surname>McBride</surname><given-names>DJ</given-names></name>, <name><surname>Bignell</surname><given-names>GR</given-names></name>, <name><surname>Leung</surname><given-names>K</given-names></name>, <name><surname>Butler</surname><given-names>AP</given-names></name>, <name><surname>Teague</surname><given-names>JW</given-names></name>, <name><surname>Martin</surname><given-names>S</given-names></name>, <name><surname>Jonsson</surname><given-names>G</given-names></name>, <name><surname>Mariani</surname><given-names>O</given-names></name>, <name><surname>Boyault</surname><given-names>S</given-names></name>, <name><surname>Miron</surname><given-names>P</given-names></name>, <name><surname>Fatima</surname><given-names>A</given-names></name>, <name><surname>Langerod</surname><given-names>A</given-names></name>, <name><surname>Aparicio</surname><given-names>SA</given-names></name>, <name><surname>Tutt</surname><given-names>A</given-names></name>, <name><surname>Sieuwerts</surname><given-names>AM</given-names></name>, <name><surname>Borg</surname><given-names>A</given-names></name>, <name><surname>Thomas</surname><given-names>G</given-names></name>, <name><surname>Salomon</surname><given-names>AV</given-names></name>, <name><surname>Richardson</surname><given-names>AL</given-names></name>, <name><surname>Borresen-Dale</surname><given-names>AL</given-names></name>, <name><surname>Futreal</surname><given-names>PA</given-names></name>, <name><surname>Stratton</surname><given-names>MR</given-names></name>, <name><surname>Campbell</surname><given-names>PJ</given-names></name></person-group>
<year>2012</year>
<article-title>The life history of 21 breast cancers</article-title>. <source/>Cell
<volume>149</volume>:<fpage>994</fpage>–<lpage>1007</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2012.04.023</pub-id>.<pub-id pub-id-type="pmid">22608083</pub-id></mixed-citation>
</ref>
<ref id="B188">
<label>188.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrison</surname><given-names>CD</given-names></name>, <name><surname>Liu</surname><given-names>P</given-names></name>, <name><surname>Woloszynska-Read</surname><given-names>A</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Luo</surname><given-names>W</given-names></name>, <name><surname>Qin</surname><given-names>M</given-names></name>, <name><surname>Bshara</surname><given-names>W</given-names></name>, <name><surname>Conroy</surname><given-names>JM</given-names></name>, <name><surname>Sabatini</surname><given-names>L</given-names></name>, <name><surname>Vedell</surname><given-names>P</given-names></name>, <name><surname>Xiong</surname><given-names>D</given-names></name>, <name><surname>Liu</surname><given-names>S</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Shen</surname><given-names>H</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Omilian</surname><given-names>AR</given-names></name>, <name><surname>Hill</surname><given-names>A</given-names></name>, <name><surname>Head</surname><given-names>K</given-names></name>, <name><surname>Guru</surname><given-names>K</given-names></name>, <name><surname>Kunnev</surname><given-names>D</given-names></name>, <name><surname>Leach</surname><given-names>R</given-names></name>, <name><surname>Eng</surname><given-names>KH</given-names></name>, <name><surname>Darlak</surname><given-names>C</given-names></name>, <name><surname>Hoeflich</surname><given-names>C</given-names></name>, <name><surname>Veeranki</surname><given-names>S</given-names></name>, <name><surname>Glenn</surname><given-names>S</given-names></name>, <name><surname>You</surname><given-names>M</given-names></name>, <name><surname>Pruitt</surname><given-names>SC</given-names></name>, <name><surname>Johnson</surname><given-names>CS</given-names></name>, <name><surname>Trump</surname><given-names>DL</given-names></name></person-group>
<year>2014</year>
<article-title>Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancer</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>111</volume>:<fpage>E672</fpage>–<lpage>E681</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1313580111</pub-id>.<pub-id pub-id-type="pmid">24469795</pub-id></mixed-citation>
</ref>
<ref id="B189">
<label>189.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burrell</surname><given-names>RA</given-names></name>, <name><surname>McGranahan</surname><given-names>N</given-names></name>, <name><surname>Bartek</surname><given-names>J</given-names></name>, <name><surname>Swanton</surname><given-names>C</given-names></name></person-group>
<year>2013</year>
<article-title>The causes and consequences of genetic heterogeneity in cancer evolution</article-title>. <source/>Nature
<volume>501</volume>:<fpage>338</fpage>–<lpage>345</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature12625</pub-id>.<pub-id pub-id-type="pmid">24048066</pub-id></mixed-citation>
</ref>
<ref id="B190">
<label>190.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landau</surname><given-names>DA</given-names></name>, <name><surname>Carter</surname><given-names>SL</given-names></name>, <name><surname>Stojanov</surname><given-names>P</given-names></name>, <name><surname>McKenna</surname><given-names>A</given-names></name>, <name><surname>Stevenson</surname><given-names>K</given-names></name>, <name><surname>Lawrence</surname><given-names>MS</given-names></name>, <name><surname>Sougnez</surname><given-names>C</given-names></name>, <name><surname>Stewart</surname><given-names>C</given-names></name>, <name><surname>Sivachenko</surname><given-names>A</given-names></name>, <name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Wan</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>W</given-names></name>, <name><surname>Shukla</surname><given-names>SA</given-names></name>, <name><surname>Vartanov</surname><given-names>A</given-names></name>, <name><surname>Fernandes</surname><given-names>SM</given-names></name>, <name><surname>Saksena</surname><given-names>G</given-names></name>, <name><surname>Cibulskis</surname><given-names>K</given-names></name>, <name><surname>Tesar</surname><given-names>B</given-names></name>, <name><surname>Gabriel</surname><given-names>S</given-names></name>, <name><surname>Hacohen</surname><given-names>N</given-names></name>, <name><surname>Meyerson</surname><given-names>M</given-names></name>, <name><surname>Lander</surname><given-names>ES</given-names></name>, <name><surname>Neuberg</surname><given-names>D</given-names></name>, <name><surname>Brown</surname><given-names>JR</given-names></name>, <name><surname>Getz</surname><given-names>G</given-names></name>, <name><surname>Wu</surname><given-names>CJ</given-names></name></person-group>
<year>2013</year>
<article-title>Evolution and impact of subclonal mutations in chronic lymphocytic leukemia</article-title>. <source/>Cell
<volume>152</volume>:<fpage>714</fpage>–<lpage>726</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2013.01.019</pub-id>.<pub-id pub-id-type="pmid">23415222</pub-id></mixed-citation>
</ref>
<ref id="B191">
<label>191.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>JC</given-names></name>, <name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Kim</surname><given-names>J</given-names></name>, <name><surname>Getz</surname><given-names>G</given-names></name>, <name><surname>Whetstine</surname><given-names>JR</given-names></name></person-group>
<month>11</month>
<month>1</month>
<year>2016</year>
<article-title>Regulation of transient site-specific copy gain by microRNA</article-title>. <source/>J Biol Chem doi:<pub-id pub-id-type="doi">10.1074/jbc.M115.711648</pub-id>.</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>